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Abstract
The human specific pathogen Neisseria meningitidis is a major cause of bacterial 
sepsis and meningitis. Effective vaccines have been developed against group A and 
C strains, but as yet there is no suitable vaccine available for group B N. 
meningitidis. The activation of Dendritic Cells (DCs) is fundamental to the initiation 
of an immune response. Microorganisms and microbial products induce DC 
maturation, including expression of co-stimulatory molecules, HLA molecules, 
chemokine receptors and cytokines. Maturation and migration of DCs to secondary 
lymphoid organs is required for the optimal induction of T-lymphocyte responses. 
This study investigated the importance of lipopolysaccharide (LPS) in the human 
pathogen N. meningitidis for DC maturation, migration and activation of T cells. DCs 
activated with wild type N. meningitidis increased expression of co-stimulatory 
molecules and HLA-DR, and produced high levels of cytokines (TNFa and IL-12). 
Expression of the chemokine receptor CCR7 was increased and DCs migrated in 
response to the chemokine MIP3|3 and showed enhanced migration through an 
endothelial monolayer. In co-culture experiments, T cell proliferation was enhanced 
by DCs that had been activated with wild type bacteria. In addition, T cell IFNy 
production was increased and IL-4/IL-13 decreased compared to controls, this is 
consistent with Thl differentiation. In contrast, although DCs activated by the LPS 
deficient isogenic mutant IpxA- increased expression of co-stimulatory molecules and 
HLA-DR, they produced less cytokines (TNFa and IL-1) than DCs stimulated with 
wild type bacteria and little or no IL-12. In addition, they did not increase expression 
of CCR7 or migrate in the presence of MIP3|3. DCs stimulated with IpxA- were able 
to activate T cells to proliferate but did not induce Thl differentiation. TLR4 has 
been shown to be important for responses to LPS but the Asp299Gly polymorphism 
described in humans was found not to affect monocyte responses to wild type N. 
meningitidis. These findings have important implications for vaccine design to group 
B N. meningitidis and suggest that in vitro responses to DCs may be used as a 
surrogate for in vivo immunisation experiments to test vaccine efficacy.
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Chapter 1 Introduction
1.1 Host defence
All multi-cellular organisms have some form of defence system to protect the host 
from invading pathogens. In vertebrates host defence has traditionally been divided 
into two components, the innate and the adaptive immune systems. The adaptive 
immune system is exclusive to vertebrates and is composed of two major cell types, 
T and B lymphocytes. The receptors for both T and B lymphocytes are generated 
somatically during development by gene rearrangement, resulting in a large and 
diverse repertoire of antigen receptors. Following recognition of specific antigen by a 
receptor clonal expansion of lymphocytes occurs. This is essential in generating an 
efficient immune response. Clonal expansion is the proliferation and differentiation 
of lymphocytes into effector cells. The persistence of long lived memory 
lymphocytes after an initial infection results in future protection by rapid responses 
to subsequent infections by the same pathogen.
Adaptive immunity is restricted to vertebrates but the ability to recognise and defend 
against invading pathogens is common to all multi-cellular organisms and is known 
as innate immunity. The innate immune system is dependent on a limited number of 
germ line encoded receptors. As a result of this limitation, receptors of the innate 
immune system have evolved to recognise molecular structures on pathogens that are 
common to a large number of micro-organisms. These molecular structures are 
conserved products of microbial metabolism that are essential for the survival or 
pathogenicity of the micro-organism and thus are not subject to change. The 
molecular structures recognised by the innate immune system have been designated 
pathogen associated molecular patterns (PAMPs) (Janeway-CA J., 1998)(Medzhitov 
R. et al., 1997). Examples of PAMPs include the lipopolysaccharides of Gram-
15
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negative bacteria, the teichoic acids of Gram-positive bacteria, unmethylated CpG 
motifs characteristic of bacterial DNA, double stranded RNA found in viruses, and 
mannans of yeast cell walls (reviewed in (Medzhitov R. et al., 1997)). The receptors 
of the innate immune system, which recognise the conserved patterns on microbes 
are called pattern recognition receptors (PRRs) (Janeway-CA J., 1998) (Medzhitov R. 
et al., 1997). Examples include mannose binding lectin (MBL), mannose receptor, 
DEC-205, CD 14 and the toll-like receptor family (TLR).
The innate and adaptive branches of the vertebrate immune system have traditionally 
been dealt with as two separate entities. However dendritic cells (DCs) represent a 
unique link between these two systems. As a component of the innate immune 
system, DCs have the ability to recognise and respond to invading micro-organisms. 
Adaptive immune responses are then initiated when T cells recognise antigenic 
peptides bound to MHC molecules expressed on DCs.
1.2 Dendritic cells
As professional antigen presenting cells (APCs), the main role for DCs in an immune 
response is not to clear invading pathogens, but to alert the immune system to the 
potential danger. Following recognition and uptake of a pathogen, DCs release pro- 
inflammatory cytokines and chemokines that recruit other cells such as macrophages, 
neutrophils and NK cells to the site of infection. DCs then migrate to the secondary 
lymphoid organs where they present processed antigen to T lymphocytes.
16
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1.2.1 Dendritic cell lineages and origins
Dendritic cells are derived from CD34+ haematopoietic bone marrow stem cells (Fig 
1.1). In humans there are many different populations of DCs that reside in different 
tissues. These different DC populations may be derived from different lineages. 
Though DCs have been identified in tissue sections ex vivo, until recently in vitro 
culture of immature DCs has not been possible. The ability to culture DCs from 
monocytes in vitro in the presence of GMCSF and IL-4 has enabled more extensive 
investigations into all aspects DC biology (Sallusto F. et al., 1994). Monocytes also 
differentiate into DCs following transendothelial migration and phagocytosis in the 
absence of additional cytokines (Randolph G.J. et al., 1998a) (Randolph G.J. et al., 
1999).
Another DC type can be derived from plasmacytoid cells, which are circulating 
C D llc’ cells (Fig 1.1). Plasmacytoid cells cultured in vitro with IL-3 acquire a DC 
phenotype (Grouard G. et al., 1997). They are thought to be of lymphoid lineage as 
they are IL-3 dependent and express pTa, a molecule that assembles with the T cell 
receptor (TCR) (3 chain to form a pre TCR (Res P.C. et al., 1999). Plasmacytoid DCs 
have been identified as the major type 1 interferon (IFNa/|3) producing cells 
(Kadowaki N. et al., 2000) (Celia M. et al., 1999a). They respond to viral antigens 
and express only TLRs 7 and 9 (Kadowaki N. et al., 2001).
Langerhans cells (LCs) are a type of DC that populate squamous epithelia including 
skin, conjunctiva and respiratory and genital mucosal surfaces (Girolomoni G. et al., 
2002). LCs contain Birbeck granules, unique intracellular organelles that are 
involved in endocytosis. They also express CD la  and E-cadherin. The adhesion
17
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molecule E-cadherin retains LCs in the epidermis by homotypic interactions with 
keratinocytes. LCs differentiate in the skin from a circulating myeloid CD34+and 
CDla+ precursor, probably under the influence of TGF-|3 and IL-15 (Girolomoni G. 
et al., 2002)(Liu Y.J., 2001). LCs can be derived in vitro by culturing CD34+ cells in 
GM-CSF, TNFa, TGF-(3, and flt-3 ligand (Gatti E. et al., 2000).
Another DC subset referred to as interstitial DCs are also derived from CD34+ 
haematopoietic stem cells. These cells differentiate in steady state conditions and 
have been identified in the human foetus and new bom rats (Fossum S., 1989). 
Interstitial DCs express CD2, CD9, CD68 and Factor XHIa (Liu Y.J., 2001), and 
reside in many tissues including the dermis layer of skin and mucosal surfaces.
Immature LCs and interstitial DCs are already committed to a DC phenotype. They 
have dendrites or veils and express moderate levels of co-stimulatory molecules. 
Monocytes and plasmacytoid cells only differentiate into DCs after appropriate 
stimulation (Fig 1.1).
Mice have a similarly complex number of DC subsets that include CD8a+ 
‘lymphoid’ DCs, CD8a' ‘myeloid’ DCs, CD 8a'CD llb‘ DCs and LCs, as well as 
other subsets identified in specific tissues and organs (reviewed in (Pulendran B. et 
al., 2001)).
18
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Figure 1.1 Dendritic cell lineages
Haematopoietic stem cells (CD34+) differentiate into common lymphoid precursor 
(CLP) and common myeloid precursor (CMP). The CMPs differentiate into 
Langerhans cell precursors and interstitial DC precursors in blood. The Langerhans 
cell precursors (CD llc+CDla+) migrate from blood to the skin epidermis and 
become Langerhans cells. The C D llc+CDla" cells migrate to other tissues and 
become interstitial DCs. Both of these processes of DC differentiation are 
independent of antigen. CMP cells also give rise to monocytes (pre-DC 1), which can 
differentiate into DCs following phagocytosis of bacteria. The CLP cells are thought 
to differentiate into plasmacytoid cells (pre-DC2), which produce large amounts of 
IFNa/p and differentiate into plasmacytoid DCs during viral infection.
Adapted from (Liu Y.J., 2001).
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Many of the notions of DC lineage and precursors are still controversial. There are 
arguments that suggest that the CD8a+ DC in mouse and the plasmacytoid DC in 
humans are not of lymphoid origin and can be derived from myeloid precursors. For 
example the mouse DC8a" myeloid DC can be induced to express CD8a in vitro 
(Brasel K. et al., 2000). It is also not clear why so many different DC subsets are 
required. It may be related to specific locations within the body. Five different types 
of DC have been identified in human tonsils, which may have different functions in 
the T and B cell local micro- environments (Summers K.L. et al., 2001). It is also 
possible that the different DC subsets have evolved to respond to different pathogens. 
For example the plasmacytoid DCs express TLR7 and TLR9 and play an important 
role in the defence against viral infections (Kadowaki N. et al., 2001).
1.2.2 Antigen capture and processing by dendritic cells
DCs constantly sample their environment using three main mechanisms of 
endocytosis. Small molecules and solutes are taken up constitutively by non-specific 
macropinocytosis. This is a cytoskeletal dependent type of fluid phase endocytosis, 
mediated by membrane ruffling and the formation of large vesicles (l-3pm). 
Immature DCs are able to take up extracellular fluid equivalent to one cell’s volume 
every hour (Sallusto F. et al., 1995). DCs take up large volumes of fluid by this 
mechanism and concentrate the soluble antigens in protease containing endocytic 
compartments by the rapid exchange of water across their cell membrane via 
aquaporins (de Baey A. et al., 2000).
Larger molecules binding to PRRs are internalised by receptor mediated endocytosis. 
Membrane receptors cluster in clatharin coated pits together with the bound ligand.
20
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These pits pinch off as coated vesicles inside the cell and then traffic through the 
endosomal/lysosomal pathway (Steinman R.M. et al., 1995).
Large insoluble particles up to 6 pm in size are captured by phagocytosis. Receptors 
cluster at the antigen binding site and generate a phagocytic signal. This results in 
local polymerisation of actin filaments underneath the phagocytic target and 
remodelling of the plasma membrane to form extensions (pseudopods), which engulf 
the captured particle. The reorganisation of the actin cytoskeleton is controlled by 
small GTPases of the Rho family (reviewed in (Castellano F. et al., 2001)).
Antigens taken up by macropinocytosis or receptor mediated endocytosis are 
directed to the endosomal/lysosomal pathway where they are processed and loaded 
on to MHC class II molecules for presentation. In comparison, particles taken up by 
phagocytosis do not traffic to the endosomal/lysosomal pathway but are degraded 
and loaded onto MHC class II molecules within the phagosome (Ramachandra L. et 
al., 1999)(Ramachandra L. et al., 2000).
DCs express several receptors that mediate endocytosis and/or phagocytosis. For 
example, the mannose receptor is a C-type lectin containing multiple carbohydrate- 
binding domains, which bind to a variety of antigens expressing mannose or fucose 
residues (Sallusto F. et al., 1995). The mannose receptor traffics to early endosomes 
where it disassociates from its ligands at endosomal pH and recycles to the cell 
surface to engage in further antigen uptake (reviewed in (Stahl P.D., 1992). DEC 
205, a homologue of the mannose receptor, is expressed by DCs and binds 
carbohydrate conjugated antigen (Kato M. et al., 2000). Following internalisation
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DEC-205 traffics directly to late endosomes and lysosomes before recycling to the 
cell surface (Mahnke K. et al., 2000). Fc receptors FcyRI (CD64), FcyRII (CD32) 
and FcyRIII (CD 16), expressed on DCs, capture and internalise IgG bound immune 
complexes (Fanger N.A. et al., 1996)(Sallusto F. et al., 1994). These receptors are 
not recycled following internalisation, but are degraded in endosomes along with the 
bound antigen. The adhesion molecule DC-SIGN also plays a role in DC antigen 
capture, internalisation and delivery to the late endosome and lysosome 
compartments (Engering A. et al., 2002).
After internalisation by DCs, most protein antigens are digested to small peptide 
chains, which associate with MHC class II molecules in endocytic compartments. 
Endosomes are rich in enzymes, especially the cystein proteases of the cathepsin 
family. These proteases act optimally at acidic pH and have broad substrate 
specificity. They digest internalised antigen to small peptide fragments for loading 
onto MHC class II molecules (reviewed in (Watts C., 2001a)). The enzyme gamma- 
interferon inducible lysosomal thiol reductase (GILT) reduces disulphide bonds 
optimally at acidic pH and is important in the reduction and unfolding of antigenic 
proteins (Watts C., 2001b). Unfolded peptides of around 25 residues bind to the 
MHC class II peptide-binding groove and avoid further digestion.
Newly synthesised MHC class II molecules traffic to the endosomal-lysosomal 
pathway. It is still unclear at what point the MHC II molecules fuse with the 
endosomal-lysosomal pathway but evidence suggests that at least some MHC II 
molecules are trafficked to the early endosomes (Pond L. et al., 1999). Newly 
synthesised class II molecules are engaged by an invariant chain protein (Ii), which
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encourages export from the ER and targets to the endosomal pathway. Ii also acts as 
a surrogate peptide in the MHC binding groove, stabilising the a/|3 dimmer. The Ii is 
removed from the binding groove and replaced by antigenic peptide, this is 
facilitated by endosomal proteases and the HLA-DM protein in a process known as 
DM-peptide exchange (reviewed in (Watts C. et al., 2000)(Watts C., 2001a)).
Dendritic cells are also able to present on MHC class I complexes. MHC class I 
presentation is usually implemented for endogenous antigens in virally infected cells 
or tumour cells. Loading of MHC class I molecules takes place in the ER using 
peptides generated in the cytosol. However DCs are able to initiate CD8 T-cell 
responses to exogenous antigens in a process known as cross-presentation, where 
material taken up by endocytosis can translocate from the endosomes to the cytosol. 
This process is dependent on transporter associated with antigen processing (TAP)- 
dependent (Albert M.L. et al., 1998)(Rescigno M. et al., 1998b) (Sigal L.J. et al., 
1999). The ability of DCs to cross-present antigen from tissues has important 
implications for DC induction of peripheral tolerance involving CD8+ T cells (Albert 
M.L. et al., 2001). Recent evidence has shown that DCs can also present lipid antigen 
to T cells via the CD1 pathway (Prigozy T.I. et al., 2001). The CD1 family of 
molecules are structurally similar to the classical MHC class I molecules.
1.2.3 Dendritic cell maturation
After exposure to microbial products or inflammatory stimuli, DCs undergo a series 
of coordinated maturation events. Micro-array techniques have established at least 
255 genes are regulated during DC differentiation and maturation including secreted 
proteins, adhesion molecules, signalling molecules and genes involved in lipid
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metabolism (Le Naour F. et al., 2001). Maturation is associated with a decrease in 
endocytosis and endocytic receptor expression in conjunction with transport of 
MHC/peptide complexes to the cell surface and an increase in expression of surface 
co-stimulatory molecules (Chow A. et al., 2002)(Sallusto F. et al., 1994)(Sallusto F. 
et al., 1995) (table 1.1).
Immature DCs Mature DCs
High endocytosis Low endocytosis
High phagocytosis Low Phagocytosis
High intracellular MHCII High surface MHCII
High CCR1, CCR5, CCR6 Low CCR1.CCR5, CCR6
Low CCR7 High CCR7
Low CD54, CD80, CD86 High CD54, CD80, CD86
Low CD40 High CD40
Low CD83 High CD83
Table 1.1 Properties of immature and mature dendritic cells
On receiving a maturation signal, DCs transport MHC-antigen complexes that are 
arrested at the peptide loading stage to the cell surface (Inaba K. et al., 2000) (Lutz 
M.B. et al., 1997). A change in pH of the MHC II containing lysosomal 
compartments during DC maturation results in the activation of enzymes and the 
loading of peptide onto MHC molecules followed by presentation on the surface of 
the DC (Trombetta E.S. et al., 2003). This phenomenon explains why DCs can 
present peptides from antigens previously internalised hours before maturation
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occurs. Interestingly, co-stimulatory molecules and MHC class I molecules have 
been identified in the MHC class II vesicles that migrate to the cell surface. This 
results in clustering of MHC molecules and co-stimulatory molecules on the surface 
of DCs ready for T cell activation (Turley S.J. et al., 2000).
Following stimulation, DCs increase their expression of the co-stimulatory molecules 
CD80 (B7-1) and CD86 (B7-2) (Caux C. et al., 1994)(Inaba K. et al., 1994). 
Increased expression of these molecules is important for generating an optimal T cell 
response. CD80 and CD86 both bind to CD28 and cytotoxic T-lymphocyte antigen-4 
(CTLA4) on T cells. CD28 ligation enhances the magnitude and duration of T-cell 
responses, inhibits apoptosis, increases cytokine production and increases expression 
of cell adhesion molecules (reviewed in (Chambers C.A., 2001)(Lenschow D.J. et 
al., 1996)). The engagement of CD80 or CD86 with CTLA-4 results in an inhibitory 
effect. CTLA-4 has a higher affinity for CD80 and CD86 than CD28; it is not 
expressed constitutively on T cells but is expressed following TCR and CD28 
ligation (Chambers C.A., 2001).
A combination of cytokines including TNFa, IL-la, IL-1|3, IL-6, IL-8, IL-12 and 
IL-18 are released by DCs after receiving a maturation signal including micro­
organisms or microbial products such as LPS, or by CD40 ligation (Morelli A.E. et 
al., 2001)(Saint-Vis B. et al., 1998)(Verhasselt V. et al., 1997). The release of pro- 
inflammatory cytokines TNFa, IL-1 and IL-6 aids the local inflammatory response at 
the site of infection. TNFa induces activation of endothelial cells, increasing the 
infiltration of leukocytes to the site of infection. IL-6 is a potent growth and 
differentiation factor for B and T cells, and along with IL-1 systemically induces
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fever. IL-1 and TNFa also activate other DCs and macrophages arriving at the site of 
infection. The chemokine IL-8 released by DCs upon activation attracts other 
leukocytes, including neutrophils and basophils, to the site of infection. The 
cytokines IL-12 and IL-18 are both important in the activation of naive T helper cells 
to a Thl phenotype, as discussed in detail below.
1.2.4 Dendritic cell migration
DC maturation is closely linked to migration from the site of inflammation to the 
secondary lymphoid tissues (Roake J.A. et al., 1995). This movement of DCs is well 
known, but the precise mechanisms of migration in vivo are not fully understood 
although several important factors have been identified.
Chemokines are small soluble molecules that have been shown to play an important 
role in DC migration. There are two families of chemokines, the CXC and the CC 
chemokines, which are distinguished according to the position of their first two 
cystine residues (Sozzani S. et al., 1999). The receptors for chemokines are also 
classified CXCR or CCR according to their ligands. The chemokine MIP3a (CCL20) 
is expressed by activated venous endothelial cells and is involved in the recruitment 
of DC precursors. Endothelial cells of the lymphatic system constitutively express 
chemokines MIP3(3 (CCL19) and 6Ckine (CCL21), which attract activated DCs and 
naive T cells. Other chemokines are not constitutively expressed by tissues but are 
induced as part of the inflammatory response. Following recognition of an invading 
pathogen by receptors such as TLRs, tissue macrophages release chemokines to 
attract leukocytes, including immature DCs, to the site of infection. Inducible
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chemokines include IL-8 (CXCL8), M IP-la (CCL3), MIP-ip (CCL4), RANTES 
(CCL5) and IP-10 (CXCL10) (reviewed in (Luster A.D., 2002)).
Immature DCs express CCR1, CCR2, CCR5, CCR6 and CXCR1 and they respond to 
M IP-la, MIP-lp, RANTES, MCP-3 (CCL7), MCP-4 (CCL13) and MIP-3a 
(CCL20) (Sozzani S. et al., 1997). Following stimulation, DCs decrease their 
expression of CCR1 and CCR5 (Sallusto F. et al., 1998)(Sozzani S. et al., 1998), and 
become unresponsive to their ligands (MIP-la, MIP-ip, RANTES and MCP-3). At 
the same time as the decrease in CCR1 and CCR5 expression there is an increase in 
CCR7 expression and DCs become responsive to chemokines MIP-3|3 (CCL19) and 
6Ckine (CCL21) (Sallusto F. et al., 1998)(Sozzani S. et al., 1998). This change in 
expression of chemokine receptors by DCs following stimulation contributes to their 
migration from the peripheral tissues to the draining lymph nodes. Chemokines 
MIP-3P and 6Ckine are expressed in T cell zones of lymph nodes, by high 
endothelial venules of lymphatic tissues and by lymphatic endothelial cells 
(Kellermann S.A. et al., 1999).
In order to reach the secondary lymphoid tissues DCs must first pass through the 
extra-cellular matrix of the tissues at the site of inflammation and cross endothelial 
barriers. This process involves binding of adhesion molecules. For example 
Langerhans cells (LCs) are retained in the skin by E-cadherin binding to 
keratinocytes. Following stimulation expression of E-cadherin on LCs is decreased 
and they emigrate from the skin (Jakob T. et al., 1998)(Tang A. et al., 1993). The 
adhesion molecule ICAM-1 is also important for DC migration from the skin to 
lymph nodes. ICAM-1 knock out mice have a reduced number of DCs in their
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regional lymph nodes but no change in the number of DCs in the skin compared to 
wild type controls. It was also shown that ICAM-1 expression on regional lymphatics 
is essential, rather than ICAM-1 expression by DCs (Xu H. et al., 2001).
Antibody inhibition studies in vitro have shown that adhesion molecules CD 11a, 
CD llb, CD18 and VLA-4 are important for DC binding and migration across 
vascular endothelium (Brown K.A. et al., 1997)(D'amico G. et al., 1998). CD18 and 
PEC AM-1 are especially important for transmigration through endothelial layers, 
and the integrins VLA-4 and VLA-5 are important for DC binding to the extra 
cellular matrix (D'amico G. et al., 1998). It is unclear however if these in vitro 
observations mean that these adhesion molecules are important for DC migration in 
vivo. The DC specific C-type lectin DC-SIGN, binds to ICAM-2 on endothelial cells 
and mediates DC tethering and rolling under physiological flow conditions. Both 
vascular and lymphatic endothelium in lymphoid tissue abundantly express the DC- 
SIGN ligand ICAM-2 in steady state conditions, indicating a possible role for ICAM- 
2 and DC-SIGN interactions in DC migration (Geijtenbeek T.B. et al., 2000).
The transporter protein multi-drug resistant-1 p-glycoprotein (MDR1 p-glycoprotein) 
and multi-drug resistant protein 1 (MRP1) have both been found to play an important 
role in DC migration to lymph nodes. Blocking of either of these lipid transporters 
with monoclonal antibodies results in inhibition of migration. It is thought that these 
molecules facilitate DC migration in response to the MIP3|3 (Randolph G.J. et al., 
1998b)(Robbiani D.F. et al., 2000).
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The migration of DCs from the periphery to the lymphatic system has always been 
closely associated with DC maturation, but recent studies have indicated that 
maturation and migration may not be as closely associated as initially thought. For 
example DC stimulation with prostaglandin E2 (PGE2) in combination with other 
stimuli results in migration. However in the absence of PGE2, DCs were found to 
mature but not migrate (Luft T. et al., 2002)(Scandella E. et al., 2002). Furthermore 
PGE2 given in combination with other stimuli resulted in an increase in CCR7 
expression and increased sensitivity to CCR7 ligands MIP3(3 and 6Ckine (Scandella 
E. et al., 2002).
There is also evidence of migration in the absence of maturation. TNFa and other 
inflammatory stimuli were found to induce CCR7 expression and migration of LCs 
from inflamed skin to lymph nodes without increased CD83 or CD86 expression 
(Geissmann F. et al., 2002)(Randolph G.J., 2002). This has implications for the role 
of DCs in priming regulatory T cells and controlling peripheral tolerance as 
discussed later (section 1.2.7).
1.2.5 Dendritic cell interactions with T cells
Dendritic Cells migrate to the T cell areas of secondary lymphoid organs where they 
interact with and stimulate T cells (Stoll S. et al., 2002). Adhesion molecules play an 
important part in the initial interactions of DCs and T cells. Naive resting T 
lymphocytes express high levels of ICAM-3. Initial contact between DCs and T cells 
is mediated by ICAM-3 and DC-SIGN, followed by ICAM-1 and LFA-1 interactions 
(Bleijs D.A. et al., 2001)(Montoya M.C. et al., 2002). Although these initial adhesion 
molecule contacts are antigen independent, following TCR binding to MHC
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activated LFA-1 binds ICAM-1 with higher avidity, thus stabilising the complex 
(Figure 1.2a).
The point of contact between the DC and T cell is known as the ‘immunological 
synapse’, where TCRs and MHC molecules cluster together in a central area with co- 
stimulatory molecules. These are surrounded by a ring of adhesion molecules 
forming a stable complex ((Dustin M.L. et al., 2000) (Grakoui A. et al., 1999) and 
reviewed in (Davis D.M., 2002)(van der Merwe P.A., 2002)) (Figure 1.2b). The 
stability of the synapse and the length of time it is formed controls T cell stimulation.
Both the number of MHC-TCR interactions and their duration effect T cell 
stimulation. Co-stimulatory molecules and their ligands such as CD28-CD80/CD86, 
CD40-CD40 ligand (CD40L), 0X40-0X40 ligand (OX40L), CD27-CD70 enhance 
T cell receptor signalling and provide additional signals that aid the proliferation of T 
cells. Interestingly, different co-stimulatory molecules are required for CD4+ cell 
priming than for CD8+ cell priming. CD28, CD40L and OX40L expression are all 
essential for CD4+ cell priming, whereas CD8+ cells require 4-1BBL and to a certain 
extent CD28 (Chen A.I. et al., 1999) (Howland K.C. et al., 2000)(Kaech S.M. et al., 
2002)(Whitmire J.K. et al., 2000). The requirement for co-stimulation of CD4+ T 
cells can be overcome by higher concentrations of antigen and longer duration of 
TCR-MHC signalling (Iezzi G. et al., 1999).
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Figure 1.2 Contact between dendritic cells and T cells and the formation of the 
immunological synapse
(a) Mature DCs adhere to naive T cells upon arrival in the lymph node through 
DC-SIGN/ICAM-3 interactions, thus allowing the formation of low avidity 
LFA-l/ICAM-1 bonds. Following ligation of the TCR by peptide loaded MHC, 
LFA-1 is activated and stabilises the formation of the immunological synapse 
through high avidity LFA-l/ICAM-1 and CD2/LFA-3 interactions. Adapted from 
(Bleijs D.A. et al., 2001).
(b) The immunological synapse involves the supramolecular organisation of T cell 
receptor, co-stimulatory and adhesion molecules. The signalling complexes of 
MHC/TCR and co-stimulatory molecules cluster at the centre of the synapse; these 
are surrounded by a ring of adhesion molecules including LFA-l/ICAM-1 and 
CD2/LFA-3 associations. Adapted from (Davis D.M., 2002).
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Other molecules with co-stimulatory roles in T cell activation are constantly being 
identified. New members of the B7 (CD80/CD86) family expressed by DCs include 
B7-H3 (Chapoval A.I. et al., 2001) and B7-DC (Tseng S.Y. et al., 2001). The human 
inducible co stimulator protein (ICOS) expressed on T cells is a member of the CD28 
family and plays a role in T cell stimulation and differentiation (Aicher A. et al.,
2000)(Greenwald R.J. et al., 2002).
1.2.6 Differentiation of T helper cells to type 1 (Thl) or type 2 (Th2) phenotypes
Naive T cells are fastidious in their requirements for priming. They require high 
levels of antigen loaded MHC molecules and co-stimulatory molecules, which are 
expressed on activated DCs. Naive CD4+ T cells have the potential to develop into 
IFNy producing Thl effector cells or IL-4/IL-5/IL-13 producing Th2 effector cells. 
Thl cells are important in the activation of macrophages, the induction of IgG 
antibodies to mediate opsinisation and phagocytosis and in the support of activated 
CD8+ effector cells. Thl responses confer resistance to intracellular pathogens. Th2 
cells stimulate the growth and differentiation of mast cells and eosinophils as well as 
the production of antibody isotypes including IgE. Th2 cells are involved in the 
response against extra cellular pathogens. DCs are fundamental in determining the 
balance between Thl and Th2 effector cells (reviewed in (Jankovic D. et al.,
2001)(Kalinski P. et al., 1999)(Maldonado-Lopez R. et al., 2001))
Initially different DC subsets were thought to promote the differentiation of Thl and 
Th2 cells. In vitro, myeloid DCs were found to promote a Thl response and 
lymphoid/plasmacytoid DCs induced a Th2 response (Rissoan M.C. et al., 1999). It 
has since been demonstrated however that myeloid DCs can induce a Th2 response
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following stimulation with a glycoprotein (ES62) secreted by a filarial nematode 
(Whelan M. et al., 2000) or by stimulation with toxin from the extra-cellular 
bacterium Vibrio cholerae (de Jong E.C. et al., 2002). It has also been shown that 
plasmacytoid DCs can produce type 1 interferons (IFNa/|3) and induce a Thl 
response following stimulation with influenza virus and CD40 ligation (Celia M. et 
al., 2000).
Three signals are required for the optimal priming and activation of naive Th cells. 
Signal 1 is the antigen specific recognition of MHC peptide by TCR; signal 2 is co­
stimulation via CD80/CD86 interactions with CD28 and other co-stimulatory 
molecule interactions such as CD40-CD40L and OX40-OX40L; and signal 3 is 
mediated by soluble factors (cytokines). IL-12 is the best characterised signal 3 and 
is essential for the development of a Thl response and the defence against 
intracellular bacteria (Heufler C. et al., 1996). Individuals found lacking a functional 
IL-12 receptor are unable to mount a Thl response and are susceptible to 
intracellular infections with mycobacteria and salmonella (de Jong R. et al., 1998). 
IL-12 is a heterodymic cytokine composed of p40 and p35 subunits that together 
form the biologically active p70 molecule. The p35 subunit is constitutively 
transcribed and is regulated post translationally, whereas transcription of the p40 
subunit is induced following stimulation (reviewed in (Abdi K., 2002)). The IL- 
12p40 subunit also combines with an IL-12p35 related molecule, p i9, to form the 
biologically active IL-12 related cytokine IL-23 (Oppmann B. et al., 2000). DCs 
produce IL-12 following stimulation with certain pathogens including 
Staphylococcus aureus (Heufler C. et al., 1996), Mycobacteria tuberculosis 
(Giacomini E. et al., 2001) and Toxoplasma gondii (Sousa C. et al., 1999b) (Sousa
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C.R. et al., 1997). Other factors such as IFN7 and CD40 ligation have been found to 
increase DC IL-12 production (Sousa C. et al., 1999b). CD40 ligation alone does not 
lead to IL-12 production, but together with a microbial stimulus enhances IL-12 
production (Schulz O. et al., 2000). Memory T cells can induce DC IL-12 production 
by CD40L binding of CD40 along with IFNy stimulation, thus enhancing the 
immune response, whereas naive T cells are unable to induce IL-12 production in 
DCs (Snijders A. et al., 1998).
IL-18 and type 1 interferons produced by DCs have also been implicated in inducing 
Thl responses. Naive T cells do not make IFNy in response to IL-18 alone because 
they lack a functional IL-18 receptor. However a positive feedback mechanism 
occurs as IL-12 stimulation of naive T cells results in up regulation of IL-18 receptor 
expression. IL-18 signalling then increases IL-12 receptor expression (reviewed in 
(Akira S., 2000)).
Thus far no DC derived soluble factors have been identified that induce a Th2 
response. IL-4 production is essential, but produced by T cells and not DCs 
(Banchereau J. et al., 2001). DCs generated in the presence of prostaglandin E2 
(PGE2) express co-stimulatory molecules and induce naive Th cells to proliferate 
and differentiate into Th2 cells. PGE2 treated DCs were unable to produce IL-12 
upon stimulation with LPS or other microbial products (Kalinski P. et al., 1997). Co- 
stimulatory molecules can play an influential role in Th2 development depending on 
the activating stimulus. The Th2 response induced by DCs stimulated with a protein 
extract from the helminth Schistosoma mansoni is dependent on OX40-OX40L 
interactions whereas the Th2 response induced by DCs stimulated with cholera toxin
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is not (de Jong E.C. et al., 2002). The lack of soluble Th2 inducing factors could be 
explained by the theory that a Th2 response is the default pathway, which occurs 
when DCs are activated and express a high concentration of co-stimulatory 
molecules but do not secrete Thl inducing cytokines such as IL-12.
There are other factors that influence Thl/Th2 differentiation including the kinetics 
of DC-T cell interactions and cell ratio numbers. A relatively short TCR stimulation 
time promotes Thl polarisation whereas prolonged TCR stimulation is required for 
the development of a Th2 response even in the presence of IL-4 (Iezzi G. et al.,
1999). Delay between DC activation and interaction with T cells may also favour a 
Th2 response. For example, DCs stimulated with the Thl inducing stimulus LPS 
were initially found to induce a Thl response but when the same DCs were used to 
stimulate naive T cells at later time points (after 48 hours), T cells differentiated to a 
Th2 phenotype (Langenkamp A. et al., 2000). The ratio of DCs to T cells may also 
influence polarisation. Low ratios of 1 DC to 300 T cells resulted in a Th2 response, 
whereas a ratio of 1 DC to 4 T cells gave a Thl response. These observations of 
kinetics and ratios influencing polarisation are interesting, but the in vivo 
significance of these observations has yet to be explored.
1.2.7 The role of DCs in inducing regulatory T cells and tolerance
The role of DCs in inducing and maintaining regulatory T cells and tolerance is 
currently an area of major interest. There is increasing evidence that certain subsets 
of T cells exert regulatory control limiting immune responses to self-antigen and 
preventing autoimmune disease. In mice, T regulatory cells make up 5-10% of 
peripheral CD4+ T cells. They express CD25 and CTLA-4, but do not proliferate
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after activation and have a suppressor effect on other T cells (Sakaguchi S.,
2000) (Thornton A.M. et al., 2000). Stimulation of naive CD4+ T cells with immature 
DCs resulted in CTLA-4+, non-proliferating T cells that did not produce IFNy, IL-2 
or IL-4 but did produce IL-10. These IL-10 producing T cells inhibited the 
proliferation of Thl cells in co-culture in a contact dependent but antigen 
independent manner (Jonuleit H. et al., 2000). Another study found that injecting 
immature DCs pulsed with influenza matrix protein or keyhole limpet hemocyanin 
resulted in antigen specific inhibitory IL-10 producing T cells (Dhodapkar M.V. et 
al., 2001). This regulation induced only by immature DCs means that it is unlikely 
that pathogen stimulated mature DCs will result in a tolerogenic response. The 
possibility of immune responses to self-antigens is also limited, as immature DCs can 
not induce an effective immune response.
1.3 Neisseria meningitidis
N. meningitidis is an encapsulated Gram-negative diplococcus, which is exclusively 
a human pathogen. To this day N. meningitidis remains a leading cause of bacterial 
meningitis and sepsis. Reports of illness resembling meningococcal disease can be 
dated back to the 16th century, though the organism was first isolated from a patient 
with meningococcal disease in 1887 (reviewed in (Rosenstein N.E. et al., 2001)).
The mortality rate among patients with meningococcal sepsis is still around 40%, and 
11-19% of survivors have sequelae that can include hearing loss, mental retardation 
or limb amputation (Rosenstein N.E. et al., 1999). During infection N. meningitidis 
often crosses the endothelium of the blood-brain barrier and enters the subarachnoid
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space. This infection of the meninges occurs in -50% of cases, resulting in 
meningitis (Rosenstein N.E. et al., 1999).
1.3.1 Classification of bacteria and epidemiology
N. meningitidis is classified into serogroups according to the chemical composition 
of the polysaccharide capsule. Thirteen different serogroups have been identified of 
which only 5 have been associated with disease causing isolates. These are the 
serogroups A, B, C, Y and W-135 (Rosenstein N.E. et al., 2001). Serogroups A, B 
and C account for most cases of meningococcal disease world wide with serogroups 
B and C responsible for the majority of cases in industrialised countries. Serogroup 
A strains and to a lesser extent serogroup C strains dominate in third world countries 
(Schwartz B. et al., 1989). There is an area of sub-Saharan Africa referred to as the 
‘meningitis belt’, which extends from Ethiopia in the east to Senegal in the west. 
Recurrent outbreaks of serogroup A disease occur in this region. In 1996 the largest 
outbreak ever recorded occurred here, with a total number of 152,813 cases reported, 
and 15,783 deaths, though this is likely to be an underestimate.
N. meningitidis are classified further into serosubtypes on the basis of their class 1 
outer membrane proteins (OMPs), then into serotypes on class 2 or class 3 OMPs and 
finally into immunotypes based on their lipopolysaccharide (Fig 1.3)
1.3.2 The surface structure and composition of N. meningitidis
The polysaccharide capsule protects the bacteria by reducing phagocytosis and 
complement mediated bacteriolysis (Fig 1.3)(Vogel U. et al., 1999). Strains that are 
capsule deficient are more readily phagocytosed by DCs and other phagocytes (Kolb-
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Maurer A. et al., 2001)(Unkmeir A. et al., 2002). Pili, composed of protein subunits 
called pillins, protrude through the capsule from the inner membrane (Fig 1.3). They 
are adhesive molecules that orchestrate the initial adhesion of bacteria to host 
epithelial and endothelial cells by binding to the complement membrane co-factor 
protein, CD46, expressed by most cells (Nassif X. et al., 1994).
The outer membrane of N. meningitidis is composed of an asymmetric lipid bi-layer 
into which are embedded many outer membrane proteins (OMPs) (Fig 1.3). The 
OMPs are essential for bacterial nutrient acquisition and protein secretion. The major 
OMPs of N. meningitidis are divided into 5 classes based on their molecular 
weights(Tsai C.M. et al., 1981). The class 1 OMP is a porin (PorA), which forms 
cation secretive pores in the outer membrane (Tommassen J. et al., 1990). Class 2 
and class 3 OMPS are PorBl and PorB2. These are mutually exclusive between N. 
meningitidis serotypes and form anion selective pores in the outer membrane.
Porins are expressed as trimers, where each monomer is a 6-stranded (3 barrel with 8 
surface exposed loops. The high variability in these surface exposed loops forms the 
basis for serosubtyping and serotyping (reviewed in (Massari P. et al., 2003b)). 
Porins interact directly with the membranes of target cells, forming aqueous 
transmembrane channel. PorB also aids the survival of N. meningitidis by protecting 
host cells from apoptosis by reducing mitochondrial depolarisation and release of 
cytochrome C (Massari P. et al., 2003a)(Massari P. et al., 2003b).
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Figure 1.3 Surface structure of Neisseria meningitidis
As with all Gram-negative bacteria, N. meningitidis have an outer membrane (OM) 
and an inner membrane (IM) separated by a periplasmic space (PS), which contains a 
peptidoglycan layer (PG). The OM is an asymmetric lipid bilayer with the outer 
leaflet composed of phospholipids and lipopolysaccharide (LPS) and the inner leaflet 
just phospholipids. There are surface exposed proteins embedded in the OM, 
including porins that function as channels for the acquisition of nutrients and opacity 
proteins that play a role in bacterial adhesion. Meningococci are surrounded by a 
polysaccharide capsule. Pili protrude through the membranes and the capsule. 
Adapted from (Poolman J.T., 1995)(Rosenstein N.E. et al., 2001) and (Steeghs 
2001b.)
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The class 4 OMP is the reduction-modifiable protein M (RmpM), which is a 
homologue of E. coli OmpA. It is constitutively expressed by all menigococcal 
strains and is antigenically invariable (Prinz T. et al., 2000). RmpM anchors the 
meningococcal outer membrane to the periplasmic space and is firmly associated 
with other OMPs such as porins and iron limitation inducible OMPs (Fig 1.3) 
(Klugman K.P. et al., 1989).
The opacity proteins Opa and Opc comprise the class 5 OMP family. Opa proteins 
are predicted to form 8-stranded (3 barrels in the outer membrane, exposing 4 loops to 
the surface. Opc spans the membrane 10 times exposing 5 surface loops. These 
opacity proteins recognise different receptors on host cells and aid bacterial adhesion 
and invasion. OpacEA mediates attachment to the carcinoembryonic antigen CD66, 
which is related to the cell adhesion molecule (CEACAM) family. Opans and Opc 
both bind heparin sulphate proteoglycans and extra cellular matrix proteins 
fibronectin and vitronectin (de Vries F.P. et al., 1998) (Virji M. et al., 1996) and 
reviewed in (Hauck C.R. et al., 2003)).
In certain growth conditions N. meningitidis can express other OMPs in addition to 
the 5 major classes of OMP. For example, in iron limiting growth conditions they 
express receptors for haem, lactorferrin and tansferrin. With the completion of 
genome sequences for one serogroup A strain and one serogroup B strain of N. 
meningitidis new OMPs with as yet unknown functions are being identified (Parkhill 
J. et al., 2000)(Tettelin H. et al., 2000).
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Lipopolysaccharide (LPS) is present in the outer leaflet of the outer membrane (Fig 
1.3). LPS is composed of a hydrophobic lipid A moiety anchoring it in the outer 
membrane, and a core hydrophilic oligosaccharide exposed on the bacterial surface 
(Fig 1.4). Meningococcal LPS is often referred to as lipo-oligosaccharide (LOS) as it 
lacks the O antigen found in the LPS of other Enterobacteriaceae. N. meningitidis is 
further divided into 12 immunotypes based on the heterogeneous LPS outer core 
(Andersen S.R. et al., 1996)(Scholten R.J. et al., 1994). The lipid A of 
meningococcal LPS is much more conserved than the heterogeneous outer 
oligosaccharide core. LPS is negatively charged and has a strong affinity for divalent 
cations, which together form a strong permeability barrier in the outer membrane into 
which OMPs are integrated.
The biosynthesis pathway of lipid A in E. coli has been worked out. In the first step 
of lipid biosynthesis the enzyme lpxA-acyltransferase catalyses the transfer of the 
acyl chain from (R)-3-hydroxy-myristol-acyl carrier protein (ACP) to the 3-OH 
hexose of UDP-N-acetylglucosamine (Coleman J. et al., 1988). Mutations in the 
early stages of the lipid A biosynthesis pathway in E. coli are conditionally lethal 
(Galloway S.M. et al., 1990). However an early block in lipid A biosynthesis in N. 
meningitidis was found to be non-lethal (Steeghs L. et al., 1998). Lipid A 
biosynthesis was interrupted by the insertion of an inactivation cassette in the IpxA 
gene of N. meningitidis. Although this IpxA- mutant was viable, it had a reduced 
growth rate. It was found to be totally deficient in LPS as shown by SDS-page and 
ELISA (Steeghs L. et al., 1998). Further studies of the OMPs from the LPS deficient 
and the wild type N. meningitidis showed that expression of the major OMPs was not 
affected, although the phospholipid composition had changed in the absence of LPS
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Figure 1.4 Schematic of Neisseria meningitidis LPS
The lipid A moiety integrates into the meningococcal 
outer membrane, whilst the oligosaccharide core is 
exposed on the surface. The oligosaccharide core is 
composed of galactose (Gal), N-aceyl-glucosoamine 
(GlcNac), glucose (Glc), heptose (Hep) and 2-keto-3- 
deoxyoctulosonic acid (Kdo) units. (Adapted from Steeghs 
2001b)
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(Steeghs L. et al., 2001a). Expression of the polysaccharide capsule was essential for 
viability of the LPS deficient IpxA- N. meningitidis.
1.3.3 Colonisation and carriage
The natural environment for N. meningitidis is the nasopharynx where the bacteria 
reside as commensal organisms. Disease results when meningococci cross the 
nasopharyngeal epithelium and enter the blood stream. In Europe, asymptomatic 
carriage occurs in -10% of the population with invasive disease occurring in 0.3-7.1 
per 100,000 (Balmer P. et al., 2002). N. meningitidis is an occasional pathogen, 
invasive disease occurs accidentally during normal bacteria and host interactions. 
The factors that result in invasive disease are not fully understood, immune status of 
the host and the bacterial strain are both important along with environmental 
conditions. Immune defects that compromise the host can promote invasive disease. 
These include deficiencies in late complement components, in protein C and in 
mannose binding lectin (Vogel U. et al., 1999).
Transmission of N. meningitidis is via aerosol. Colonisation occurs following 
adherence of bacteria to epithelial cells of the nasopharynx. N. meningitidis is highly 
variable and new variants with different virulence and transmissibility factors are 
continuously generated. Meningococci have a natural competency for 
transformation, horizontal DNA exchange and recombination, which creates a wide 
genetic diversity (Taha M.K. et al., 2002). The ability of meningococci to vary their 
expression of different molecules in a process known as phase variation results in 
even greater bacterial diversity (de Vries F.P. et al., 1996).
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Different bacterial structures are important for different stages of the bacteria’s life 
cycle. Initial adherence to epithelial cells is mediated by type IV pili, which bind to 
the widely expressed CD46 (membrane cofactor protein MCP). Attachment of the 
bacteria is accompanied by elongation of the host cell micovilli and filopodia. 
Optimal adhesion is through coordinated regulation of different structures on the 
bacterial surface. After initial attachment pili and capsule expression are down 
regulated by the transcriptional regulatory protein crgA, allowing intimate 
association between the bacteria and the host plasma membrane. This is mediated by 
the surface proteins Opa and Opc, which are both important in attachment and 
colonisation of non-encapsulated bacteria (Merz A.J. et al., 2000).
The ability of meningococci to vary expression of the polysaccharide capsule is 
important in many stages of its life cycle. Transmission of meningococci from the 
nasopharynx is increased as the expression of capsule aids shedding. Capsule 
expression also protects bacteria in the blood stream from opsinisation and 
bacteriolysis (see below).
1.3.4 Invasion and the immune response
Invasion occurs via bacterial directed endocytosis by epithelial cells. Internalised 
bacteria survive and dived within epithelial cells in phagocytic vacuoles. This 
process is aided by PorB, which translocates the target cell membrane and inhibits 
maturation of the vacuoles (Rudel T. et al., 1996). Traversal of epithelial membranes 
into sub-epithelial stromal tissues occurs without obvious disruption to lateral 
junctional complexes or epithelial barrier properties.
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In the blood stream capsule expression and LPS sialyation aid survival by conferring 
resistance to complement and phagocytosis, enabling meningococci to grow and 
divide. During this growth blebs are released, which are outer membrane vesicles 
rich in lipopolysaccharide, OMPs and lipids. This blebbing process contributes to the 
high level of endotoxin (LPS) observed in the blood stream of patients with septic 
shock (Brandtzaeg P. et al., 2002)(Namork E. et al., 2002). In fatal cases of 
meningococcal septicaemia 95% had plasma endotoxin levels higher than 100 EU/ml 
(Brandtzaeg P. et al., 2002).
LPS released into the blood stream is a potent stimulator of inflammatory pathways, 
inducing the release of both pro- and anti-inflammatory cytokines, chemokines, 
soluble receptors and colony stimulating factors (reviewed in (Hackett S.J. et al.,
2001)). The pro inflammatory cytokine TNFa plays an important role in the clinical 
manifestations of severe meningococcal disease. TNFa works synergistically with 
IL-1 inducing hypotension with a fall in systemic vascular resistance and central 
venous pressure along with an increased cardiac output. This results in pulmonary 
oedema and haemorrhage (reviewed in (Hackett S.J. et al., 2001)). Levels of other 
cytokines, including IL-1, IL-6, IL-8, IL-10 and IL-12 have been found to positively 
correlate with TNFa levels. Along with elevated levels of pro-inflammatory 
cytokines in patients with severe meningococcal disease, elevated levels of the anti­
inflammatory cytokine IL-10 have also been observed. Severe meningococcal 
disease is associated with a disregulation of cytokine levels where the balance 
between pro and anti-inflammatory cytokines is no longer maintained.
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LPS activates cells via the TLR4/CD14 signalling complex and is the major 
stimulator for the release of cytokines and other inflammatory mediators during 
meningococcal disease. However other components expressed by N. meningitidis 
also contribute to the release of cytokines as shown by the release of TNFa, IL -la  
and IL-6 by monocytes stimulated with LPS deficient N. meningitidis (Uronen H. et 
al., 2000).
1.3.5 Vaccine development
Vaccines based on the polysaccharide capsule for serogroups A, C, Y and W135 
were developed 25 years ago but these do not induce protective immunity in children 
under the age of 2 and do not offer any long term protective memory (Baimer P. et 
al., 2002b)(Pollard A.J. et al., 2000). To improve the immunogenicity, 
polysaccharide was conjugated to a protein carrier. These conjugate vaccines induce 
bactericidal antibodies and immunological memory in young children (Richmond P. 
et al., 2001). In November 1999 a national immunisation programme with 
meningococcal serogroup C conjugated vaccines was introduced in the UK. The 
introduction of the vaccine has had a significant impact, resulting in an 86.7% 
reduction in disease caused by serogroup C meningococci (Balmer P. et al., 2002a). 
Contrary to prior concerns, there has been no increase in the overall incidence of 
serogroup B disease since the introduction of the serogroup C conjugate vaccine. 
Meningococci can switch their capsule and change their serogroup in vitro by 
horizontal DNA exchange and transformation (Swartley J.S. et al., 1997). However, 
there is no evidence of an increase in capsule switching from serogroup C to 
serogroup B following the vaccination programme. A slight increase in the incidence
47
Chapter 1 Introduction
of disease caused by serogroup W135 isolates has been observed, though this was 
associated with pilgrims returning from the Hajj (Balmer P. et al., 2002a).
The development of an effective serogroup B vaccine remains the major challenge in 
the prevention of meningococcal disease. Serogroup B isolates account for 73% of 
meningococcal disease cases in the UK (903 in 2001) (Balmer P. et al., 2002a). The 
serogroup B capsular polysaccharide is poorly immunogenic. It shares homology 
with the glycopeptides of the neural cell adhesion molecules (NCAMs), which 
results in the immunological tolerance of the serogroup B capsular polysaccharides. 
Approaches based on components other than capsular polysaccharides are being 
explored to find a suitable serogroup B vaccine. One area under investigation is the 
development of vaccines with outer membrane vesicles (OMVs), which contain LPS 
and OMPs. Trials have been undertaken in both Cuba and Norway using OMV 
vaccines for serogroup B N. meningitidis and efficacies in the range of 50-80% have 
been reported (reviewed in (Jodar L. et al., 2002)). However, little protection in 
children below the age of 4 was achieved. Also these vaccines only elicit strain 
specific protection, though in adults broader responses to heterologous strains were 
reported (Jodar L. et al., 2002). The PorA content of the OMV vaccine and to a lesser 
extent the Opc protein, elicited the bactericidal antibody response and variations in 
PorA (serosuptype) will therefore change the effectiveness of the OMV vaccine.
Approaches using vaccines based on other OMPs, which are conserved between 
strains are being investigated. The transferrin protein B (TbpB) and the neisserial 
surface protein A (NspA), a membrane protein of unknown function, are both being
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explored as potential vaccine candidates (Moe G.R. et al., 2001)(Rokbi B. et al., 
2000)(Rosenstein N.E. et al., 2001)(West D. et al., 2001).
LPS has also been investigated as a potential vaccine candidate, however its 
endotoxic properties presents a problem. It is more likely that LPS will be included 
as a component of potential vaccines because of its adjuvant properties.
1.4 Dendritic cell interactions with micro-organisms
A wide range of micro organisms have been shown to activate DCs including Gram- 
negative bacteria (e.g. Escherichia coli), Gram-positive bacteria (e.g. Staphalococcus 
aureus), protozoa (e.g. Leishmania major and Toxoplasma gondii), fungi (e.g. 
Candida albicans) and viruses (e.g. influenza virus). Purified products derived from 
micro-organisms including LPS, peptidoglycan, lipoteichoic acid and outer 
membrane proteins have also been shown to induce DC activation in vitro (reviewed 
in (Sousa C. et al., 1999a)).
The DC response is not the same to each micro-organism. Differences in the 
expression of DC surface molecules and the release of cytokines by DCs may affect 
the immune response mounted against the micro-organism. For example the fungus
C. albicans exists as unicellular yeasts or as filamentous hyphae and DCs can 
discriminate between the two forms of the fungi. DC interactions with the unicellular 
yeast results in DC maturation and IL-12 production and a Thl response, whereas 
DCs activated by hyphae did not produce IL-12 and induced a Th2 response. The 
hyphae form were also able to escape from the phagosomes (d'Ostiani C.F. et al., 
2000).
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DCs respond to viral infection by activating a potent cytotoxic T lymphocyte (CTL) 
response and producing type I interferons (IFNa/|3). Infection of monocyte derived 
DCs by influenza virus results in increased expression of surface MHC class I and 
interferon production (Celia M. et al., 1999b). The influenza virus double stranded 
RNA was found to be a key component in eliciting this immune response. Though 
myeloid DCs have been shown to be activated by viral antigens, plasmacytoid DCs 
are the major type I interferon producing cells. They are activated by viruses and 
viral components and can induce the stimulation or virus specific CD4+ and CD8+ T 
cells (Celia M. et al., 2000) (Fonteneau J.F. et al., 2003).
Some viruses however have harnessed DC biology to aid their pathogenesis. The best 
characterised example is Human Immunodeficiency Virus (HIV), which infects DCs 
at the site of infection, usually mucosal surfaces. The DCs then traffic to the lymph 
nodes where the virus infects CD4+ T cells (reviewed in (Bhardwaj N., 1997)(Klagge 
I.M. et al., 1999)). The measles virus also utilizes DC biology. DCs infected with 
measles virus are prevented from maturing and are thus unable to prime an anti­
measles T cell response (reviewed in (Bhardwaj N., 1997)(Klagge I.M. et al., 1999)).
1.4.1. Dendritic cells and pattern recognition receptors
The pattern recognition receptors of the innate immune system recognise a wide 
variety of micro-organisms and are a subject of great interest. DCs express many of 
these receptors that bind to micro-organisms including DEC-205 and the mannose 
receptor, these bind and internalise mannosylated antigens and target them to 
intracellular processing compartments (Kato M. et al., 2000),(Mahnke K. et al.,
2000). DCs also express scavenger receptors that bind a diverse array of ligands
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including lipoteichoic acid and lipopolysaccharides and induce phagocytosis (Dunne
D.W. et al., 1994)(Peiser L. et al., 2000). DCs express other receptors that are 
important in the internalisation of opsonised particles such as the Fc family of 
receptors that bind immunoglobulin complexed particles (Fanger N.A. et al., 1996); 
complement receptors that bind and internalise components of the complement 
pathway opsonised to micro-organisms (e.g. C lq and MBL).
These receptors play a fundamental role in the internalisation of various micro­
organisms, but it is unlikely that they can distinguish between many different 
pathogens as they bind to ligands common to a wide range of micro-organisms. 
Other receptors such as Toll-like receptors (TLRs) are likely to play a role in the 
signalling of pathogens to DCs explaining how DCs can mount subtly differing 
responses to different pathogens.
The TLRs are a recently described family of receptors expressed by many cells of the 
immune system. TLRs are homologous to the Drosophila Toll protein, which is 
important in the development of the embryonic dorsal ventral axis. Drosophila Toll 
was first thought to have an immune function because its cytoplasmic domain shares 
homology with that of the mammalian interleukin-1 receptor (IL-1R) (Gay N.J. et al., 
1991). The Spatzle/Toll/Cactus pathway in Drosophila induces the production of the 
anti-fungal peptide drosomycin during fungal infection (Lemaitre B. et al., 1996). 
Data base searches initially revealed 5 homologues of Drosophila Toll in the human 
genome termed Toll-like receptors (TLRs) 1-5. Now the total number of identified 
human TLRs is 10 (Means T.K. et al., 2000)(Rock F.L. et al., 1998). The 10 human
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TLRs and Drosophila Toll are type 1 transmembrane proteins with a conserved 
intracellular domain also common to IL-1R known as Toll/IL-IR (TIR) domains.
Though mammalian TLRs were predicted to have an immune function, it has not 
been easy to identify agonistic ligands. The C3HeJ mouse is hypo-responsive to LPS 
due to a single missense mutation within the tlr4gem  (Watson J. et al., 1978) 
(Hoshino K. et al., 1999)(Qureshi S.T. et al., 1999). The importance of TLR4 in LPS 
signalling was confirmed when DCs from TLR4 knock out mice were found not to 
respond to LPS (Kaisho T. et al., 2001b)(Kaisho T. et al., 2001a). Several other 
accessory molecules have been implicated in the binding and recognition of LPS, 
including CD14, LPS binding protein (LBP) and MD-2. Together with TLR 4, these 
molecules form an LPS binding complex (Fig 1.5). Other ligands for TLR 4 include 
heat shock protein 60 (HSP60), one of the first endogenous ligands identified to 
signal through TLRs (Ohashi K. et al., 2000).
TLR 2 is involved in the recognition of a broad range of microbial products 
including peptidoglycan from Gram-positive bacteria, bacterial lipoproteins, 
mycobacterial cell-wall lipoarabinomannan (LAM), yeast cell walls and LPS from P. 
gingivalis (Hirschfeld M. et al., 1999)(Hirschfeld M. et al., 2001), (Lien E. et al., 
1999)(Means T.K. et al., 1999b) (Means T.K. et al., 1999a)(Schwandner R. et al.,
1999)(Underhill D.M. et al., 1999). This broad range of molecules that signal 
through TLR2 can be partly explained by the co-operation of TLR2 with other TLRs, 
namely TLR1 and TLR6. TLR2 forms heterodimers with TLR6 in response to 
macrophage-activating lipopeptide 2kDa (MALP-2) (Takeuchi O. et al., 2001) and
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blocking of either TLR2 or TLR6 inhibits responses to peptidoglycan or yeast 
zymosan (Ozinsky A. et al., 2000).
Recent studies have shown that TLR3 responds to double stranded RNA (ds RNA), 
which is a product of most viruses at some point in their life cycle (Alexopoulou L. 
et al., 2001). Flagellin, the principle structural component of bacterial flagella in both 
Gram-positive and Gram-negative bacteria signals through TLR5 (Hayashi F. et al.,
2001) and TLR7 is activated by imadazoquinolins, which are synthetic anti-viral 
complexes. However, the natural ligand for TLR7 has yet to be identified, though it 
is likely to be a viral specific molecule (Hemmi H. et al., 2002). Bacterial DNA 
signals through TLR9, which unlike mammalian DNA is rich in unmethylated CpG 
motifs and has immunogenic effects (reviewed in (Krieg A.M., 2000) & (Hemmi H. 
et al., 2000)). TLR9 knock out mice are unresponsive to CpG DNA.
The signalling pathway common to the IL-1R and the TLR family resulting in the 
activation of nuclear factor xB  (NFxB) has been well studied. NFxB is a 
transcription factor that has a central role in the control of expression of a wide 
variety of genes involved in immune responses, including cytokines IL-1, IL-6, IL-8 
and TNFa, and co-stimulatory molecules CD80 and CD86. Myeloid differentiation 
factor 88 (MyD88) is an adapter protein with a TIR domain that associates with 
TLRs and the IL-1R through homophillic interactions of their TIR domains. MyD88 
recruits IL-1 receptor kinase (IRAK), and in turn IRAK recruits another adaptor 
protein called TNF receptor associated factor 6 (TRAF6). The transcription factor 
NFxB is activated and released to translocate to the nucleus by the degradation of 
IxB (Fig 1.5).
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Figure 1.5 The TLR 4 signalling pathway
The LPS signalling complex consists of TLR4, MD-2, LBP and CD 14. The TIR 
domain of TLR4 binds the TIR domain of MyD88, which in turn interacts with 
IRAK via their death domains (DD). The IKK complex phosphorylates IkB releasing 
N F kB , which translocates to the nucleus controlling many genes including pro- 
inflammatory cytokines and co-stimulatory molecules. The MyD88 independent 
pathway observed in TLR 4 signalling is also shown. Adapted from (Bowie A. et al.,
2000)(Underhill D.M. et al., 2002)
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The MyD88/IRAK pathway is common to almost all TLRs and shares many 
elements with IL-1R signalling. There are however other signalling pathways 
activated by TLRs including the TLR3 MyD88 independent pathway and the TLR4 
MyD88 independent pathway (Oshiumi H. et al., 2003)(Yamamoto M. et al., 2002). 
The TLR4 MyD88 independent pathway results in the increase of co-stimulatory 
molecules in DCs but not cytokine production.
The TLR family play a crucial role in the innate immune response. Analysis by RNA 
expression shows that the antigen presenting cells (APCs) DCs and macrophages 
express the full repertoire of TLRs 1-10 (Muzio M. et al., 2000b) (Muzio M. et al., 
2000a). Signalling of TLRs in DCs triggers maturation, including increased 
expression of surface MHC and co-stimulatory molecules, as well as production of 
pro-inflammatory cytokines (Kaisho T. et al., 2001b). As the maturation of DCs is 
essential for the stimulation of naive T cells, the control of the adaptive immune 
system by the innate immune system is at least in part regulated through TLRs.
1.4.2 Dendritic Cells and Neisseria meningitidis
The Gram-negative human pathogen N. meningitidis induces DC activation and 
maturation. DCs stimulated with an LPS deficient group B N. meningitidis produced 
a different cytokine response to the wild type bacteria (Dixon G.L. et al., 2001). Wild 
type N. meningitidis induced DC IL-12 production, whereas in the absence of LPS 
not IL-12 production was detected. This study also showed the importance of LPS in 
the context of the bacteria, as the addition of exogenous LPS did not restore the 
cytokine response to that of the wild type N. meningitidis (Dixon G.L. et al., 2001). 
The different DC response to the LPS deficient N. meningitidis was shown in further
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studies, these also showed no difference in the induction of DC cytokine production 
between the wild type N. meningitidis and a capsule deficient mutant. The un­
encapsulated bacteria bound more readily to DCs and were internalised quicker than 
the capsulated wild type organism, but cytokine production remained the same 
(Kolb-Maurer A. et al., 2001).(Unkmeir A. et al., 2002).
1.5 Aims
The aim of the following work was to investigate further the phenotype of DCs 
following stimulation with N. meningitidis, and the importance of LPS as a 
component of the bacterial outer membrane. Along with DC activation as measured 
by surface marker expression and cytokine production, other aspects of DC biology 
were explored. These included the migratory capabilities of DCs following 
stimulation with N. meningitidis, as well as DC interactions with T cells following 
stimulation with N. meningitidis. The ability of DCs to migrate to the secondary 
lymphoid organs and present antigen to T cells is a crucial part of a DC’s function. 
Both these aspects of DC biology must be considered when deciphering the critical 
components of N. meningitidis in terms of potential vaccines.
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2.1 Introduction
G eneral m ethods com m on  to m ore than on e chapter are explained  here in detail. 
M ore sp ec ific  m ethods are covered  in each o f  the results chapters. A ll reagents, 
equipm ent and antibodies used are listed  in this section .
2.2 Reagents and equipment
2.2.1 General reagents
B elo w  is a list o f  all reagents used in this work.
Reagent Supplier
A ccu tase T C S ce ll w orks, B uckingham , UK
A garose Invitrogen, P a isley , U K
B o v in e  serum  album in (B SA ) Sigm a, P oo le , U K
B refeld in  A Sigm a, P oo le , U K
C ellfix B D  B iosc ien ce , O xford, U K
C FSE M olecular Probes, L eiden , Netherlands
C holera toxin Sigm a, P oole , U K
C itifluor (g lycerol & PB S) Cititfluor, L ondon, U K
C ollagen ase  type 2 Invitrogen, P a isley , U K
D im eth y lsu lp h ox id e (D M SO ) ICN B iom ed ica l, B asingstoke, UK
D N A  ladder (50bp) Invitrogen, P aisley , U K
D eo x y n u cleo tid e  triphosphates (D N T Ps) Prom ega, Southam pton, U K
Ethenediam inetetraacetic acid, d isodium  
salt (E D TA )
B D H  M erck, P oo le , U K
Ethanol B D H  M erck, P oo le , U K
Foetal ca lf serum  (FCS) H yclon e, C ram lington, U K
G elatin 3 0 0  b loom Sigm a, P oo le , U K
G el loading so lu tion Sigm a, P oole , U K
G entam icin Invitrogen, P aisley , U K
G lycerol B D H  M erck, P oole , U K
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Reagent Supplier
G on ococca l agar B D  b iosc ien ce , O xford, U K
G ran u locyte-m on ocyte co lo n y  stim ulating  
factor (G M C SF)
Schering-P lough, H enilw orth , NJ, U S A
H ank’s balanced  salt so lution , w ithout 
Phenol R ed (H B SS)
Invitrogen, P aisley , IJK
H in f 1 restriction en zym e" Prom ega. Southam pton, U K
R ecom binant hum an interleukin-2 (rIL-2) Chiron, E m eryville , C A , U S A
R ecom binant hum an interleukin-4 (rIL-4) Schering-P lough , H enilw orth , NJ, U S A
Ion om ycin Sigm a, P oole , U K
N -[2 -H yd roxyeth y l]p ip eraz in e-N ’-[2- 
ethansu lfon ic  acid] (H EPES)
Invitrogen, P aisley , U K
K anam ycin Sigm a, P oole , U K
L -G lutam ine Invitrogen, P aisley , U K
L ipopolysaccharide ( E .co li) 011 1 B :4 Sigm a, P oole , U K
Lym phoprep
N ycom ed  (A m ersham ), L ittle C halfont, 
U K
M C B D  131 m edium Invitrogen, P a isley , UK
MIP3f5 Peprotech EC ltd, London, U K
M onoparin sodium  heparin CP Pharm aceuticals, W rexham , UK
M uller H inton broth D IFC O , B D  b ioscien ce , O xford, U K
O ligon u cleo tid e  PCR primers S igm a-G en osys, P oo le , U K
Paraform aldehyde (CH 20 ) n Sigm a, P oo le , U K
Percoll A m ersham , L ittle C halfont, U K
P en icillin /S trep tom ycin Invitrogen, P a isley , U K
Perm eabilisation  so lu tion Caltag, B urlingam e, C A , U S A
Pertussis toxin Sigm a, P oo le , U K
Phosphate buffered sa lin e tablets (PBS) O xoid , B asin gstok e, U K
P hytohem agglu tin in  (PHA) Sigm a, P oo le , U K
phorbal 12-m yristate 13-acetate (PM A) Sigm a, P oo le , UK
P oly  (I:C) S igm a, P oole , U K
Potassium  chloride (KC1) B D H  M erck, P oo le , U K
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Reagent Supplier
Prostoglandin  E2 S igm a, P oo le , UK
Q IA m p b lood  kit Q iagen, C raw ley, U K
RPM I 1640  m edium  w ith lO m M  L- 
glutam ine
Invitrogen, P aisley , U K
RPM I 1640  m edium  w ithout phenol red Invitrogen, P a isley , U K
R SA  1 restriction en zym e Prom ega, Southam pton, U K
Saponin Sigm a, P oo le , U K
Sodium  azide (N aN s) B D H  M erck, P oole , U K
S tap h ylococcu s enterotoxin  B (SEB) Sigm a, P oo le , U K
Sodium  chloride (N aC l) B D H  M erck, P oo le , U K
Sodium  hydroxide (NaO H ) B D H  M erck, P oole , U K
[m ethyl 3H] T hym id ine A m ersham , L ittle C halfont, U K
Taq polym erase w ith 10X  PCR buffer and 
M gC l2
Prom ega, Southam pton, U K
TM P so lu tion Europa B ioproducts, C am bridge, UK
Triton X -1 0 0 Sigm a, P oo le , U K
Trypan b lue Sigm a, P oo le , U K
T rypsin-E D T A Invitrogen, P a isley , U K
R ecom binant hum an tum our necrosis 
factor (rT N F a)
G ift from  Dr. K K otow itz
T w een  20  (P o lyoxeth y len e sorbitan  
m onolaurate)
Sigm a, P oo le , U K
V IT O X O xoid, B asin gstok e, U K
2.2.2 Antibodies for flow cytometry, tissue culture and confocal microscopy
A ll the antibodies listed  here are m onoclonal anti-hum an antibodies, w ith the 
excep tion  o f the secon d  and third layers. The conjugated fluorochrom e, isotype and 
sp ecies in w hich  the antibodies are derived is given .
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Antibody Isotype Clone Supplier
C D la P E M ouse IgG2a N A 1/34 Dako, Cambridge, UK
C D 3 purified M ouse IgG2a S4.1 Caltag, Burlingame, CA, USA
C D 3 FITC M ouse IgG2a S4.1 Caltag, Burlingame, CA, USA
C D3 PE M ouse IgG2a S4.1 Caltag, Burlingame, CA, USA
C D3 Tri-Color® M ouse IgG2a S4.1 Caltag, Burlingame, CA, USA
C D 4 FITC M ouse IgG2a S3.5 Caltag, Burlingame, CA, USA
C D 4 PE M ouse IgG2a S3.5 Caltag, Burlingame, CA, USA
C D 8 Purified M ouse IgG2a 3B5 Caltag, Burlingame, CA, USA
C D 8  FITC M ouse IgG2a 3B5 Caltag, Burlingame, CA, USA
C D 8  PE M ouse IgG2a 3B5 Caltag, Burlingame, CA, USA
C D llb M ouse IgG l 2LPM19C Dako, Cambridge, UK
CD 14 purified M ouse IgG2a Tuk 4 Caltag, Burlingame, CA, USA
CD 14 FITC M ouse IgG2a Tiik 4 Caltag, Burlingame, CA, USA
C D 14 PE M ouse IgG2a Tuk 4 Caltag, Burlingame, CA, USA
C D 18 M ouse IgG l MHM23 Dako, Cambridge, UK
CD 19 purified M ouse IgG l SJ25-C1 Caltag, Burlingame, CA, USA
CD 19 FITC M ouse IgG l 4G7 BD  B ioscience, Oxford, UK
C D 25 FITC M ouse IgG l CD25-3G 10 Caltag, Burlingame, CA, USA
C D 25 PE M ouse IgG l C D25-3G 10 Caltag, Burlingame, CA, USA
C D 40 PE M ouse IgM 14G7 Caltag, Burlingame, CA, USA
C D45R A  PE M ouse IgG2b MEM 56 Caltag, Burlingame, CA, USA
CD45RO PE M ouse IgG2a UCHL1 Caltag, Burlingame, CA, USA
CD 56 purified Ab M ouse IgG l M EM -188 Caltag, Burlingame, CA, USA
C D 80(B 7-1) PE M ouse IgG l DAL-1 Caltag, Burlingame, CA, USA
CD83 PE M ouse IgG2b HB15 Caltag, Burlingame, CA, USA
CD 8 6  PE M ouse IgG l BU63 Caltag, Burlingame, CA, U SA
C C R 5PE M ouse IgG2b 45531 R&D, system s M inneapolis, MN, USA
CCR7 purified Ab M ouse IgG2a 150503 R&D, system s M inneapolis, MN, U SA
DC-SIGN (CD209) M ouse IgG2b 120507 R&D, system s M inneapolis, MN, U SA
HLA-DR (Class II) 
FITC
M ouse IgG2b TU 36 Caltag, Burlingame, CA, USA
HLA-DR (Class II) 
PE
M ouse IgG2b TU 36 Caltag, Burlingame, CA, USA
ICAM-1 (CD54) M ouse IgG l 15.2 Serotec, Oxford, UK
ICAM -2 (CD 102) M ouse IgG l B -T l Serotec, Oxford, UK
ICAM -3 (CD50) M ouse IgG l K S128 Dako, Cambridge, UK
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Antibody Isotype Clone Supplier
LFA-1
(CD 11 a/CD 18)
M ouse IgG2a 38 Serotec, Oxford, UK
! L-selectin (CD62L) M ouse IgG2b FMC46 Dako, Cambridge, UK
PECAM-1 (CD31) M ouse IgG l M BC78.2 Caltag, Burlingame, CA, USA
V LA -4
(CD49d/CD29)
M ouse IgG l 44H6 Serotec, Oxford, UK
IL-1 a  PE M ouse IgG l AS5 BD B ioscience, Oxford, UK
IL-2 PE M ouse IgG l 5344.111 BD B ioscience, Oxford, UK
IL-4 PE M ouse IgG l 3010.211 BD B ioscience, Oxford, UK
IL -6  PE M ouse IgG l A S12 BD Bioscience, Oxford, UK
IL-8  PE M ouse IgG l A S14 BD B ioscience, Oxford, UK
IL -10P E Rat IgG l JES3-9D7 Pharmingen, BD B ioscience, Oxford, UK
IL-12 (p40/p70) PE M ouse IgG l C11.5 Pharmingen, BD Bioscience, Oxford, UK
IFN7 FITC M ouse IgG2b 25723.11 BD B ioscience, Oxford, UK
IFN yPE M ouse IgG2b 25723.11 BD B ioscience, Oxford, UK
T N F a PE M ouse IgG l 6401.1111 BD B ioscience, Oxford, UK
MIP1 a FITC M ouse IgG2A 14215.41 R&D, system s M inneapolis, M N, USA
RANTES FITC M ouse IgG l 21445.1-1 R&D, system s M inneapolis, MN, USA
M ouse IgG l FITC M ouse IgG l MOPC-21 Caltag, Burlingame, CA, USA
M ouse IgG l PE M ouse IgG l MOPC-21 Caltag, Burlingame, CA, USA
M ouse IgG2a FITC M ouse IgG2a 5.205 Caltag, Burlingame, CA, USA
M ouse IgG2a PE M ouse IgG2a 5.205 Caltag, Burlingame, CA, USA
M ouse IgG2b FITC M ouse IgG2b M OPC-195 Caltag, Burlingame, CA, USA
M ouse IgG2b PE M ouse IgG2b MOPC-195 Caltag, Burlingame, CA, USA
M ouse IgM PE M ouse IgM
MOPC-
104E
Caltag, Burlingame, CA, USA
M ouse IgG l PE M ouse IgG l X 40 BD B ioscience, Oxford, UK
M ouse IgG l PE M ouse IgG l MOPC-21 Pharmingen, BD Bioscience, Oxford, UK
M ouse IgG2a PE M ouse IgG2a G 155-178 Pharmingen, BD Bioscience, Oxford, UK
M ouse IgG2a M ouse IgG2a 20102 .1 R&D, system s M inneapolis, MN, USA
M ouse IgG2b PE M ouse IgG2b 20116 R&D, system s M inneapolis, M N, USA
2nd and 3rd A ntibody L ayers Supplier
F(ab’)2 goat anti m ouse IgG FITC Dako, Cambridge, UK
F(ab’)2 goat anti mouse IgG PE Dako, Cambridge, UK
F(ab ’)2 goat anti rabbit IgG FITC Sigma, Poole, UK
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2nd and 3rd A ntibody L ayers Supplier
F(ab’)2 goat anti rabbit IgG PE Sigma, Poole, UK
F(ab’)2 goat anti rabbit IgG Biotin Dako, Cambridge, UK
Streptavidin FITC Pharmingen, BD B ioscience, Oxford, UK
Streptavidin CyChrome Pharmingen, BD B ioscience, Oxford, UK
2.2.3 Antibodies and standards for ELISAs
A ntibody pairs and standards (purified recom binant cytok ines) for hum an IL-6, 
IL -10, IL -12(p40) and T N F a  w ere purchased together as C ytoSets™  from  
B ioS ou rce  (C am arillo, C A , U S A ) for E L ISA  determ ination.
2.2.4 General consumables
B elo w  is a list o f  con su m ab les and sm all p ieces o f equipm ent used throughout this 
work.
Materials Supplier
B ijou  7 ml SL S, W ilford, N ottingham , U K
F alcon  tubes 5 ml B D  Falcon, B D  B io sc ien ce , O xford, U K
F alcon tubes 15 m l TPP, Trasadingden, Sw itzerland
F alcon tubes 50  m l TPP, T rasadingden, Sw itzerland
M axisorb E L ISA  plates - 96  w ell N algen e N unc, R ochester, N Y , U S A
G oat anti-m ouse IgG  m icrobeads
M iltenyi B iotech , B ergisch  G ladbach, 
Germ any
96  w ell round bottom  plates for 
F A C S staining
G reiner B io -on e , 
Fricekenhausen, G erm any
T issu e culture p lates - 6 w ell C om in g  (Costar), C om in g , N Y , U S A
T issu e culture p lates - 12 w ell C om in g  (Costar), C om in g , N Y , U S A
T issu e culture p lates - 24  w ell C om in g  (Costar), Corning, N Y , U S A
T issu e culture p lates - 96  w ell C om in g  (Costar), C om in g , N Y , U S A
TC flasks 25 cm 3 B D  Falcon, B D  B io sc ien ce , O xford, UK
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Materials Supplier
U niversal tubes 20  m l H elena B io sc ien ce
C ryo v ia ls N algen e N unc, R ochester, N Y , U S A
TC coated flasks (Primira) B D  Falcon, B D  B io sc ien ce , O xford, UK
F illin g  tube U niversal H ospital Supplies, L ondon, UK
Filter m ats (for Harvester) PerkinElm er (W allac) C am bridge, UK
C overslip s (for m icroscopy) B D H  M erck, P oole , D orset, U K
M acs m agnet Stand
M iltenyi B iotech , B ergisch  G ladbach, 
Germ any
M in i-M acs C olum ns
M iltenyi B iotech , B ergisch  G ladbach, 
Germ any
M in i-M acs M agnet
M iltenyi B iotech , B ergisch  G ladbach, 
Germ any
S lid es (for m icroscopy) B D H  M erck, P oo le , D orset, U K
W ax (for harvester) PerkinElm er (W allac) C am bridge, UK
T ransw ells - 6 .5  m m  Polycarbonate  
m em brane (5 pm  pore)
C orning (Costar), C om in g , N Y , U S A
2.2.5 Equipment
Major Equipment Supplier
F A C Scalibur f lo w  cytom eter
B ecton  D ick in son , (B D  B io sc ien ce), O xford, 
U K
C ell harvester D ynatech Laboratories, C hantilly, V A , U S A
LK B 1218 R ackB eta scintillation  
counter
PerkinElm er (W allac) C am bridge, U K
M R X  m icroplate reader D ynatech Laboratories, C hantilly, V A , U S A
C onfocal m icroscop e L eica  M icrosystem s U K , M ilton  K eynes, U K
P hoen ix  PC R  m achine H elena B io sc ien ce , B eaum ont, T X , U S A
A lpha im ager A lpha Innotech, C annock, Staffordshire U K
Fluorescent m icroscop e L eica M icrosytsem s U K , M ilton  K eynes, U K
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2.2.6 General buffers, solutions and culture media
Milli Q purified water was used to make up the following buffers and solutions 
where appropriate.
Phosphate buffered saline (PBS) 1 PBS tablet to 100 ml H2O
lOx PBS 67.5 g NaCl 
0.625 g Na2H P04
10.5 g KH2PO4
made up to 1000 ml H20
pH 4.6
FACS washing buffer 1 XPBS
0.02% Sodium Azide 
0.5% BSA
Tris borate EDTA (TBE) 108 g Trizma Base 
55 g Boric Acid 
7.44 g EDTA 
made up to 1000 ml H20
ELISA buffer A 8.0 g NaCl 
1.42 g Na2HP04.H20  
0.2 g KH2P 0 4 
0.2 g KC1
made up to 1000 ml H20
L pH 7.4
ELISA block Buffer A 
0.5% BSA
ELISA diluent Buffer A 
0.5% BSA 
0.1% Tween 20
ELISA wash 9.0g NaCl 
1 ml Tween 20 
made up to 1000 ml H20
MiniMACs buffer 250 ml PBS
1 ml 0.5 M EDTA (pH8) 
1.25 g BSA
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Cell wash medium RPMI 1640
5% FCS (heat inactivated [HI])
DC culture medium
T cell culture medium
Human umbilical cord 
storage medium
HUVECS wash medium
HUVECS culture medium
RPMI 1640 
5% FCS (HI)
2.4 mM L-glutamine
100 U/ml Penicillin/Streptomycin
(with 100 ng/ml rGM-CSF and 50 ng/ml rIL-4
when specified)
PM I1640 
10% FCS (HI)
2.4 mM L-glutamine
100 U/ml Penicillin/Streptomycin 
(with 10 U/ml rIL-2 when specified)
PMI 1640
10 mM L-Glutamine
80 pg/ml Gentamicin
100 U/ml Penicillin/Streptomycin
RPMI 1640 
5% FCS (HI)
10 mM L-Glutamine
80 pg/ml Gentamicin
100 U/ml Penicillin/Streptomycin
MCBD 131 
20% FCS
10 mM L-Glutamine
100 U/ml Penicillin/Streptomycin
Trans well medium MCBD 131
20% Human Serum (HI)
10 mM L-Glutamine
100 U/ml Penicillin/Streptomycin
Saponin permeabilisation wash HBSS
0.1% saponin 
2mM Hepes buffer 
0.05% Sodium Azide
66
Chapter 2 M aterials and M ethods
2.3 Cell preparation and culture
2.3.1 Separation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were prepared from venous blood 
donated by healthy volunteers. Blood was taken by venesection (60-100 ml), 
carefully transferred to a heparinized flask (10 IU/ml of blood) and diluted with an 
equal volume of RPMI 1640 medium at 37 °C. The diluted blood was layered onto 
Ficoll/Hypaque at a density of 1.077 g/ml (lymphoprep) and centrifuged at 400g for 
25 minutes at room temperature. The mononuclear cells at the interface were 
recovered and washed three times in cell wash medium. The PBMC were counted on 
a haemocytometer with trypan blue to check viability.
2.3.2 Monocyte isolation
Monocytes have a lower nuclear to cytoplasm ratio than peripheral blood 
lymphocytes (PBL) and they can be separated from PBL by density centrifugation on 
a discontinuous percoll gradient.
Standard Isotonic Percoll (SIP) was prepared by adding 1 part lOx PBS to 9 parts 
percoll (density of 1.793 g/ml). The SIP was then diluted with cell wash medium to 
give 34% SIP (1.045 g/ml), 47.5% SIP (1.059 g/ml) and 60% SIP (1.076 g/ml). The 
PBMC pellet was resuspended in 8 ml of 60% SIP, and 2 ml of this suspension was 
placed into each of four 15ml tubes. Next 4.5 ml of 47.5% SIP was layered on top of 
the 60% SIP cell suspension, followed by 2 ml of the 34% SIP. The tubes were 
centrifuged at 1750 g for 45 minutes at room temperature (Fig 2.1) (Hilkens C.M. et 
al., 1997) (and personal communication with Dr. E deJong).
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CENTRIFUGE 
-----------------------►
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Figure 2.1 Discontinuous percoll gradient separation of monocytes
M on ocytes w ere separated from  P B M C s by centrifugation on a d iscontinuous percoll 
gradient. A fter centrifugation m on ocytes form ed a layer at the interface b etw een  the 
34%  and 47.5%  SIP. P latelets and aggregated ce lls  form ed a susp en sion  in the 34%  
SIP and lym p h ocytes form ed a layer at the interface b etw een  47.5%  and 60%  SIP. 
A ny contam inating red b lood  ce lls  and cell debris pelleted  at the bottom  o f  the tube.
F o llo w in g  centrifugation, the upper layer o f  platelets and aggregated ce lls  w as 
rem oved  and the m on ocytes harvested from  the upper interface. T he m on ocytes w ere  
w ashed  three tim es in co ld  ce ll w ash m edium , counted before the final w ash , and 
then resuspended to a final concentration o f  0 .5  x lO 6 ce lls /m l in D C  culture m edium . 
T he purity o f  the m on ocyte  preparation w as checked  by F A C S analysis for 
contam inating lym p h ocytes using  C D 3, C D  14 and C D  19 antibodies (Fig 2 .2). B efore  
purification, P B M C  contained b etw een  10-20%  C D 1 4 + m on ocytes. A fter purification  
on the d iscon tin u ou s percoll gradient the upper fraction w as found to b e  contain  95%  
C D 1 4 + (Fig 2 .2 ). T he rem aining 5% o f  contam inating ce lls  in the upper fraction w ere  
lik ely  to be T ce lls  ( 3% C D 3 + ) and B ce lls  (1 %  C D 1 9 + ) (F ig 2 .2).
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Figure 2.2 Purity of monocytes following separation by discontinuous percoll 
density gradient.
T he ce ll com p on en ts o f  P B M C s before and after separation on  a percoll gradient 
stained w ith  antibodies to C D 14 , C D 3 and C D 19 . C e lls  w ere not gated.
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2.3.3 Freezing and thawing of peripheral blood lymphocytes
Peripheral blood lymphocytes (PBLs) were recovered from the lower lymphocyte 
rich interface of the percoll gradient, washed twice in cell wash medium and 
resuspended to a concentration of 107 cells/ml in FCS with 10% DMSO. The cell 
suspension was transferred in 1 ml aliquots to cryo-vials and placed in a -80°C 
freezer. After 24 hours the cryo-vials were transferred to liquid nitrogen storage.
When T cells were required for an assay, a cryo-vial containing frozen lymphocytes 
was removed from liquid nitrogen storage and placed into a 37 °C waterbath. The 
tube was agitated gently until only a small ice clump was left. The cell suspension 
was then carefully dropped onto 20 ml of RPMI with 10% FCS at 37 °C in a 
universal tube using a Pasteur pipette. After centrifugation at 300 g for 10 minutes at 
room temperature, the cell pellet was resuspended in 10 ml of cell wash medium, 
washed twice and counted on a haemocytometer with trypan blue to check cell 
viability. T cells were then purified by negative selection.
2.3.4 Purification of CD3+ T cells and CD4+ CD45RA+ T cells by negative 
selection.
T cells and T cell subsets were purified from PBMC using the MACS magnetic cell 
sorting system. Cells to be depleted were labelled with lymphocyte subset specific 
antibodies followed by magnetic anti-immunoglobulin micro beads. After magnetic 
labelling, the cells were passed through a separation column held in a strong magnet. 
The column matrix serves to create a high-gradient magnetic field. The magnetically 
labelled cells are retained in the column while non-labelled cells pass through.
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CD3+ lymphocytes were purified from monocyte depleted PBMC. Unwanted cells 
were labelled with CD14 (10 pg/ml), CD19 (10 pg/ml) and CD56 (10 pg/ml) 
antibodies for 30 minutes on ice in a final volume of 200 pi. The cells were then 
washed twice in 10 ml of cold minimacs buffer, resuspended in 80 pi of buffer and 
20 pi of goat anti mouse immunoglobulin bead suspension, then incubated for 
15 minutes at +4°C with gentle mixing every 5 minutes. The cell and bead mix was 
then washed in 1.5 ml of cold minimacs buffer, centrifuged at 490 g for 7 minutes 
and resuspended in 500 pi of buffer. A column was placed in the holding magnet and 
washed twice with 500 pi of cold minimacs buffer. The cell and bead suspension was 
added to the top of the column held in the magnet. A sterile 20 ml universal was 
placed underneath the column to collect the eluted cells. The column was washed 
three times with 500 pi of cold minimacs buffer. The eluted cells were counted on a 
haemocytometer and resuspended to 1 x 106 cells/ml in T cell culture media.
In experiments where naive CD4+ CD45RA+ T cells were required, the same 
negative isolation procedure as above was followed but with the addition of CD8 
(10 pg/ml) and CD45RO (10 pg/ml) antibodies in the initial antibody incubation 
stage. The purity of the isolated cells checked with antibodies to CD4 and CD45RA 
was found consistently to be 97% CD4+ and 94% CD45RA+ (Fig 2.3)
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Figure 2.3 Purification of CD4+ CD45RA+ T cells
A fter purification  w ith  antibodies and beads on a m in im acs co lu m n , e luted  ce lls  w ere  
stained w ith  C D 4 and C D 45R A  antibodies and analysed  b y  flo w  cytom etry.
2.3.5 Dendritic cells
The d evelop m en t o f  in vitro culture techniques for generating dendritic ce lls  (D C s)  
from  m o n o cy tes  has lead  to a greater understanding o f  D C  b io lo g y  and has m ade it 
p o ssib le  for detailed  studies on the functions o f  D C s to  be carried out (S allusto  F. et 
al., 1994)
2.3.5.1 Generating dendritic cells from monocytes
M o n o cy tes  w ere resuspended  to 0 .5  x lO 6 c e lls /m l in D C  culture m edium  
supp lem ented  w ith  100 n g/m l o f  recom binant hum an G M -C SF  and 50  n g /m l o f  
recom binant hum an IL-4. The m on ocytes w ere added to 12 w e ll tissu e  culture p lates  
at lx lO 6 c e lls /w e ll (2  m l/w e ll) , or in 24  w ell plates at 0 .5 x l0 6 c e lls /w e ll (1 m l/w e ll)  
and cultured for 6  days at 37  °C  in an atm osphere o f  5% C O 2 in air. O n day 6  the  
D C s w ere exam in ed  b y  light m icroscop y  for typ ica l D C  m orp h ology  o f  large, 
irregular shaped v e iled  ce lls . T he D C s w ere then gen tly  w ash ed  from  the w e lls  o f  the
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tissue culture plate in RPMI using sterile Pasteur pipettes and resuspended in fresh 
DC culture medium (without GMCSF or IL-4) to a concentration of 105-106 cells/ml.
The quality of FCS used in culture media proved to be critical, especially in the 
development of DCs from monocytes. Batch testing of different FCS with very low 
endotoxin content was carried out and the most effective batch of FCS was selected. 
FCS was heat inactivated at 56°C for one hour, aliquoted and stored at -20°C.
2.3.5.2 Phenotypic characteristics of dendritic cells
Dendritic cells were identified by flow cytometry using forward and side scatter 
characteristics (Fig 2.4 gate R2). DCs were CD la  positive, CD 14 low, and negative 
for lymphocyte markers CD3 and CD 19 (Fig 2.4). DCs without stimulation also 
expressed CD40, CD80, CD86 and HLA DR (Fig 3.1).
2.4 Cell phenotyping
In the experiments described in this work, cells were characterised by staining with 
monoclonal antibodies for specific surface molecules or for intra cellular cytokine 
expression.
2.4.1 Surface staining
Cells were incubated with the appropriate monoclonal antibody (usually 5pg/ml 
unless otherwise stated) in 96 well plates on ice in the dark for 30 minutes. For each 
monoclonal antibody, a matching isotype control was used to control for non-specific 
binding.
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Figure 2.4 Phenotypic characteristics of dendritic cells
D C s w ere large, granular ce lls  as show n in gate R 2 (A ). T h ey  w ere  C D  la  p ositive , 
C D  14 lo w  and C D  19 and C D 3 negative. Shaded areas represent ce ll surface stain ing  
w ith  m on oclon a l antibodies com pared to the appropriate iso typ e control, so lid  lines  
(B).
C ells  w ere w ash ed  tw ice  in 2 0 0  pi o f  ice  co ld  F A C S w ash in g  buffer at 2 0 0  g  for
5 m inutes. W hen directly  conjugated m on oclon al antibodies w ere  used , the ce lls  
w ere resuspended  in 2 0 0  pi o f  C e llfix  for an a lysis b y  flo w  cytom etry. I f  a secon d  
antibody layer w a s required, sam ples w ere incubated on ice  in the dark for 
3 0  m inutes w ith  FITC or PE conjugated F (ab ’ )2  goat anti-m ouse IgG , then w ashed  
and fix ed  as above.
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2.4.2 Intra cellular staining
For the detection of intracellular cytokines, 10 pg/ml of Brefeldin A was added to the 
cell culture to block the secretion of protein from the Golgi. Cultured cells were 
harvested, washed in cell wash medium and fixed in 1 ml of 2% paraformaldehyde in 
PBS for 15 minutes. Cells were then washed with FACS washing buffer, centrifuged 
at 200 g for 5 minutes, and resuspended in 25 pi of permeabilisation solution. 
Cytokine specific antibodies and the relevant isotype controls were added for 30 
minutes in the dark at room temperature. Cells were washed in 2 ml of FACS 
washing buffer and fixed in 200 pi Cellfix before analysis by flow cytometry.
2.4.3 Flow cytometry
Fixed cells were analysed on a FACScalibur flow cytometer using CellQuest 
software. DCs were identified and gated by their distinctive size and granularity 
characteristics (Fig 2.3). At least 5000 events within the DC gate were collected. For 
the analysis of T cells a CD3+ gate was used (unless otherwise stated), and at least
20,000 events within this gate were collected.
2.5 Enzyme-linked immunosorbent assay (ELISA)
As well as detecting cytokine production by intracellular staining, secreted cytokines 
in supernatants were measured by ELISA. Culture supernatants were harvested by 
centrifugation at 250 g for 10 minutes and then frozen at -80°C until analysed.
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The following method is based on the manufacturers instructions. Maxisorb 96-well 
ELISA plates were coated with 100 pl/well of coating antibody at 1 pg/ml for 18 
hours at 4°C. Plates were washed twice in ELISA wash buffer and blocked for 
2 hours with 300 pl/well of blocking solution on a rotator at room temperature. After 
4 washes, standards and samples were added (100 pl/well) in duplicates. The 
standards were 1:2 serial dilutions of human recombinant protein over the following 
ranges; IL-6 (5,000 pg/ml to 2.5 pg/ml); IL-10 (5,000 pg/ml to 2.5 pg/ml); 
IL-12(p40) (10,000 pg/ml to 5 pg/ml) and TNFa (10,000 pg/ml to 5 pg/ml) (Fig 2.5). 
Samples for IL-6 and IL-10 were used undiluted, samples for IL-12(p40) were tested 
at 1:10 dilution and TNFa at 1:100 dilutions. Blank wells were left as negative 
controls. The plates were incubated for 18 hours at 4°C and then washed 4 times 
followed by the addition of 50 pl/well of biotinylated cytokine specific detection 
antibodies. After 2 hours on a rotator at room temperature, the plates were washed 4 
times followed by the addition of 100 pl/well of streptavidin-horseradish peroxidase 
conjugate. The plates were then incubated for 45 minutes on a rotator in the dark. 
After a further 4 washes, 100 pi of the chromogen TMB substrate buffer were added 
and the plates left to develop on a rotator in the dark for 20-40 minutes until 
sufficient colour appeared. The reaction was stopped by addition of 100 pl/well of 
1.8N H2SO4. The optical density was measured at 450 nm (reference filter 650 nm) 
on a Dynatech MRX microplate reader and analysed using the Revelation software 
(Fig 2.5).
76
Chapter 2 M aterials and M ethods
Standard curves for ELISAs
IL10 
IL6 
IL 12 
TNF
0.6
0.4
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PO/ml
1000 10000
Figure 2.5 ELISA standard curve.
E xam p les o f  standard curves for cytok in e E L IS A s read on  the D ynatech  M R X  
m icroplate reader. T he standard curves w ere form ed from  serial d ilu tions o f  
recom binant cy tok in es starting at 10 ,000  p g /m l for T N F a  and IL -12(p 40) and 
5 ,0 0 0  p g /m l for IL -10  and IL-6.
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2.6 Preparation of Neisseria meningitidis
2.6.1 Bacterial strains
The work presented in this thesis is based on a group B clinical isolate of N. 
meningitidis (H44/76) and an isogenic LPS deficient mutant of the same strain 
(IpxA-), both kindly provided by Professor Peter van der Ley, RIVM, Bilthoven, 
Holland. The serogroup B N. meningitidis strain H44/76 (sero (sub)-type 
(B:15:P1.7,16), ET-5 complex) was isolated from a fatal septicaemia in 
Norway (Andersen S.R. et al., 1995). The viable LPS deficient isogenic mutant IpxA- 
was constructed by insertional inactivation of the IpxA gene with a kanamycin 
cassette as described previously (Steeghs L. et al., 1998). The protein product of IpxA 
is an enzyme required for the first committed step in lipid A biosynthesis. The 
absence of LPS was previously confirmed by Limulus amebocyte lysate (LAL) 
assay, whole cell ELISA using LPS specific monoclonal antibodies and gas 
chromatography/mass spectrometry (Steeghs L. et al., 1998). The IpxA- isogenic 
mutant and the parent both showed similar binding patterns to monoclonal antibodies 
for outer membrane proteins (Steeghs L. et al., 1998)(Steeghs L. et al., 2001a). Purity 
of the IpxA- mutant was maintained by growth on agar plates containing kanamycin 
(100 pg/ml). A cartoon representation of both the wild type and the LPS deficient 
isogenic mutant {IpxA-) H44/76 are shown in Figure 2.6. When grown in the 
presence of cmpNANA, wild type H44/76 has sialated LPS.
2.6.2 Growth and preparation of Neisseria meningitidis
Growth and preparation of live N. meningitidis was carried was carried out in a Class 
I safety cabinet housed in a category 3 containment facility at negative pressure. 
Aliquots of N. meningitidis strains were stored in Mueller-Hinton broth with 15%
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g ly cero l at -8 0 °C . B acteria w ere plated d irectly  from  frozen  stock s onto fresh  
g o n o co cca l agar p lates supplem ented w ith  V ito x , and incubated at 36°C  in an  
atm osphere o f  6%  C O 2 . O rganism s w ere sub-cultured at least on ce , and harvested in 
stationary phase at 16 to 18 hours after the prev iou s sub-culture for use. C o lon ies  
w ere streaked from  plates w ith  sterile cotton w o o l sw ab s into R PM I 1640 (w ithout 
p h en ol red). T he optical d ensity  (O D ) o f  a ten  fo ld  d ilu tion  o f  the bacterial 
su sp en sion  w as determ ined using  a spectrophotom eter at 5 4 0  nm . The bacterial 
su sp en sion  w as then adjusted to  an O D  o f  1.0. It w a s sh ow n  b y  serial d ilu tions, 
plating and v ia b ility  counts, that a su sp en sion  o f  organ ism s in stationary phase at O D
1.0 conta ins around 109 organism s/m l (G . D ix o n  personal com m u n ication ).
Wild Type IpxA-
C apsule
Organism
LPS
Figure 2.6 Schematic representation of N. meningitidis H44/76 wild type and the 
LPS deficient isogenic mutant IpxA-,
T he w ild  type bacterium  p o ssesse s  a capsule and L PS. T he IpxA- iso g en ic  m utant is  
to ta lly  LPS d efic ien t but p o ssess  a capsule. A dapted  from  (Jack D .L . et a l., 1998) and  
(D ix o n  2 0 0 0 ).
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Bacteria for use in DC activation experiments were fixed in 0.5% paraformaldehyde 
in PBS for 15 minutes then washed thoroughly in RPMI medium. This treatment 
rendered bacteria non-viable as judged by viability counts and propidium iodide 
staining (G. Dixon personal communication). Aliquots of fixed bacteria at a 
concentration of 109 organisms/ml were stored at -80°C until use.
FITC labelled N. meningitidis bacteria were used in phagocytosis studies. After 
fixation, the bacteria were incubated with 0.5 mg/ml of FITC for 20 minutes at 37 °C 
followed by 4 washes in RPMI 1640 (without phenol red) to remove excess unbound 
FITC. The OD of the bacterial suspension was adjusted to 1.0 as before. FITC 
labelling of N. meningitidis has no effect on the bacteria’s ability to stimulate DCs 
(H. Uronen personal communication).
Meningococcal LPS from N. meningitidis serogroup B strain H44/76 was prepared 
by Dr. Svein Andersen (Edward Jenner Institute for Vaccine Research, Newbury, 
UK). Briefly LPS was extracted by hot aqueous phenol extraction, ultra- 
centrifugation, gel filtration and cold ethanol NaCl precipitation. The final product 
contained <0.3% protein and was without detectable nucleic acids (Andersen S.R. et 
al., 1996).
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3.1 Introduction
DC maturation is a process that includes the loss of endocytic activity and an 
increase in surface co-stimulatory and MHC molecules as well as the production of 
cytokines and chemokines. DC maturation is induced by many different micro­
organisms including bacteria, viruses and protozoa as well as by purified microbial 
products including LPS, peptidoglycans, lipoteichoic acid and CpG DNA and by 
cytokines TNFa and IL-1 (3, (reviewed in (Sousa C. et al., 1999)). The Gram-negative 
bacteria N. meningitidis has been shown to induce DC maturation and cytokine 
production (Dixon G.L. et al., 2001)(Kolb-Maurer A. et al., 2001)(Unkmeir A. et al., 
2002)
The work described in this chapter lays the foundations for the rest of this study by 
establishing conditions for DC activation by N. meningitidis, including the role of 
bacterial concentration.
3.2 Methods
3.2.1 Stimulation of dendritic cells
Monocyte derived DCs were harvested from plates on day 6, washed and 
resuspended to 5 x 105 cells/ml, then stimulated with wild type N. meningitidis, the 
LPS deficient IpxA-, purified meningococcal LPS or other stimuli at varying 
concentrations for 16-18 hours. Other stimuli used include Prostaglandin E-2 (PGE- 
2), pertussis toxin (PT), cholera toxin (CT) and poly IC (synthetic viral-like double 
stranded RNA) as their ability to bias DCs to a Thl or Th2 response has been 
reported (de Jong E.C. et al., 2002). Brefeldin A (10 pg/ml) was added to the cultures
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for 18 hours when intracellular cytokines were to be measured. Maturation markers 
on DCs were measured by flow cytometry, as were intracellular cytokines. Cell 
culture supernatants were stored at -80 °C for later analysis by ELISA.
3.3 Results
3.3.1 M aturation of dendritic cells in response to N. meningitidis 
The ability of N. meningitidis to induce maturation of DCs was examined by culture 
of immature day 6 monocyte-derived DCs with wild type or IpxA- strains of N. 
meningitidis', purified meningococcal LPS or in medium alone for 18 hours. 
Stimulation of DCs with the wild type N. meningitidis resulted in an increase in 
expression of CD40, CD80, CD83, CD86 and HLA-DR, as well as a decrease in 
CD14 as compared to DCs cultured in medium alone (Fig 3.1). These changes in 
expression of surface markers are consistent with DC maturation. Stimulation with 
the LPS deficient IpxA- also resulted in DC maturation, though increases in some 
markers, especially CD80, CD83 and CD86 were not as great as with the wild type 
bacteria. Purified meningococcal LPS also proved to be a good inducer of DC 
maturation as measured by an increase in expression of co-stimulatory and activation 
markers, although LPS did not induce maturation to the same extent as the wild type 
bacteria. Increases in other markers including CD25 and HLA DQ were also seen 
(data not shown). DCs cultured in medium alone displayed the characteristics of 
immature DCs; i.e. low expression of CD 14, low expression of co-stimulatory 
molecules CD40, CD80 and CD86 and negative for DC maturation marker CD83.
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Figure 3.1 Dendritic cell maturation in response to N. meningitidis.
DCs were stimulated for 18 hours in the presence of medium alone, 10 ng/ml of 
purified meningococcal LPS, 107 organisms/ml of wild type or IpxA- N. meningitidis 
or IpxA- (107 organisms/ml) plus purified LPS (10 ng/ml). The cells were then 
stained for surface markers. DCs were gated according to size and granularity and 
analysed for CD 14, CD40, CD80, CD83, CD86 and HLA-DR expression as shown 
(filled histograms) along with appropriate isotype control (solid lines), the MFI 
(Median Fluorescent Intensity) of each peak is given. The data are a representative of 
6 independent experiments.
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3.3.2 Effect of bacterial concentration on dendritic cell maturation
To determine the dependence of DC maturation on bacterial concentration, DCs were 
stimulated with wild type and IpxA- bacteria at concentrations from 105 to 
107 organisms/ml (Fig 3.2). As before DCs were cultured for 18 hours before 
antibody staining for surface markers.
DCs responded to both the wild type and IpxA- bacteria in a dose dependent manner 
with an increase in expression of maturation markers corresponding to an increase in 
bacterial concentration. At all concentrations of bacteria, the wild type organisms 
induced greater DC maturation than the LPS deficient isogenic mutant IpxA- (Fig 
3.2). At low concentrations (105 organisms/ml), the wild type N. meningitidis 
increased expression of DC CD40, CD80, CD83 and HLA DR; and decreased CD 14 
typical of DC maturation. However, IpxA- only induced an increase in DC surface 
marker expression at 106 organisms/ml and above. At lower concentrations of 
bacteria there was a greater difference in the ability of the wild type compared to the 
IpxA- N. meningitidis to induce DC maturation, especially in CD80 and CD83 
expression.
3.3.3 Dendritic cell cytokine production after stimulation with N. meningitidis 
To investigate cytokine production by DCs after stimulation with N. meningitidis, 
DCs were cultured for 18 hours with wild type or IpxA- H44/76 at 107 organisms/ml; 
purified meningococcal LPS (10 ng/ml); prostaglandin E2 (PGE2) (10'6M) or in 
medium alone. For analysis by intracellular cytokine staining, brefeldin A was added 
to the culture medium to block protein secretion from the Golgi.
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Figure 3.2 Maturation of dendritic cells in response to different concentrations 
of wild type and IpxA- N. meningitidis H44/76
D C s w ere stim ulated  for 18 hours in the presence o f  105, 106 or 107 organ ism s/m l o f  
w ild  typ e and IpxA- N. meningitidis H 4 4 /76 . D C  responses to m edium  alone and 
10 n g /m l o f  purified  m en in gococca l L PS are a lso  show n. T he c e lls  w ere stained for 
surface m arkers C D  14, C D 40 , C D 8 0 , C D 83 and H L A -D R  and the data are expressed  
as the m ean w ith  the SE M  o f  4  independent experim ents. A  non-param etric M ann- 
W h itn ey  U  test w as used  to m easure s ign ifican ce o f  proliferation  com pared to the 
m edium  control.
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Intracellular cytokine levels were measured by flow cytometry (Fig 3.3). The wild 
type N. meningitidis induced DCs to produce IL-la, IL-6, TNFa and IL-12(p70). 
DC stimulation with the IpxA- bacteria resulted in IL-la, IL-6 and TNFa production, 
but to a much lesser degree than the wild type, and very little IL-12(p70) production. 
Purified meningococcal LPS was found to be a poor inducer of cytokine production 
in DCs with only low levels of IL-6 detected. The addition of exogenous purified 
LPS to cultures of DCs with the LPS deficient IpxA- bacteria did not restore cytokine 
production to that observed with the wild type bacteria (Fig 3.3).
Intracellular cytokine staining is a very useful tool for looking at cytokine production 
in cells as it allows the identification and gating of specific cell populations. 
However, IL-10 was found to be difficult to measure by intracellular staining (data 
not shown). ELISAs measure the overall secreted cytokines in cell free culture 
supernatants and this enabled DC IL-10 production to be measured. Supernatants 
from DC cultures were collected after 18 hours stimulation (without brefeldin A) and 
stored at -80°C until used. Sandwich ELISAs for the cytokines IL-6, IL-10, 
IL-12(p40) and TNFa were performed on the supernatants (Fig 3.4).
Results obtained by ELISA were consistent with intracellular cytokine assays. DCs 
stimulated with the wild type N. meningitidis secreted very high levels of IL-10, 
IL-12(p40) and TNFa. The -bacteria induced IL-6 but little IL-10, IL-12(p40) or 
TNFa. Purified LPS induced very little cytokine production (some IL-6) and PGE2 
did not induce any detectable cytokine production (Fig 3.4).
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Figure 3.3 Cytokine production by dendritic cells in response to wild type and 
LPS deficient IpxA- N. meningitidis.
DCs were stimulated for 18 hours with 107 organisms/ml of wild type or IpxA- N. 
meningitidis, meningococcal LPS (10 ng/ml), IpxA- (107 organisms/ml) plus purified 
LPS (10 ng/ml) or medium alone. Cells were permeabilised and stained for 
intracellular cytokines IL-la, IL-6, TNFa and IL-12(p70). Data are representative of 
5 different experiments. The percentage of positive cells in the upper right quadrant 
is given.
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Figure 3.4 Secreted cytokines by dendritic cells measured by ELISA
D C s w ere stim ulated for 18 hours w ith  107 organ ism s/m l o f  w ild  typ e H 4 4 /7 6  or the  
L PS d efic ien t IpxA-, m en in gococca l LPS (1 0  n g /m l), P G E 2 (1 0 '6 M ) or m edium  
alone. C ell free supernatants w ere co llected  and cy tok in es IL -6, IL -10 , T N F a  and  
IL -1 2 (p 4 0 ) w ere m easured b y  E L ISA . D ata are exp ressed  as the m ean and SE M  o f  4  
separate experim ents (* p < 0 .0 5  b y  paired student t test com pared to m edium  
control).
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3.3.4 Activation of dendritic cells with other stimuli
DCs activated by cholera toxin and prostaglandin E2 (PGE2) have been well 
characterised and found to induce a Th2 response in naive T helper cells. Whereas 
DCs stimulated with poly I:C and pertussis toxin have been shown to induce a Thl 
response (de Jong E.C. et al., 2002)(Kalinski P. et al., 1997). For this reason it was 
important to assess the activation of DCs induced by N  meningitidis compared to 
these other characterised stimuli in this system.
DCs were cultured for 18 hours in the presence of cholera toxin (1 pg/ml); PGE2 
(10'6M); Poly I:C (20 pg/ml), pertussis toxin (1 pg/ml), wild type N. meningitidis 
(107 organisms/ml) or in medium alone. DC maturation was assessed by surface 
marker expression (Fig 3.5). Cholera toxin, pertussis toxin, Poly I:C and PGE2 
induced DC maturation as can be seen by an increase in CD40 and HLA DR and a 
decrease in CD 14 compared to the medium control. Interestingly both cholera toxin 
and PGE2 caused a decrease in CD83 expression compared to the medium control. 
The wild type N. meningitidis induced the greatest maturation as observed by 
increases in these surface markers.
DC cytokine production in response to these stimuli was also measured. After 18 
hours culture in the presence of cholera toxin (1 pg/ml); PGE2 (10’6M); Poly I:C 
(20 pg/ml) and pertussis toxin (1 pg/ml) cell free supernatants were collected and 
stored at -80°C. Sandwich ELISAs for the cytokines IL-6, IL-10, IL-12(p40) and 
TNFa were performed on the supernatants (Fig 3.6).
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Figure 3.5 Dendritic cell surface marker expression after stimulation with other 
characterised stimuli
D C s w ere stim ulated  for 18 hours in the presence o f  cholera to x in  (1 pg /m l);  
prostaglandin  E 2 (P G E 2) (10 '6 M ); P o ly  I:C (2 0  p g /m l) or pertussis tox in  (1 p g /m l). 
D C s cultured w ith  w ild  type H 4 4 /7 6  N. meningitidis (1 0 7 organ ism s/m l) or m edium  
a lon e are sh ow n  for com parison. D C s w ere then stained for C D  14, C D 4 0 , C D 83 and  
H L A -D R  exp ression . T he data are representative o f  3 independent experim ents.
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Interestingly changes in surface marker expression, with the exception of CD83, 
indicated that there was little difference in the level of DC stimulation by these 
microbial products. However when cytokine secretion was analysed by ELISA, Poly 
I:C and pertussis toxin did induce cytokine production, notably TNFa, IL-6 and IL- 
12(p40) but little IL-10. Prostaglandin E2 and cholera toxin induced almost no 
detectable cytokine production. None of the stimuli induced cytokine levels to that of 
the wild type N. meningitidis.
3.4 Discussion
Dendritic cell maturation is associated with several co-ordinated events; including 
loss of endocytic receptors, increased expression of co-stimulatory molecules (CD40, 
CD80, CD86), increases in surface MHC molecules, a change in expression of 
chemokine receptors from CCR5 to CCR7 and cytokine production. These changes 
that occur during DC maturation facilitate migration, antigen presentation and T cell 
activation. The morphology of mature DCs is also different to immature DCs. 
Immature DCs are irregular shaped with a “ruffled” surface. Upon maturation DCs 
become rounded but with many long and fine dendritic projections (Palucka K. et al., 
1999).
LPS is regarded as the major immunogenic component of Gram-negative bacteria, 
and purified LPS alone can induce DC activation and maturation. The importance of 
LPS in DC activation was investigated here using the LPS deficient IpxA- strain of A. 
meningitidis. Wild type N. meningitidis H44/76 induced DC maturation, as shown by
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Figure 3.6 Cytokine production by dendritic cells after stimulation with Thl or 
Th2 inducing stimuli.
D C s w ere stim ulated for 18 hours in the presence o f  cholera  tox in  (C T)(1 pg/m l);  
prostaglandin  E 2 (P G E 2) (10 '6 M ); P o ly  I:C (2 0  p g /m l), pertussis tox in  (PT) 
(1 p g /m l), w ild  type H 4 4 /7 6  (1 0 7 organ ism s/m l) or m edium  alone. C ell free 
supernatants w ere co llec ted  and cytok in es IL -6, IL -10 , T N F a  and IL -12(p 40) w ere  
m easured b y  E L ISA . T he data are a representative o f  3 independent experim ents.
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an increase in surface co-stimulatory and MHC molecules, and by the production of 
cytokines. The IpxA- also induced DC maturation, but not to the same extent as the 
wild type. Thus bacterial components other than LPS must be responsible for the DC 
response to IpxA-. Possible candidates are the OMPs PorA and PorB. These are 
immunogenic, inducing CD86 expression and proliferation in B cells. They have 
been shown to signal via the TLR2 MyD88 dependent pathway (Massari P. et al., 
2002). Bacterial DNA, rich in unmethylated CpG motifs is also immunogenic and 
signals via TLR9 and may also account for the DC response induced by IpxA- 
(Sparwasser T. et al., 1998).
OMP expression by the IpxA- bacteria and the wild type is very similar, the only 
difference being an increase in cell surface lipoproteins in the outer membranes of 
IpxA- organisms. Therefore, the differences observed between DC stimulation with 
the wild type compared to the IpxA- was most likely due to the absence of LPS. The 
IpxA- N. meningitidis were only able to induce DC activation at concentrations of 
106 organisms/ml or higher, whereas the wild type activated DCs at low 
concentrations of bacteria (105 organisms/ml), indicating that LPS is an important 
component in stimulating DCs at low bacterial concentrations.
The addition of exogenous purified meningococcal LPS with IpxA- bacteria did not 
reconstitute the DC response to that of the wild type bacteria, even though the LPS 
added (10 ng/ml) was equivalent to the LPS content of 107 organisms/ml. This is 
based on the measurement of the LPS content of N. meningitidis by 
spectrophotometric analysis of the LPS specific sugar 2-keto-3-deoxyoctonic acid
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(KDO), which demonstrated that there are approximately 1.5 x 105 molecules of LPS 
per bacterium (Dixon 2000).
The inability of exogenous LPS to restore DC responses to IpxA- to that of the wild 
type N. meningitidis was puzzling and suggested that LPS must be coupled to the 
bacteria for optimal DC responses. There are several possible reasons for this. One 
explanation could be differences in the structural confirmation of LPS. Purified LPS 
molecules aggregate into large supra molecular structures whereas in whole bacteria 
LPS molecules are anchored in the outer membrane (Erridge C. et al., 2002). It is 
possible that the formation of these aggregates affect the recognition of LPS by its 
receptors and hence reduces the endotoxicity of purified LPS preparations compared 
to LPS in the membrane of bacteria. A further explanation is that on the surface of 
the bacteria LPS would be in close proximity to, and even complexed with outer 
membrane proteins. LPS is known to signal through TLR4 (Beutler B., 2000) and the 
OMPs on N. meningitidis have been shown to signal through TLR2 (Massari P. et al., 
2002). Perhaps simultaneous engagement of both of these receptors, and others, is 
required for optimal DC responses. Moreover soluble molecules such as LPS are 
taken up by macro-pinocytosis, whereas whole bacteria are internalised by receptor 
mediated endocytosis and phagocytosis (reviewed in (Lanzavecchia A., 1996)). 
These different methods of uptake deliver purified LPS and IpxA- bacteria to separate 
compartments of the endocytic pathway and this may affect the way in which DCs 
are activated.
In this study, purified meningococcal LPS alone was a poor inducer of DC 
activation, especially compared to wild type N. meningitidis. Stimulation with
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meningococcal LPS did result in an increase of DC surface co-stimulatory and MHC 
molecules, but very little cytokine production, especially IL-12. This is in contrast to 
previous studies that have shown DC activation and cytokine production by LPS 
(Rescigno M. et al., 1998a) (Verhasselt V. et al., 1997). These previous studies used 
LPS from Escherichia coli whereas LPS used here was from N. meningitidis. LPS 
from N. meningitidis may not be as potent as the LPS from E. coli in the stimulation 
of DCs. Though this has not been tested directly in DCs, in monocytes E. coli LPS is 
a more potent inducer of IL1(3 production than LPS from N. meningitidis (Erridge C. 
et al., 2002). Furthermore, following extensive treatment by phenol extraction and 
ethanol precipitation the N. meningitidis LPS used here was highly pure, containing 
less than 0.3% protein (Andersen S.R. et al., 1996). Commercially available E. coli 
LPS preparations have been found to contain impurities. This situation was 
highlighted when LPS was found to activate through both TLR2 and TLR4 (Yang 
R.B. et al., 1999). It was only after purification of LPS preparations that it was found 
that TLR4 was the LPS signalling receptor and not TLR2 (Tapping R.I. et al., 2000). 
The impurities in commercially available E. coli LPS could explain the previously 
reported DC maturation and cytokine production.
The tissue factor Prostaglandin E2 and toxin from the extra-cellular bacterium Vibrio 
cholerae are both associated with Th2 responses (de Jong E.C. et al., 2002). In 
contrast toxin from the intracellular bacteria Bordetella pertussis and the synthetic 
viral RNA molecule poly IC have been shown to induce a Thl response (Ausiello 
C.M. et al., 2002)(de Jong E.C. et al., 2002). These stimuli all induced DC 
maturation in terms of increased surface marker expression. However there were 
differences in the cytokine production induced by these stimuli. The Thl inducing
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Poly IC and PT both induced DCs to produce cytokines (IL-6, TNFa and IL-12), 
although the amounts produced were much less than observed with the wild type 
N. meningitidis. In contrast the Th2 inducing CT and PGE2 did not induce any 
detectable cytokine production by DCs.
These experiments established conditions for DC activation by N. meningitidis. 
Differences were found in DC maturation and cytokine production by the LPS 
deficient IpxA- compared to the wild type N. meningitidis. Next DC activation was 
investigated further by exploring the effects of N. meningitidis stimulation on DC 
migration.
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4.1 Introduction
Following stimulation by pathogens or inflammatory stimuli, DCs leave the 
peripheral site of infection and migrate through the tissues to the draining lymph 
nodes where they interact with naive T cells. The ability of DCs to migrate is related 
to changes in expression of adhesion molecules and chemokine receptors.
The role of adhesion molecules in the migration of leukocytes through endothelium 
has been well studied. Selectins and their mucin ligands are the major molecules 
involved in tethering and rolling whereas integrins and their immunoglobulin super 
family ligands mediate firm adhesion. Although not much is known of the adhesion 
molecules involved in DC migration, it is likely that the same molecules that mediate 
migration of other leukocytes are involved. Immature and mature DCs express many 
adhesion molecules including ICAM-1, ICAM-2, ICAM-3 and PECAM-1. ICAM-1 
expression increases upon DC stimulation (Starling G.C. et al., 1995) whereas 
ICAM-2 and ICAM-3 are expressed at a high density on DCs and show little change 
upon DC maturation (Hart D.N. et al., 1993). The involvement of these molecules in 
the migration of DCs is not fully understood. The (32 integrin CD 18 has been shown 
to be essential for the migration of DCs to the peripheral tissues, including the lungs 
(Schneeberger E.E. et al., 2000) and the immunoglobulin-super family adhesion 
molecule ICAM-1 is important in Langerhans cell migration to lymph nodes (Xu H. 
et al., 2001).
Chemokines are also very important for DC migration. Immature DCs express 
chemokine receptors CXCR1, CCR1 and CCR5 and respond to inducible
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chemokines produced at inflammatory sites including MCP-1 (CCL2), M IP-la 
(CCL3) and RANTES (CCL5) (Sozzani S. et al., 1997). Following activation, DCs 
increase their expression of CCR7 and decrease expression of CXCR1, CCR1 and 
CCR5. The increase in CCR7 is thought to be important for DC migration through 
lymphatics, where the CCR7 ligands MIP-3|3 (CCL19) and 6Ckine (CCL21) are 
constitutively expressed (Sallusto F. et al., 1998).
In the previous results section, LPS expressed by the bacteria was shown to be 
required for optimal DC activation by N. meningitidis and cytokine production. In 
this next section, the requirement for LPS in N. meningitidis to induce DC migratory 
factors such as chemokines, chemokine receptors, adhesion molecules and DC 
migration were investigated.
4.2 Methods
4.2.1 HUVEC extraction and primary culture
Human umbilical vein endothelial cells (HUVEC) are an easily available and a well 
characterised source of primary endothelial cells. The method for extraction was 
originally described by (Gimbrone M.A., Jr. et al., 1974), (Jaffe E.A. et al., 1973) 
and modified in our laboratory by Dr. Karolena Kotowicz (Kotowicz K. et al., 1996).
Fresh intact cords were collected from the maternity ward of a local hospital with 
ethical approval and maternal consent. The collected cords were stored in ‘human 
umbilical cord storage medium’ and used within 72 hours. Suitable cords were 
sprayed on their outer surface with 70% IMS and any blood was expressed by gentle
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squeezing into a waste collection pot. Each cord was trimmed by cutting at least 
0.5 cm from both ends. One end of the cord was then clamped with artery forceps 
and the vein at the other end was dilated with blunt forceps, and cannulated with a 
sterile plastic filling tube, which was secured with small artery forceps. Blood was 
removed by flushing the vein with warm HUVEC wash medium from a 50 ml 
syringe. The vein was then filled with 1% collagenase II solution and the cords 
incubated at 37 °C in 5% CO2 for 10-20 minutes. After the incubation period, the 
digest was removed from the cord vein into a sterile Duran bottle and the cord vein 
was flushed through with an equal volume of HUVEC wash medium. The digest 
containing HUVECs was transferred to a sterile 50 ml conical tube and centrifuged at 
200 g for 7 minutes at room temperature. The supernatant was discarded and the cell 
pellet was resuspended in MCBD 131 medium supplemented with 20% FCS, 10 mM 
L-glutamine and 100 U/ml penicillin/streptomycin. The digest from a large cord 
(enough to take 20 to 30 ml of collagenase) was resuspended to 10 ml with culture 
medium and transferred to a 25 cm3 modified polystyrene tissue culture flask 
designed for the culture of adherent cells. The cells were incubated at 37 °C and 5% 
CO2 for 24 hours and then washed with fresh HUVEC culture medium and inspected 
by light microscopy. HUVECs have a characteristic cobblestone appearance, and 
form small clusters. Flasks of HUVECs were subcultured when cells were 
approaching confluence, usually around 72 hours of culture. To subculture, HUVECs 
were washed three times in warm non-supplemented RPMI 1640 to remove non­
adherent cells and FCS proteins. The cells were then rinsed in 2 ml of accutase and a 
further 2 ml of accutase added and the flask placed on a shaker at 37 °C in 5% CO2 
for 10 minutes. The cells were inspected by microscopy and when they were 
rounding and becoming dislodged they were resuspended in fresh culture media
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(MCBD 131 with 20% FCS and antibiotics). The cell suspension was divided equally 
between two 25 cm3 tissue culture flasks and made up to 10 ml with culture medium. 
The HUVECs were then cultured at 37 °C in 5% CO2.
4.2.2. Culture of endothelial cells in transwells
The 6.5 mm transwell inserts have a polycarbonate membrane with 5 pm pores. A 
solution of 10% 300 bloom gelatine was prepared in dd H2O and autoclaved. Then 
100 pi of gelatine was carefully added to the top of each transwell insert and left to 
dry overnight at room temperature. The 24 well plate containing the transwells and 
gelatine was placed in an oven at 60 °C and baked for 1-2 hours. The gelatine was 
then conditioned by adding 1 ml of MCBD with 20% FCS to each well for at least 2 
hours.
Confluent HUVECs were washed in warm RPMI and released from the tissue culture 
flask with accutase. The cell suspension was transferred to a 50 ml conical tube, 
washed and resuspended in 2 ml of transwell medium. The cells were counted on a 
haemocytometer and 100 pi of the HUVEC suspension at 106 cells/ml in transwell 
medium added to the top of each transwell insert (105 cells/well) and incubated at 
37 °C at 5% CO2. Every 2 or 3 days the transwell inserts were transferred to new 
wells with 0.6 ml of fresh transwell media. For each experiment, two transwells were 
left with only the gelatine coating without HUVECs as controls for measuring 
resistance (see below) and a control for the migration experiments.
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WELL DAY 8 DAY 10 DAY 12
1 131 166 167
2 138 171 167
3 138 162 164
4 142 173 167
5 130 169 165
6 127 166 168
7 137 171 164
8 133 177 167
9 143 181 179
10 144 179 176
11 136 180 163
12 140 174 177
BLANK 98 107 96
Table 4.1 EVOM readings of HUVEC monolayers grown on transwells
Resistance readings (Qcm‘2) were taken every other day using the EVOM. Duplicate 
readings in each well were taken from opposite sides of the transwell and the mean 
given. The monolayers were deemed confluent when the resistance readings no 
longer increased and were at least 50Q'2 greater than the control of gelatine and 
media alone (blank).
4.2.3 Integrity of HUVEC monolayers measured by resistance
An electrical voltage ohm meter (EVOM) was used to check the integrity of the 
endothelial layers in the transwells. The EVOM measures the resistance through the
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endothelial layer, which increases as the cells become confluent (Ali M.H. et al., 
1999). The EVOM probe was soaked in 100% ethanol for 20 minutes then rinsed 
with fresh RPMI 1640 prior to use. One prong of the probe was placed above the 
endothelial monolayer in the upper chamber with the other prong in the lower 
chamber. The resistance was measured every second day. Once the resistance had 
reached a steady state of around 50 Qcm'2 more than the control transwell of 
gelatine and medium only, and no longer increased, the monolayers were ready. 
Typically this occurred after 10-14 days of culture (Table 4.1). Confluence of the 
endothelial layers was confirmed by confocal microscopy (not shown).
4.2.4 Dendritic cell migration across endothelial monolayers
DCs were prepared and stimulated with Neisseria meningitidis H44/76 wild type, the 
LPS deficient isogenic mutant IpxA- (both at 107 organisms/ml), or in medium alone 
for 18 hours as described in section 3.2. If stimulation of the HUVEC monolayers 
was required, recombinant TNFa was added to the top of the transwell to give a final 
concentration of 1 ng/ml for 18 hours before adding DCs. The stimulated DCs were 
washed, resuspended to 5x106 cells/ml in DC culture medium and lOOpl of the DC 
suspension added to the top of each transwell (5 xlO5 per well). Fig 4.1 shows a 
schematic representation of the transwell system.
The media containing migrated DCs was recovered from the lower chamber of the 
transwell system and centrifuged at 350 g for 5 minutes. The pellet was resuspended 
in 100 pi RPMI with 5% FCS and the cells counted on a haemocytometer in trypan 
blue. Triplicate counts were made for each condition and time point, and the mean 
number of migrated cells was calculated.
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Transwell insert 
Dendritic Cells 
Endothelial Cell monolayer
Figure 4.1 Schematic Diagram of the Transwell system
T he transw ell w as p laced  in the w ell o f  a 2 4  w e ll tissu e  culture plate. T he endothelial 
m on olayer  w as grow n on  gelatine on  a polycarbonate m em brane w ith  5 pm  pores. 
D endritic c e lls  m igrated across the endothelia l m em brane, through the polycarbonate  
m em brane and into the cham ber b e lo w  w here they  w ere co llec ted  and counted.
4.2.5 Dendritic cell migration in the presence of the chemokine Mip3p (CCL19)
T o determ ine D C  m igration in response to the ch em ok in e M ip 3p , the transw ell 
system  w a s used  w ithout the endothelia l m onolayers and gelatin e coating. T he  
bottom  cham ber o f  the transw ell system  w as filled  w ith  0 .6  m l D C  culture m edia  
supplem ented  w ith  the ch em ok in e M IP -3p  at varying concentrations. M igrated ce lls  
w ere co llec ted  from  the low er cham bers at varying tim e points and counted as 
before.
106
Chapter 4 Dendritic Cel] M igration Following Activation by Neisseria meningitidis
4.3 Results
4.3.1 Expression of adhesion molecules on dendritic cells
DCs were stained for the following adhesion molecules; immunoglobulin super 
family members ICAM-1 (CD54), ICAM-2 (CD102), ICAM-3 (CD50) and PECAM- 
1 (CD31); and integrins VLA-4 (CD49d/CD29), LFA-1 (CDlla/CD18), C D llb  and 
CD 18 (Mac-1). DCs were also stained for the DC specific DC-SIGN (dendritic cell 
specific ICAM3 grabbing non-integrin, CD209) and for L-selectin (CD62L).
Immature DCs were found to express high levels of ICAM-1, ICAM-3, integrins 
LFA-1 and CD18, and the DC specific DC-SIGN. Immature DCs also expressed low 
levels of ICAM-2, PEC AM-1 and VLA-4, however they did not express any 
detectable L-selectin (Fig 4.2).
DC migration is closely linked to DC maturation and it is probable that DCs change 
their expression of adhesion molecules during activation to facilitate migration. DC 
expression of adhesion molecules following stimulation with N. meningitidis was 
investigated. Immature day 6 monocyte derived DCs were cultured with wild type or 
IpxA- strains of N. meningitidis', purified meningococcal LPS or in medium alone for 
18 hours and stained with monoclonal antibodies for adhesion molecules and 
integrins (Fig 4.3). For clarity from this point onwards DCs stimulated with 
10 organisms/ml of wild type N. meningitidis will be referred to as D C w t ,  those 
stimulated with 107 organisms/ml of IpxA- as D C lp x a ,  D C s  stimulated with 10 ng/ml 
of LPS as D C lp s  and DCs cultured in medium alone D C mediunv
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Figure 4.2 Expression of adhesion molecules and integrins on immature 
dendritic cells
D C s cultured in m edium  alone w ere stained for exp ression  o f  ad h esion  m o lecu les  
and integrins. IC A M -1, IC A M -2, IC A M -3, P E C A M -1 , L F A -1 , V L A -4 , C D  l i b ,  
C D  18, C D 6 2 L  and D C -S IG N  are sh ow n  (filled  h istogram s) a lon g  w ith  the 
appropriate iso typ e control (so lid  lines). The data are a representative o f  4  d ifferent 
experim ents.
O' 104 10'
DC-SIGN FITC
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D C w t expressed increased PECAM-1 (CD31), VLA-4 and CD62L as shown in Fig 
4.3. D C lp x a  and D C lp s  also expressed increased levels of PECAM-1, VLA-4 and 
CD62L, though for PECAM-1 and CD62L this increase was not as great as that seen 
on D C w t*  Although increases in CD62L were observed on DCs following 
stimulation, overall, expression was only detected on about 10% of DCs (Fig 4.3). 
CD llb, CD18, ICAM-1, LFA-1 and DC-SIGN were expressed on almost 100% of 
DCmedium* Following activation there was no change in expression of CD llb, CD18, 
LFA-1 or DC-SIGN measured by MFI (data not shown). However D C w t,  D C lp x a  
and D C lp s  all showed increased ICAM-1 expression measured by MFI (Fig 4.3). DC 
expression of ICAM-2 and ICAM-3 was found to be highly variable between donors. 
There was no overall change in expression of either ICAM-2 or ICAM-3 following 
DC stimulation (Fig 4.3).
4.3.2 Dendritic cell expression of chemokine receptors
Chemokines are small chemo-attractive cytokines that play an important role in the 
migration of cells. The expression of chemokine receptors by DCs is known to 
change during maturation. Immature DCs express CCR5 and mature DCs express 
CCR7. In order to investigate the migratory properties of DCs stimulated with N. 
meningitidis, DC expression of CCR5 and CCR7 was measured following 
stimulation with wild type or IpxA- strains of N. meningitidis H44/76 (Fig 4.4.).
D C lp x a  and D C w t  both showed a decrease in CCR5 expression compared to 
DCmedium (Fig 4.4). Interestingly CCR7 expression on DCs increased more than ten 
fold following stimulation with wild type N. meningitidis but not with IpxA- (Fig 
4.4).
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Figure 4.3 Expression of adhesion molecules and integrins on dendritic cells 
after stimulation with N. meningitidis
D C s w ere stim ulated w ith  w ild  type or IpxA- H 4 4 /7 6  N. meningitidis (both  
107 organ ism s/m l), LPS (1 0  ng /m l) or m edium  alone. D C s w ere stained for IC A M -1, 
IC A M -2, IC A M -3, P E C A M -1, L F A -1, V L A -4 , C D l l b ,  C D 1 8 , C D 62L  and D C - 
SIG N . T he percentage o f  p o sitiv e  ce lls  is sh ow n  as w e ll as the M FI for IC A M -1. The  
data are exp ressed  as the m ean and SE M  o f  4  independent experim ents. * indicate p 
va lu es o f  < 0 .0 5  com pared to the m edium  found by  the paired student t-test.
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Figure 4.4 Expression of chemokine receptors on dendritic cells after 
stimulation with Neisseria meningitidis
D C s w ere stim ulated  for 18 hours w ith  w ild  typ e or IpxA- H 4 4 /7 6  N. meningitidis 
(both  107 organ ism s/m l) or m edium  alone and stained for ch em ok in e receptors C CR5  
and C C R 7. D C s w ere gated according to s iz e  and granularity and fluorescent stain ing  
determ ined b y  flo w  cytom etry. The black so lid  lin es are ce lls  cultured in m edium  
a lon e, the red filled  h istogram s are D C s stim ulated  w ith  w ild  type N. meningitidis 
and the b lu e filled  histogram  are D C s stim ulated w ith  the IpxA-. T he data are a 
representative o f  at least 4  independent experim ents.
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4.3.3 Chemokine production by dendritic cells after stimulation with N.
meningitidis
D en d ritic  c e lls  n ot o n ly  exp ress ch em o k in e  receptors, th ey  are a lso  cap ab le o f  
producing ch em o k in es R A N T E S  (C C L 5), M I P la  (C C L3) and IL -8  (C X C L 8) to  
attract leu k o cy tes . T h e in d u ction  o f  ch em o k in e  production  b y  D C s activated  w ith  N. 
meningitidis w a s in vestiga ted . D C s w ere  cu ltured for 18 hours in  the p resen ce  o f  
B refe ld in  A  w ith  w ild  typ e or IpxA- N. meningitidis (both at 1 0 7 organ ism s/m l) or  
purified  m e n in g o c o c c a l L P S  (10  n g /m l). Intracellular ch em o k in e  le v e ls  w ere  
m easured  b y  f lo w  cytom etry  (F ig  4 .5 ) . D C w t  produced  IL -8 as d id  D C lpxa  th ou gh  
n ot to  the sam e extent. N o  IL -8  production  w a s detected  b y  D C lps (F ig  4 .5 ) . T here  
w a s n o  d etectab le  production  o f  R A N T E S  or M I P la  b y  D C s stim u lated  w ith  N. 
meningitidis or L P S  (F ig  4 .5 ).
4.3.4 Dendritic cell migration in the presence of chemokine MIP3|3 (CCL19)
D C  stim u lation  b y  w ild  typ e N. meningitidis resu lts in  a d ecrease o f  C C R 5 and an  
in crease  in  C C R 7 ex p ressio n , w h ereas the L P S  d efic ien t IpxA- d o es  n ot in d u ce an  
in crease in  C C R 7 exp ressio n . T h is su g g ests  that w ild  typ e but n ot IpxA- m igh t in d u ce  
m igration  to  M IP3|3 w h ich  is a ligan d  for C C R 7. D C  m igration  in  the p resen ce  o f  
M IP 3 p  (C C L 19) w a s therefore in vestigated . T h e lo w er  cham ber o f  an un coated  
transw ell w a s f ille d  w ith  m ed iu m  con ta in in g  d ifferent con cen tration s o f  the  
c h em o k in e  M IP3(3. D C s cultured in m ed iu m  a lon e, or w ith  w ild  typ e or IpxA- N. 
meningitidis w ere added to the upper cham ber o f  the transw ell (5 x  105). M igrated  
c e lls  w ere  co lle c te d  from  the lo w er  cham ber after 6  hours and the c e lls  w ere  cou n ted  
on  a h a em o cy to m eter  (F ig  4 .6 ) .
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Figure 4.5 Dendritic Cell chemokine production in response to N. meningitidis
D C s w ere stim ulated for 18 hours w ith  w ild  type or LPS d efic ien t IpxA- N. 
meningitidis (both 107 organ ism s/m l), LPS or in m edium  alone in the presence o f  
B refeld in  A . T he ce lls  w ere perm eabilised  and stained for intracellular chem okines  
R A N T E S , M E P la  and IL-8. D ata are a representative o f  4  experim ents. The  
p ercentage o f  p o s itiv e  c e lls  is  g iven .
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Visualisation of the DCs in the upper chamber of the transwell revealed large masses 
of clumped cells in wells containing D C w t , and some clumping in D C lpxa  wells. 
There was very little or no clumping observed in D C medium wells. In the absence of 
additional MIP3(3, a greater number of D C mediUm migrated across the transwell than 
activated DCs, and more D C lpxa  migrated than D C w t - The addition of MIP3|5 to the 
lower chamber had no effect on the ability of D C medium or D C lpxa  to migrate. 
However the migration of D C wt did increase in the presence of MIP3(3, and appeared 
to respond in a dose dependent manner (Fig 4.6). This pattern of migration is 
consistent with the expression of CCR7 observed on DCs stimulated by wild type N. 
meningitidis.
4.3.5 Migration of dendritic cells across endothelial cell monolayers
The adhesion and transmigration of leukocytes has been studied in detail (reviewed 
in (Hogg N. et al., 1995)(Worthylake R.A. et al., 2001)). Expression of adhesion 
molecules and selectins on endothelial cells is necessary for leukocyte adhesion and 
diapedisis across endothelial layers. TNFa stimulation is known to increase 
expression of selectins and adhesion molecules on the surface of endothelial cells. 
The effect of TNFa stimulation of endothelial cells on the ability of DCs to 
transmigrate was therefore investigated. HUVEC monolayers were grown to 
confluence on gelatine coated transwells and stimulated with 1 ng/ml of TNF a , then 
5 x 105 monocyte derived DCs were added to the upper transwell chamber. After 24, 
hours the medium from the lower transwell chamber was collected and the cells were 
counted on a haemocytometer. As shown in Figure 4.7, DCs migrated more readily
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across endothelia l c e lls  than gelatine alone. S tim ulation  o f  the endothelia l layer w ith  
T N F a  increased  the num ber o f  D C s m igrating across the endothelia l m onolayer.
DC migration in the presence of CCR7 chemokine MIP3p
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250
200 \
=  150
100
50 H
Medium IpxA- WT
0 5 50 500 0 5 50 500 0 5 50 500 M|P 3 p
(ng/ml)
Figure 4.6 Dendritic cell migration in the presence of chemokine MIP3p
D C s stim ulated  w ith  either w ild  type or IpxA- N. meningitidis (1 0 7 organ ism s/m l) or 
m edium  a lon e w ere added to the upper transw ell cham ber (5 x  105 cells/tran sw ell). 
T he low er  cham bers o f  the transw ells contained varying concentrations o f  the C C R 7  
sp ec ific  M IP 3p . A fter 6 hours m igrated ce lls  w ere co llected  from  the low er transw ell 
cham ber and counted  on  a haem ocytom eter. The data are the m ean num ber o f  ce lls  
recovered  in each  culture and on e SE M  o f  3 independent experim ents.
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4.3.6 Effect of dendritic cell activation on migration across endothelial layers
DCs cultured in medium alone or stimulated for 18 hours with 107 organisms/ml of 
wild type N. meningitidis were added to the upper chamber of HUVEC coated 
transwells, which were previously stimulated with 1 ng/ml of TNFa. At various time 
points the medium was collected from the lower transwell chambers and cells 
counted on a haemocytometer (Fig 4.8).
These data show that DC migration is a continuous process occurring over 24 hours. 
More DCs stimulated with wild type N. meningitidis migrate across the endothelial 
monolayer than unstimulated DCs. This increase in migration by stimulated DCs was 
observed at all time points during the 24 hour time course (Fig 4.8).
4.3.7 Migration of dendritic cells activated with wild type or IpxA- N. 
meningitidis
DCs were stimulated for 18 hours with 107 organisms/ml of wild type or IpxA- N. 
meningitidis or medium alone. After washing, 5 x 105 DCs were added to the upper 
chamber of the HUVEC coated transwell, half of which were previously stimulated 
with 1 ng/ml TNFa. After 24 hours incubation, cells were collected from the lower 
chamber of the transwells and counted on a haemocytometer.
A greater number of D C w t  migrated across TNFa activated HUVECs than D C medium 
or D C lpxa  (Fig 4.9). D C  migration across unstimulated endothelial cells was not 
effected by N. meningitidis activation and was similar in all conditions.
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Dendritic cell migration across HUVECs
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Figure 4.7 Dendritic cell migration across stimulated HUVEC monolayers
H U V E C  m on olayers w ere grow n on  gela tin e-coated  transw ells. W hen con flu en ce  
w a s reached, h a lf  o f  the H U V E C  coated  transw ells w ere stim ulated  w ith  1 ng/m l 
T N F a . M on o cy te  derived  D C s (5 x  105/w e ll)  w ere added to  the upper transw ell 
cham ber. A fter 24  hours, the ce lls  w ere co llected  from  the low er  transw ell cham bers  
and counted  on  a haem ocytom eter. D C  m igration across a gelatin e layer w ithout 
H U V E C s is a lso  show n. T he data are the m ean o f  duplicate w e lls  and are 
representative o f  6 independent experim ents.
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Tim e c o u rse  o f DC m igration  th ro u g h  HUVECs
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Figure 4.8 Dendritic cell migration across HUVEC monolayers
H U V E C  m on olayers w ere grow n on gela tin e-coated  transw ells and stim ulated  w ith  
1 ng /m l T N F a . D C s (5 x  105 ce lls/tran sw ell) stim ulated  w ith  w ild  type N. 
meningitidis or grow n in m edium  alone w ere added to the upper transw ell cham ber. 
A t 30  m inutes, 1 hour, 2 hours and 2 4  hours, c e lls  w ere  co llec ted  from  the low er  
transw ell cham ber and counted  on a h aem ocytom eter. T h e data are a representative  
o f  6 independent experim ents.
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DC migration through HUVEC monolayers
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Figure 4.9 Migration of wild type and IpxA- stimulated dendritic cells
H U V E C  m on olayers w ere grow n on gela tin e-coated  transw ells and h a lf  w ere  
stim ulated  w ith  1 n g/m l o f  T N F a . D C s (5 x  105 ce lls/tran sw ell) stim ulated  w ith  w ild  
type or IpxA- N. meningitidis (both 10 7 organ ism s/m l) or grow n in m edium  alone  
w ere added to  the upper transw ell cham ber. A fter 2 4  hours ce lls  w ere co llected  from  
the low er transw ell cham ber and counted on a haem ocytom eter. D ata are the m ean  
and SE M  o f  6 independent experim ents. The p valu es com pared to D C medium are 
sh ow n , as found b y  the M ann-W hitney U  test.
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4.4 Discussion
DC migration and maturation are closely linked but the mechanisms controlling DC 
emigration from the peripheral tissues to the secondary lymphoid organs are not 
totally understood. Adhesion molecules are important for migration of leukocytes 
across inflamed endothelium and are likely to play a role in DC migration. Here 
monocyte derived DCs were found to express a wide variety of adhesion molecules 
at high densities, including the Ig-superfamily members ICAM-1 (CD54), ICAM-2 
(CD102), ICAM-3 (CD50) and PECAM-1 (CD31). DCs also expressed the selectins 
LFA-1 (CD 11 a/CD 18), VLA-4 (CD49d/CD29) and MAC-1 (CDllb/CD18) and the 
DC specific DC-SIGN. Surprisingly DCs were found to be negative or very low for 
L-selectin (CD62L), which is found on most circulating leukocytes and is important 
for lymphocyte homing to lymph nodes (Irjala H. et al., 2001).
Of the adhesion molecules studied here, very few changed following DC stimulation 
with the wild type N. meningitidis, the LPS deficient IpxA- or purified 
meningococcal LPS. ICAM-1 increased following DC stimulation with both the wild 
type and IpxA- N. meningitidis, but the increase in ICAM-1 following stimulation 
with purified meningococcal LPS was not as great. This observation of an increase in 
DC ICAM-1 expression following stimulation with N. meningitidis is consistent with 
a previous report showing DC ICAM-1 expression increasing following stimulation 
with IFNy (Starling G.C. et al., 1995). ICAM-1 has been implicated in the migration 
of Langerhans cells from the skin to draining lymph nodes. Langerhans cells in 
ICAM-1 knock out mice were present in the skin epidermis, but migration to lymph 
nodes following stimulation was severely impaired (Xu H. et al., 2001). Further
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experiments revealed that ICAM-1 expression by lymphatic endothelium was more 
important than ICAM-1 expression by Langerhans cells. The ligands for ICAM-1 
include the integrins LFA-1 and Mac-1, which are expressed by lymphocytes and 
NK cells. Thus ICAM-1 expression by DCs is likely to be important for interactions 
with these cells. Expression of the integrin VLA-4 (a4|31 integrin) also increased on 
DCs following stimulation with N. meningitidis wild type, IpxA- and purified LPS. 
There are no reports on the role of VLA-4 in DC migration but VLA-4 binds to 
fibronectin, MAdCAM-1 and VC AM-1, and could possibly play a role in DC 
migration. DC expression of PECAM-1 (CD31) did appear to increase following 
stimulation, especially with the wild type N. meningitidis, though this was not 
statistically significant. The transmigration of leukocytes through vascular 
endothelium is dependent on PECAM-1 homophillic interactions and thus PECAM-1 
maybe important in DC migration (Muller W.A. et al., 1993). Changes in expression 
of other adhesion molecules were not significant. ICAM-2 and ICAM-3 expression 
on DCs were found to be especially varied between different donors.
Chemokines play a fundamental role in DC migration and changes in receptor 
expression on maturing DCs have been observed (Sallusto F. et al., 1998). Immature 
DCs express CXCR1, CCR1 and CCR5. These receptors are down regulated after 
DC stimulation, and at the same time expression of CCR7 is increased. In the 
experiments described here, immature DCs expressed CCR5, which decreased 
following stimulation with wild type and IpxA- N. meningitidis. In contrast CCR7 
expression increased following stimulation with wild type N. meningitidis, but not 
with IpxA-. The decrease of CCR5 and increase of CCR7 observed on DCs 
stimulated with wild type N. meningitidis is consistent with maturing DCs migrating
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from the periphery to the lymph nodes in vivo. The absence of CCR7 expression in 
DCs stimulated with IpxA- N. meningitidis suggests that LPS maybe necessary for N. 
meningitidis induced DC migration. The necessity of LPS for optimal DC migration 
following stimulation with N. meningitidis has important implications for vaccine 
design. Inefficient migration of DCs following vaccination would inhibit 
presentation to T cells in the secondary lymphoid organs, preventing protective 
immunity.
DCs are also known to be a source of some chemokines following stimulation. A 
previous report (Sallusto F. et al., 1999) showed that monocyte derived DCs are 
capable of producing chemokines M IPla, MIP1|3, IL-8 and RANTES following 
stimulation with 1 pg/ml salmonella LPS. In the experiments described here DCs did 
not produce RANTES or M IPla following activation with N. meningitidis, but they 
did produce IL-8. The lack of production of chemokines by DCs stimulated with N. 
meningitidis could be due to several factors. Firstly, it is possible that N. meningitidis 
does not induce the production of these chemokines in DCs. However N. 
meningitidis is a potent stimulator of pro-inflammatory cytokines in DCs (as shown 
in Chapter 3) and stimuli that are capable of inducing DC production of cytokines, 
including LPS, CD40 ligation and TNFa, have also been shown to induce production 
of chemokines (Sallusto F. et al., 1999). Chemokine expression was detected here by 
intra-cellular labelling following culture with brefeldin A and it maybe that brefeldin 
A interferes with chemokine production or aids the degradation of these chemokines 
whilst they are stored in the Golgi. Other studies have used brefeldin A free systems 
and measured chemokine production by ELISA in cell culture supernatants or by 
mRNA levels. A further possibility for not observing M IPla or RANTES production
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by DCs stimulated with N. meningitidis is because the time at which the cells were 
assayed (18 hours) did not include the period of chemokine production. However, 
studies with LPS and CD40 ligand stimulation of DCs showed that the optimal time 
for production of M IPla was 12 to 18 hours, and the optimal time for RANTES 
production was 18 to 24 hours (Sallusto F. et al., 1999). Further investigations area 
needed to explain the lack of chemokine production by DCs stimulated with N. 
meningitidis.
In order to ascertain if the changes in chemokine receptor expression observed 
following stimulation with N. meningitidis are related to the ability of DCs to 
migrate, experiments were carried out to measure migration in the presence of the 
CCR7 ligand MIP3|3 (CCL19). Surprisingly, DCs cultured in medium alone were 
found to migrate through the 5 p,m pores in the transwells most readily. However the 
rate and total number of migrated DCs cultured in medium alone was not affected by 
the chemokine MIP3(3. Migration of DCs stimulated with the LPS deficient IpxA- 
N. meningitidis were also unaffected by the presence of chemokine. This is probably 
because DCs in medium alone or stimulated with IpxA- do not express the MIP3(3 
receptor CCR7. DCs stimulated with the wild type N. meningitidis did respond to the 
increase in MIP3|3 in a dose dependent way, which could be attributed to the increase 
of CCR7 observed on these DCs. The difference seen in migration through the 
transwell in the absence of chemokine (i.e. DCs cultured in medium alone migrated 
most readily) may be due to the clustering and clumping of DCs in the upper 
compartment of the transwell. DCs stimulated with wild type N. meningitidis were 
observed to clump together in tight clusters. DCs stimulated with LPS deficient \pxA-
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also formed clusters but they were not as large or as frequent as the wild type 
stimulated DCs. DCs in medium alone did not cluster and were distributed evenly 
over the transwell. Furthermore it is known that the motility of DCs changes with 
maturation. Undifferentiated immature DCs are highly motile moving in random 
directions (Shutt D.C. et al., 2000). This movement of immature DCs may result in 
their migration though the 5pm pores of the polycarbonate transwell.
The transwell system was also used to investigate the ability of DCs to migrate 
across a monolayer of endothelial cells (HUVECs). In the absence of endothelial 
cells, DCs were less unable to migrate through the gelatine layer on the transwells. 
Stimulation of the endothelial cells with TNFa resulted in an increase in DC 
transmigration, especially DCs activated with N. meningitidis. Activation of 
endothelial cells is important in the transmigration of leukocytes. TNFa stimulation 
of endothelium results in an increase in expression of adhesion molecules including 
CD62E, ICAM-1 and VCAM-1 and an increase in leukocyte binding and 
transmigration (Bevilacqua M.P. et al., 1987)(Karmann K. et al., 1996). It is probable 
that the increase in cell adhesion molecules on HUVECs following TNF stimulation 
is responsible for the increase in DC transmigration. This could be investigated 
further by studies with blocking antibodies.
The way this transwell system was set up models migration from the luminal side of 
the endothelium to the tissues. In an in vivo situation, maturing DCs would exit the 
tissues and cross either vascular or lymphatic endothelium in a basal to luminal 
direction. The ability of DCs to migrate across the basal membrane and through an 
endothelial monolayer to the luminal surface has been described (D'amico G. et al.,
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1998). Moreover HUVECs may not be the best endothelial cells to use in this model. 
There are similarities between lymphatic and vascular endothelium, but there are also 
functional differences between the two. Common to other endothelium, lymphatic 
endothelium expresses CD31, CD34, VE cadherin and von Willibrand factor. The 
discovery of lymphatic specific markers, podoplannin and the hyaluronan receptor 
LYVE-1, has made possible the isolation and culture of lymphatic endothelium 
(Irjala H. et al., 2003) (Kriehuber E. et al., 2001). It would be interesting to 
investigate DC migration through lymphatic endothelium but difficulties with 
availability, purification and culture of lymphatic endothelium make this difficult.
In order to further understand the interactions of adhesion molecules during DC 
migration through endothelial cells following stimulation with N. meningitidis, 
several other lines of investigation need to be followed. Molecules on endothelium 
responsible for DC adhesion and transmigration could be identified using blocking 
antibodies. The methods described here explore the migration of DCs through 
vascular endothelium in a luminal to basal direction. A more accurate model of DC 
migration from the tissues to the lymphatics could be DC migration through 
lymphatic endothelium in a basal to luminal direction as shown in a model of reverse 
transmigration (D'amico G. et al., 1998).
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5.1 Introduction
Upon arrival at secondary lymphoid organs, DCs concentrate in T cell areas where 
they present antigen and deliver other signals to T cells. The combination of MHC- 
TCR interactions with surface co-stimulatory signals and cytokines is required for 
activation and polarisation of naive T helper cells to a Thl or a Th2 phenotype. IL-12 
produced by DCs is known to be crucial for Thl development, but other cytokines 
including IL-18 and IFNa/|3 may also play a role. The signals required for Th2 
differentiation are less understood. CD80 (B7.1) and CD86 (B7.2) which interact 
with CD28, 0X40 and OX40L, and CD40 and CD40L have been shown to play a 
role in Th2 development in some instances (de Jong E.C. et al., 2002) (MacDonald 
A.S. et al., 2002b)(Tanaka H. et al., 2000). IL-4 is crucial in Th2 development, but is 
not produced by DCs, IL-4 is produced by Th2 cells and helps to prolong the Th2 
response (MacDonald A.S. et al., 2002a).
In Chapter 3 it was shown that both the wild type and LPS deficient N. meningitidis 
activated DCs. There were differences in this activation, notably wild type N. 
meningitidis induced IL-12 production in DCs, whereas the IpxA- did not. There 
were also differences in expression of co-stimulatory molecules following DC 
activation with the wild type compared to the IpxA- N. meningitidis. These 
differences in DC activation may be important for T cell differentiation. DC and T 
cell interactions were therefore investigated following DC activation with N. 
meningitidis.
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5.2 Methods
This chapter describes T cell responses to DCs activated by wild type and IpxA- N. 
meningitidis, using highly purified CD3+ T cells and CD4+CD45RA+ naive T cells.
5.2.1 T cell culture with activated dendritic cells
DCs were stimulated with wild type N. meningitidis ( D C w t ), the LPS deficient IpxA- 
(D C lpxa) , purified meningococcal LPS (D C lps) or other bacterial products at varying 
concentrations for 16-18 hours as described in Chapter 3. They were then washed in 
10 ml of cell wash medium to remove any excess antigen, counted on a 
haemocytometer and resuspended to 105 cells/ml in T cell culture medium. One 
hundred micro litres of DC suspension (104 DCs) was added to 100 pi of T cells (105 
T cells) in each well of a 96 well U bottom plate. In some instances DCs were diluted 
over a range of concentrations starting at 105 cells/ml to give DC:T cell ratios of 1:10 
to 1:80. The culture plates were placed in a 5% CO2 incubator at 37 °C for 5 days. As 
a positive control for T cell proliferation, 105 purified T cells were stimulated with 
5 ng/ml of PH A, and as a negative control 105 purified T cells were cultured without 
stimulation. All assays were carried out in triplicate.
5.2.2 Measuring T cell proliferation
After 5 days incubation, the DC T cell cultures were pulsed with 3H-thymidine 
(1 pCi per well) for 16 hours, harvested and 3H-thymidine incorporation determined 
by liquid scintillation counting. Results are expressed as the mean counts per minute 
(cpm) of triplicate cultures.
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T cell proliferation was also determined by carboxyfluorescein succinimidyl ester 
(CFSE) staining. The succinimidyl ester of carboxyfluorescein diacetate passively 
diffuses into cells. It is colourless and non-fluorescent until its acetate groups are 
cleaved by intracellular esterases to yield highly fluorescent, amine-reactive CFSE, 
which is inherited by daughter cells upon division. CFSE staining is a useful tool for 
analysing cell division, as after each division cycle the fluorescence of each cell 
decreases by a factor of 2, thus identifying the number of divisions cells have 
undergone. Unlike 3H-thymidine incorporation which only detects cells that divide 
(undergo DNA synthesis) in the 16 hour period in which thymidine is added to the 
culture medium, CFSE staining enables the whole population of cells (both dividing 
and non-dividing) to be analysed and dividing cells can be followed over several 
cycles. This technique can also be combined with intracellular cytokine staining to 
show association between proliferation and cytokine production.
T cells were purified by negative selection, washed in RPMI 1640 without 
supplementary FCS, resuspended to 106-107 cells/ml in 10 ml of RPMI 1640 and 
incubated with CFSE at a final concentration of 2.5 pM for 10 minutes at 37 °C. The 
reaction was stopped by diluting the T cell and CFSE mix with 40 ml of RPMI-1640 
with 10% FCS. The cells were washed a further 3 times in cell wash medium, 
counted on a haemocytometer and resuspended to 106 cells/ml in T cell culture 
medium.
CFSE labelled T cells (5x105) were combined in culture with DCs (5x104) for 5 days. 
T cells were then labelled with an anti-CD3 PE antibody (5 pg/ml), or other T cell 
markers and cell proliferation determined by flow cytometry. In each experiment
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20,000 events in the CD3+ gate were collected. In some experiments DC-T cell 
cultures were visualised by fluorescent microscopy.
5.2.3 Measuring cytokine production in proliferating T cells
After 5 days culture with DCs, CFSE labelled T cells were stimulated with 10 ng/ml 
of PM A and 1 pg/ml ionomycin in the presence of 10 pg/ml Brefeldin A for 6 hours 
to induce cytokine production. T cells were first stained with CD3 tri-color® anti­
body and fixed in 2% paraformaldehyde in PBS at room temperature for 15 minutes. 
They were then permeabilised (as described in 2.4.2) and stained for intracellular 
cytokines IL-2, IL-4 and IFNy.
5.2.4 Dendritic cell priming of CD4+ CD45RA+ naive T helper cells
Initial work was carried out using CD3+ T cells, which included CD8+ cytotoxic T 
cells, CD4+ helper T cells, CD45RO+ memory cells and CD45RA+ naive cells. Naive 
T cell responses to DC stimulation were investigated using a method adapted from de 
Jong E.C. et al., 2002) (and personal communication with Dr de Jong). 
CD4+CD45RA+ T cells were isolated and cultured with DCs that had been stimulated 
with N. meningitidis wild type or IpxA- (107 organisms/ml); purified LPS (10 ng/ml); 
PGE-2 (10"6M) or medium alone. DC (5 x 103) were combined with T cells (2 x 104) 
in a 96 well flat bottom plate in the presence of the super antigen SEB 
(Staphylococcus enterotoxin B) at 100 pg/ml in a total volume of 200 pi. The cells 
were then cultured for 5 days at 37 °C in 5%CC>2 (Fig 5.1). After 5 days, cells from 
each well of the 96 well plate were transferred to a well in a 24 well plate and diluted 
to 1 ml with T cell culture medium supplemented with 10 U/ml of IL-2 and cultured 
for a further 10-12 days at 37 °C in 5%CC>2.
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Figure 5.1 Flow chart of dendritic cell and naive Th cell co-cultures
Culture o f  D C s and Th ce lls  using super-antigen fo llo w ed  by expansion  w ith IL-2 
before restim ulation and intra-cellular cy tok ine detection.
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Every second day the wells were subcultured and refreshed with IL-2 supplemented 
medium (Fig 5.2). After culture for 10-12 days in the presence of IL-2, the cells were 
observed by light microscopy. Clusters were seen to have fallen apart and T cells had 
a rounded appearance typical of resting state. The T cells were then restimulated for 
6 hours with PMA (10 ng/ml) and ionomycin (1 pg/ml) in the presence of Brefeldin 
A (10 pg/ml) and then stained for intracellular cytokines IL-4, IL-13 and IFNy as 
described in sections 2.4.2 and 5.2.3
5.3 Results
5.3.1 T cell proliferation in response to dendritic cells stimulated with 
N. meningitidis determined by 3H-thymidine incorporation
T cell proliferation in response to D C w t , D C l px a , D C l p s , and DCmedium was 
determined in allogeneic and autologous combinations by 3H-thymidine 
incorporation. Immature (non activated) DCs ( D C medium) induced T cell proliferation 
in both autologous and allogeneic MLRs above the background of T cells alone. 
Stimulated DCs induced similar levels of T cell proliferation at DC:T cell ratios of 
1 :5  and 1 :1 0 . At DC:T cell ratios of 1 :2 0  and 1 :4 0  proliferation was reduced. At a 
ratio of 1 :8 0  proliferation was almost the same as the background response by T cells 
on their own (Fig 5 .2 ) .  D C lps induced a greater T cell response at lower DC:T cell 
ratios than DCmedium- D C w t  and D C lpxa  induced greater T cell proliferation at all 
concentrations than D C medium (Fig 5 .2 ) .
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Figure 5.2 T cell proliferation in response to activated dendritic cells
D C s w ere stim ulated  for 18 hours w ith  w ild  type or LPS d efic ien t IpxA- N. 
meningitidis (1 0 7 organism s/m l), purified LPS (1 0  n g /m l) or in m edium . D C  (1 0 4 
c e lls )  w ere cultured w ith  au to logou s or a llo g en e ic  T ce lls  at ratios o f  1:5 to 1:80 
(D C :T cells). T  c e lls  cultured a lon e or w ith  P H A  (5 ng /m l) w ere included  as controls. 
R esu lts are exp ressed  as the m ean counts per m inute (C P M ) o f  triplicate cultures. 
D ata are representative o f  on e experim ent from  four.
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Wild type H44/76 N. meningitidis is a strong inducer of DC maturation and 
activation even at low concentrations (105 organisms/ml), whereas the LPS deficient 
IpxA- only induces DC activation at concentrations of 107 organisms/ml or higher 
(Fig 3.2, Chapter 3). Therefore T cell proliferation in response to DCs activated with 
different concentrations of wild type and IpxA- N. meningitidis were investigated. 
DCs were cultured with autologous and allogeneic T cells for 5 days at a ratio of 
1:10. In these experiments D C w t induced significantly greater T cell proliferation 
than the medium control at 105, 106 and 107 organisms/ml (Fig 5.3), whereas D C lp x a  
only induced significant T cell proliferation at 107 organisms/ml (Fig 5.3).
In the experiment shown, D C  stimulation with varying concentrations of N. 
meningitidis had no effect on allogeneic T cell proliferation. This maybe due to the 
high proliferative response of T cells cultured with all allogeneic D C  including 
DCmedium (Fig 5 .3 ) .
The previous experiments showed that optimal T cell proliferation occurred at a ratio 
of 1:10 (DC:T cells). Also, DCs stimulated with N. meningitidis bacteria at 
10 organisms/ml resulted in the greatest T cell proliferation. In order to investigate 
further the difference between T cell proliferation induced by D C w t* D C lp x a  or 
D C lp s , D C s  activated with wild type or IpxA- N. meningitidis (107 organisms/ml), 
purified LPS (10 ng/ml) or medium alone were cultured with autologous or 
allogeneic T cells at a ratio of 1:10. T cell proliferation was measured by 
3H-thymidine incorporation (Fig 5.4). In allogeneic DC:T cell combinations, pre­
stimulation of DCs had no effect on T cell proliferation when compared to control 
DCs cultured in medium only. In autologous combinations, both D C w t and D C lp x a
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Figure 5.3 T cell proliferation in response to dendritic cells activated with 
varying concentrations of N. meningitidis.
D C s w ere stim ulated  w ith  105, 106 or 107 organ ism s/m l o f  w ild  typ e or IpxA- N. 
meningitidis. D C s (1 0 4) w ere then cultured w ith  T ce lls  (1 0 5) for 5 days and 
proliferation  w as m easured by  3H -thym idine incorporation. T he data are exp ressed  as 
the m ean and SE M  o f  8 independent experim ents, in w h ich  triplicate cultures w ere  
perform ed and the m ean C PM  taken. A  non-param etric M ann-W hitney  U  test w as  
u sed  to m easure sig n ifica n ce  o f  proliferation com pared to the m edium  control.
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Figure 5.4 T cell proliferation in response to dendritic cells stimulated with
Neisseria meningitidis.
D C s activated  b y  w ild  type or IpxA- N. meningitidis (1 0 7 organ ism s/m l), LPS  
(1 0  n g /m l) or m edium  alone w ere com b in ed  w ith  T ce lls  in au to logou s or a llo g en e ic  
cultures at a ratio o f  1:10 (1 0 4 D C  and 105 T  ce lls) . Proliferation w as m easured b y  
3H -thym id ine uptake after 5 days. E ach poin t represents an individual experim ent 
and is the m ean C PM  o f  triplicate cultures. A  M ann-W hitney U  test w a s used  to  
m easure s ig n ifica n ce  o f  increased proliferation against the m edium  control.
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induced greater T cell proliferation than DCs cultured in medium. In contrast, LPS 
stimulation of DCs had no significant effect on their ability to induce T cell 
proliferation (Fig 5.4).
5.3.2 CFSE staining for measuring cytokine production in proliferating T cells
CFSE staining was used to determine cytokine production in dividing and non­
dividing cells. To obtain a baseline picture of T cell proliferation purified CD3+ cells 
were stained with CFSE and incubated for 5 days with PHA (5 ng/ml) (Fig 5.5).
Proliferation of T cells after activation with PHA gives distinct CFSE peaks 
corresponding to consecutive generations of daughter cells. The first peak on the 
right hand side consists of cells which have not divided, and 5-6 cell cycles of 
decreasing CFSE intensity can be seen from right to left (Fig 5.5.).
Next, CFSE staining of T cells was used to assess T cell proliferation after incubation 
with DCs that had been activated with wild type or IpxA- N. meningitidis 
(107 organisms/ml), purified LPS (10 ng/ml) or medium alone. Fluorescent 
microscopy was used to visualise the DC and T cell co-cultures at day five. T cells 
labelled with CFSE can be seen interacting with non-labelled DCs (Fig 5.6). The 
differences in intensity of green stain on the different T cells is due to the different 
numbers of proliferation cycles they have undergone.
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Figure 5.5 PHA induced proliferation of CFSE labelled T cells.
Purified  T  ce lls  w ere lab elled  w ith  C FSE  and cultured for 5 days in the presence o f  
5 n g /m l P H A . C e lls  w ere then stained w ith  C D 3 PE antibody and analysed  for C FSE  
stain ing (flu orescen ce  channel 1) in the C D 3 gate. N on -d iv id in g  C F SE  lab elled  T  
ce lls  cultured w ithout P H A  are show n (black so lid  line).
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Figure 5.6 CFSE labelled T cells and DCs viewed by fluorescent microscopy.
C F SE  lab elled  T ce lls  and D C s cultured in m edium  a lon e after 5 days culture. The  
im age w a s obtained b y  fluorescent m icroscop y  and an alysed  on  open  lab im aging  
softw are.
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After 5 days of culture, cells were stained with CD3 PE antibody and analysed for 
CFSE staining by flow cytometry in the CD3-PE gate. In both the autologous and 
allogeneic T cell responses, the pattern of proliferation observed was different to that 
obtained with PHA stimulated T cells. Rather than a clear set of peaks corresponding 
to T cells at each division cycle, T cells in culture with DCs formed 2 distinct peaks, 
one of non-dividing T cells (right hand side) and the other a peak of T cells that had 
all divided 4 or 5 times (Fig 5.7a & b).
No difference in T cell proliferation was observed by CFSE staining in allogeneic 
combinations with activated and non-activated DCs. In autologous combinations, 
fewer T cells proliferated than in the allogeneic combinations, although the T cells 
that entered into proliferation underwent the same number of divisions as in the 
allogeneic combinations. In the autologous DC:T cell combinations, pre stimulation 
of DCs with wild type or IpxA- N. meningitidis induced significantly greater number 
of T cells to undergo proliferation than DCs in medium alone (Fig 5.7c). LPS 
stimulated DCs also induced greater T cell proliferation than medium alone, though 
this was not statistically significant (Fig 5.7c).
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Figure 5.7 T cell proliferation measured by CFSE staining
C F SE  labelled  T  ce lls  w ere cultured in auto logou s or a llo g en eic  com bination  w ith  
D C s activated  b y  w ild  typ e or IpxA- (1 0 7 organ ism s/m l), LPS (1 0  n g /m l) or m edium  
alone for 5 days. C e lls  w ere stained w ith  C D 3 PE and 2 0 ,0 0 0  even ts in this gate w ere  
analysed  for C F SE  stain ing b y  flo w  cytom etry. F ig  5 .7a  sh o w s a representative  
a llo g en e ic  response; F ig  5 .7b  sh ow s a representative au to logou s response; and 
F ig  5 .7 c  is the sum m ary o f  10 independent auto logou s experim ents. The m ean  
percent o f  proliferating ce lls  and 1 SE M  is g iven . A  paired student t-test w as u sed  to  
determ ine s ig n ifica n ce  o f  increased proliferation com pared to the m edium  control.
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It is possible that DCs activated in different ways may preferentially stimulate sub 
populations of T cells. CFSE labelling allows analysis of the dividing and non­
dividing T cells for surface marker expression and cytokine production.
CFSE labelled T cells were cultured for 5 days in autologous combinations with DCs 
prestimulated with wild type and IpxA- N. meningitidis and then stained for surface 
markers including CD4, CD8, CD45RA, CD45RO and CD25.
Consistent with previous observations, D C medium did not induce many autologous 
T cells to proliferate and thus it was not possible to phenotype the proliferating cells 
in this combination. Non-proliferating cells were 77% CD4+, 21% CD8+, 41% 
CD45RO+, 32% CD45RA+ and less than 1% CD25+ (Fig 5.8). Approximately 13% 
of the total T cell population cultured with autologous D C wt had divided at least 
once. In the experiment shown, 55% of the proliferating cells were CD4+ and 29% 
were CD8+. The majority of proliferating cells were CD45RO+ and CD25+ (94% and 
93% respectively). However, there was a small population of proliferating cells that 
were CD45RA+ (15%). It is possible these cells express both CD45RA and CD45RO 
(Fig 5.8). D C lpxa did not induce as many T cells to divide as D C w t- The cells that 
had entered into at least one division represented approximately 2% of the total 
number of T cells, and 67% expressed CD4, 25% expressed CD8, 71% expressed 
CD45RO and 67% expressed CD25. Around 50% of the proliferating cells were also 
CD45RA+. It was not determined if these cells were positive for both CD45RA and 
CD45RO.
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Figure 5.8 Phenotype of proliferating T cells
CFSE labelled T cells (105) were cultured with autologous D C medium» D C lpxa or 
D C wt (104). After 5 days cells were stained with CD3 Tri color® and CD4 PE, CD8 
PE, CD45RA PE, CD45RO PE or CD25 PE. At least 20,000 events in the CD3+ gate 
were collected by flow cytometry. Data are a representative of 4 experiments. The 
percentage of positive cells in the quadrant is given.
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CFSE staining also allows cytokine production by proliferating and non-proliferating 
T cells to be analysed. CFSE labelled T cells were cultured with autologous DCs for 
6 days, and then restimulated with PMA and ionomycin for 6 hours in the presence 
of brefeldin A. The T cells were stained CD3 and for intracellular cytokines IL-2, 
IL-4 and IFNy and analysed by flow cytometry. No IL-4 production was detected 
(data not shown). IL-2 and IFNy production are shown (Fig 5.9), where at least 
20, 000 events were collected in the CD3+ gate.
As previously observed, only 2-3% of T cells cultured with autologous D C medium 
divided (Fig 5.9). Of these cells that had undergone at least one division, 50% 
produced cytokines IFNy and/or IL-2. DCs stimulated with N. meningitidis WT or 
LPXA, or meningococcal LPS induced a greater number of T cells to proliferate than 
DCmedium (5-9%). In all conditions, approximately 50% of the dividing T cells 
cultured with stimulated DCs produced IFNy and/or IL-2. The majority of all the 
IFNy and IL-2 producing T cells were non-dividing, though these cytokine producing 
cells represent only 25% of all the non-dividing cells (Fig 5.9). Twenty six percent of 
T cells cultured with PHA had divided at least once. However only 20% of the PHA 
dividing T cells produced cytokines on re-stimulation with PMA and ionomycin 
compared to 50% of dividing T cells cultured with DCs.
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Figure 5.9 Cytokine production by proliferating and non-proliferating T cells
C FSE  lab elled  T  ce lls  (1 0 5) w ere com bined  w ith  au to logou s D C s (1 0 4) that had been  
p rev iou sly  stim ulated  w ith  w ild  type or IpxA- N. meningitidis (1 0 7 organ ism s/m l), 
LPS (1 0  n g /m l) or m edium  alone. A fter 5 days the ce lls  w ere restim ulated  for 6 
hours w ith  P M A  and ion om ycin  in the p resen ce o f  brefeld in  A , fo llo w ed  b y  
perm eabilisation  and intracellular stain ing for IFNy and IL-2. C e lls  w ere stained w ith  
C D 3 Tri co lo r®  and 2 0 ,0 0 0  events in the C D 3 + gate w ere co llec ted  b y  f lo w  
cytom etry. D ata are representative o f  8 experim ents. The percentage o f  p o sitiv e  ce lls  
in each  quadrant is g iven .
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These experiments showed little difference in cytokine production by T cells cultured 
with DCmedium» D C wt or D C lpxa- However these studies used unfractionated CD3+ 
cells, which included CD4+, CD8+, CD45RA+, and CD45RO+T cells, many of which 
were precomited to specific cytokine production (i.e. IL-2/IFNy). The unique 
function of DCs as professional antigen presenting cells is their ability to prime and 
activate naive T cells. The logical next direction was therefore to investigate the 
ability of DCs to prime and activate naive T cells after stimulation with N. 
meningitidis.
5.3.3 Dendritic cell activation of naive helper T cells
DCs that had previously been stimulated with N. meningitidis were cultured with 
purified CD4+ CD45RA+ T cells at ratios from 1:10 to 1:80 DC:T cell. After 5 days 
proliferation was determined by 3H -thymidine incorporation and liquid scintillation 
counting. Prostaglandin E2 (PGE2) was also used to stimulate DCs before culture 
with naive T cells as a control for Th2 induction, since PGE2 stimulated DCs are 
known to promote a Th2 response by naive T cells (Hilkens C.M. et al., 1995).
DCs induced proliferation of naive T cells at DC:T cell ratios of 1:10 and 1:20. 
D C wt and D C lpxa both induced greater T cell proliferation than DCs cultured in 
medium alone. DCs stimulated with PGE2 did not increase T cell proliferation above 
that induced by D C medium (Fig 5.10).
147
Chapter 5 T Cell Interactions with Dendritic Cells Activated by Neisseria meningitidis
25000
20000
15000 -5
Q.O 10000
5000 -
10 20 40 80
T cells /D C
LPXA
Medium
— T cells alone
Figure 5.10 Proliferation of naive T cells after culture with DCs
P urified  C D 4 +C D 4 5 R A + T ce lls  (1 0 5) w ere cultured w ith  D C s at D C :T  cell ratios o f  
1:10 to 1:80. D C s w ere p rev iou sly  stim ulated  w ith  N. meningitidis w ild  type or IpxA- 
(1 0 7 organ ism s/m l), purified  m en in gococca l LPS (1 0  n g /m l), Prostaglandin E2 (10' 
6 M ) or in m edium  alone. Proliferation w as m easured b y  3H -thym id ine uptake after 5 
days. R esu lts  are exp ressed  as the m ean counts per m inute (C P M ) o f  triplicate 
cultures. D ata are from  on e representative experim ent.
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Naive T helper cells can develop into a Thl, a Th2 or a ThO phenotype upon 
stimulation. Various different methods were tried to determine the effects of DCs 
activated with N. meningitidis on naive T helper cell development, the most 
successful of which was the method adapted from (de Jong E.C. et al., 2002). 
Purified naive CD45RA+ T cells (2 x 104) were cultured with DCs (5 x 103) 
previously stimulated with wild type or IpxA- N. meningitidis, purified 
meningococcal LPS, PGE2 or in medium alone, together with super antigen SEB. 
The initial culture period with DCs and SEB is to polarise naive Th cells, followed 
by an expansion of these cells in IL-2. Cells were restimulated with PMA and 
ionomycin for 6 hours in the presence of brefeldin A before intra cellular cytokine 
staining for IL-4, IL-13 and IFNy (Fig 5.11).
Naive T cells cultured without DCs produced very little cytokine upon restimulation 
with PMA and ionomycin (Fig 5.11). T cells that were cultured with D C medium 
produced cytokines ( IL-4, IL-13 & IFNy) upon restimulation. T cells cultured with 
D C wt produced more Thl cytokine (IFNy) and less Th2 cytokines (IL-4 & IL-13) 
compared to T cells that were cultured with DCmedium- In contrast D C lpxa and D C lps 
induced a T cell profile similar to that of the DCmedium- PGE2 is known to induce Th2 
polarising effects and was used as a control (Fig 5.11 & 5.12). T cells cultured with 
DCs stimulated by PGE2 produced more Th2 cytokines and less Thl cytokines than 
the medium control. A summary of 10 independent experiments is shown in Figure 
5.12.
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Figure 5.11 IL-4 and IFNy production by naive CD45RA+ T cells after culture 
with activated dendritic cells
D C s (5 x  103) stim ulated  w ith  w ild  type or IpxA- N. meningtidis, purified  L PS, PG E - 
2 or m edium  a lon e w ere cultured w ith  purified C D 4 +C D 4 5 R A + T ce lls  (2  x  104) in  
the presence o f  super antigen SE B  for fiv e  days and then expanded  in IL-2 for a 
further 10 days. T he ce lls  w ere then restim ulated for 6 hours w ith  P M A  and 
io n o m y cin  in the p resence o f  brefeld in  A  fo llo w ed  b y  perm eabilisation  and 
intracellular sta in ing for IL-4 and IFNy. D ata are a representative o f  10 experim ents; 
the p ercentages o f  p o sitiv e  ce lls  in the quadrants are g iven .
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Figure 5.12 Bar charts representing cytokine production by naive CD45RA+ T 
cells after culture with dendritic cells.
DCs (5 x 103) stimulated with wild type or IpxA- N. meningtidis, purified LPS, PGE-
2 or medium alone were cultured with purified CD4+CD45RA+ T cells (2 x 104) in 
the presence of super antigen SEB for five days and then expanded in IL-2 for a 
further 10 days. The cells were then restimulated for 6 hours with PMA and 
ionomycin in the presence of brefeldin A followed by permeabilisation and 
intracellular staining for IL-4, IL-13 and IFNy. Data are expressed as the mean and 
SEM of 10 separate experiments, p < 0.05 compared to the medium control (*) and 
wild type N. meningitidis (**) are given (paired student t-test).
151
Chapter 5 T Cell Interactions with Dendritic Cells Activated by Neisseria meningitidis
TH2 IL-4 TH1 IFNy
p < c os d c w t
DCLPX^
DCMecSum
30 10 10 30 50 70
% positive
TH2 IL-13 TH1 IFNy
DCWT
DC iPX/K
DC Medium
30 10 10 30 50 70
% positive
*  P values compared with medium control
* *  P values DC PGe2 compared with DCwt
152
Chapter 5 T Cell Interactions with Dendritic Cells Activated by Neisseria meningitidis
5.4 Discussion
Dendritic cells have the capacity to stimulate T cells in both allogeneic and 
autologous combinations (Crow M.K. et al., 1982)(Scheinecker C. et al., 1998). This 
stimulatory capacity is much greater than that of other antigen presenting cells such 
as B cells and macrophages (Crow M.K. et al., 1982). In autologous combinations, 
DCs stimulated with wild type or IpxA- N. meningitidis enhanced T cell proliferation 
compared to DCs cultured in medium alone. The increase in T cell proliferation in 
culture with DCs stimulated with bacteria maybe due to the increase of peptide 
loaded MHC molecules on the surface of DCs interacting with the TCR on T cells 
and/or an increase in co-stimulatory molecules on the DCs interacting with CD28 on 
T cells (Bouloc A. et al., 2000) (Howland K.C. et al., 2000) (Scheinecker C. et al., 
1998). This is supported by experiments that showed DCs stimulated with wild type 
or IpxA- N. meningitidis had increased surface expression of HLA DR molecules and 
B7 co-stimulatory molecules CD80 and CD86 (Fig 3.1, chapter 3). The interactions 
of co-stimulatory molecules on DCs with those on T cells is important for T cell 
stimulation and activation, (i.e. CD80/CD86 on DCs interacting with CD28 on T 
cells) (Bouloc A. et al., 2000) (Howland K.C. et al., 2000) (Scheinecker C. et al., 
1998)(Wells A.D. et al., 1997). CD40-CD40L interactions have also been shown to 
play an important role in T cell stimulation. (Howland K.C. et al., 2000), and an 
increase in CD40 expression by DCs was observed following stimulation with N. 
meningtidis.
Initial experiments to investigate T cell proliferation used 3H-thymidine 
incorporation. This is a commonly used technique to measure proliferation of in vitro 
cell cultures and gives an overall indication of cell division within the culture during
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the period that 3H-thymidine is added. However, this method gives no information on 
individual cell populations and only cells that divide within the pulse time are 
detected. One failing of the 3H-thymidine method is that all the cells dividing in the 
pulse time will incorporate the same amount of 3H-thymidine as half of the cells 
dividing twice in the same time. It is therefore impossible to know precisely how 
many cells have divided and at what rate division occurs (Lyons A.B. et al., 1994). 
An alternative method is labelling with CFSE as it documents all of the divisions that 
occur during the culture period, and each generation of cells can be identified.
The overall results obtained with CFSE staining were similar to those observed by 
3H-thymidine incorporation but this technique provided additional information. The 
CFSE staining revealed that a small population of T cells cultured with DCs divided 
many times, as opposed to the whole T cell population dividing just a few times 
during the culture period. This was seen for T cells in both autologous and allogeneic 
combinations. In contrast, T cells stimulated with PHA were shown to form many 
peaks of decreasing CFSE labelling. The reason for the different profiles obtained 
with MLR and PHA is not clear. Most of the T cells enter into at least one division 
with PHA, but it is not known if T cells stop after a certain number of divisions or if 
there is a delay in T cells entering division with PHA stimulation to form these 
characteristic peaks of division.
DCs stimulated with wild type N. meningitidis at 10 , 10 and 10 organisms/ml 
induced T cell proliferation significantly above controls with D C mediuin. DCs 
stimulated with IpxA- at 107 organisms/ml also induced induced significant T cell 
proliferation compared to controls. Whereas DCs stimulated with 105 or
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106 organisms/ml of IpxA- did not induce significant T cell proliferation. This is 
consistent with DC maturation observed in chapter 3. The wild type N. meningitidis 
induced DC maturation at concentrations as low as 105 organisms/ml, where as at 
low concentrations (less than 106 organisms/ml) IpxA- was shown not to activate 
DCs.
Both CD4+ and CD8+ T cells were found to proliferate in combination with DCs. As 
might be expected, the proliferating T cells expressed the IL-2 receptor (CD25+) and 
CD45RO, an activation marker found on effector/memory T cells, and were negative 
for CD45RA. Since purified CD45RA+ T cells were shown to proliferate following 
stimulation by DCs (Fig 5.10), it is likely that CD45RA+ T cells convert to a 
CD45RO+ phenotype following stimulation. There was no detectable difference in 
expression of surface markers on T cells cultured with DCs in autologous or 
allogeneic combinations or when DCs were stimulated with wild type or IpxA- N. 
meningitidis. However some of the proliferating T cells responding to D Q pxa were 
CD45RA+. These may have been double positive cells as only 0.5% of proliferating 
cells were negative for CD45RO.
Naive CD4+ T cells have the potential to differentiate into IFNy producing (Thl) or 
IL-4 producing (Th2) cells. It has been suggested that a third signal is needed for T 
cell polarisation (Kalinski P. et al., 1999). It was not possible to use antigen specific 
T cell responses alone to investigate cytokine responses in naive T cells, as the 
number of antigen specific naive T cells is too small. Therefore to investigate 
cytokine responses in naive T cells a system was used where engagement of the TCR 
by allogeneic MHC surrogated the peptide specific response. This signal was further
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enhanced by the binding of super antigen SEB. This is signal 1 from the 3 signal 
hypothesis (Kalinski P. et al., 1999). Signal two is produced by co-stimulatory 
molecules and is dependent on the maturation state of the DCs induced by pathogen 
stimulation. The third polarising signal is not fully understood, but is also thought to 
be pathogen specific and produced by the DCs. IL-12 is a known Thl stimulator. 
Individuals with a mutation in their IL-12 receptor have impaired Thl responses and 
are prone to infections by intracellular bacteria (de Jong R. et al., 1998). Studies with 
neutralising antibodies (Giacomini E. et al., 2001) and knockout mice (MacDonald 
A.S. et al., 2002a) have also shown IL-12 is essential for good Thl development. 
IL-18 and type 1 interferons (IFNa/p) are also factors involved in Thl development 
(Giacomini E. et al., 2001). Wild type N. meningitidis is a strong inducer of DC 
maturation and IL-12 production (as shown in Chapter 3). This could explain the Thl 
biased response in naive T cells activated by D C w t-  The LPS deficient IpxA- does 
induce DC maturation but without IL-12 production (section 3.3.3). The T cell 
response to D Q pxa  was similar to that induced by D C medium with neither a Thl or Th2 
bias. Purified meningococcal LPS also induced DC maturation without IL-12 
production, and the naive T cell response to D C lp s  was also neither a Thl nor a Th2 
response, but similar to that of T cells cultured with D C medium- In contrast D C p g e 2 did 
induce a Th2 bias in responding T cells. Interestingly, PGE2 increased DC surface 
marker expression, including co-stimulatory molecules and HLA-DR, but there was 
no stimulate detectable DC cytokine production (Chapter 3).
The DC signal for Th2 development is not clear, though several co-stimulatory 
molecules including CD28-CD80/CD86 and CD40-CD40L are known to play a role 
(de Jong E.C. et al., 2002). Th2 responses have been considered to be a default
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process that occurs when T cells are stimulated without Thl inducing cytokines. 
Consistent with this hypothesis, Leishmania major usually induces a Thl response, 
but results in a Th2 response in IL-12 knock out mice (Mattner F. et al., 1996). In 
contrast it has been shown that an extract from a filarial worm will induce a Th2 
response in vitro in the presence of IL-12 (Whelan M. et al., 2000). Also IL-12 knock 
out mice infected with non-lethal doses of Toxoplasma gondii or Mycobacterium 
avium were found not to develop a Th2 response (Jankovic D. et al., 2002). This 
suggests that a Th2 response is not the default pathway occurring in the absence of 
IL-12 and might explain why DCs stimulated with IpxA- expressed high surface 
MHC and co-stimulatory molecules and produced inflammatory cytokines, but not 
IL-12, did not a induce a strong Thl nor a Th2 response.
Though significant, the changes in T cell cytokine production between those 
stimulated with D C w t,  D C p g e 2 and DCmediUm were not large. There are several 
potential explanations for this. Firstly variation between individual donors may 
disguise the overall effect. Responses of some individuals are naturally biased 
towards Thl whilst others are Th2 biased (Hammad H. et al., 2001). Also other 
cytokines, such as IL-18 and IFNa, produced by DCs may be involved in inducing a 
Thl response but these were not measured. It is important to note however, that 
although these differences between DCs stimulated in different ways were not large, 
they were reproducible. Also published literature using similar techniques have 
found noteable but not large differences in T cell differentiation (de Jong E.C. et al., 
2002).
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In summary we found that DCs activated with the wild type N. meningitidis 
stimulated T cells to proliferate and induced a Thl biased response in naive T cells, 
whereas DCs stimulated with IpxA- induced T cell proliferation but not a Thl 
response. The lack of polarisation seen with IpxA- or LPS stimulated DCs is probably 
a consequence of the low or absent IL-12 production by these DCs.
158
Chapter 6 Dendritic Cell Expression of Toll-Like Receptors (TLRs)
Chapter 6
Dendritic Cell Expression of Toll-Like Receptors
(TLRs)
6.1 Introduction.................................................................................................. 161
6.2 Methods........................................................................................................ 163
6.2.1 Staining of blood leukocytes and DCs with polyclonal antibodies 
against TLRs 1-4......................................................................................163
6.2.2 Intracellular staining for TLRs in dendritic cells............................  164
6.2.3 TLR polymorphisms........................................................................165
6.2.4 Monocyte TNFa production in response to LPS.............................. 166
6.3 Results...........................................................................................................168
6.3.1 Expression TLRs by blood leukocytes............................................. 168
6.3.2 Expression of TLRs on the surface of dendritic cells.....................  168
6.3.3. Surface expression of TLRs on dendritic cells following stimulation 
with N. m eningitid is................................................................................. 170
6.3.4 Intracellular TLR staining in dendritic cells................................... 170
6.3.5 TLR 4 polymorphism...................................................................... 177
6.3.5.3 Detection of the TLR 4 polymorphism by PCR and enzyme 
Digestion..............................................................................................................177
6.3.5.4 effect of TLR 4 polymorphism on monocyte responses to LPS 
andM meningitidis............................................................................................ 179
6.4 Discussion.................................................................................................. 181
159
Chapter 6 Dendritic Cell Expression of Toil-Like Receptors (TLRs)
6.1 Introduction
The recent discovery of the Toll-Like Receptor family (TLRs) has transformed our 
understanding of the recognition of pathogens by the innate immune system. Since the 
discovery of this family, much work has been done to characterise ligands that activate 
TLRs. Many different molecules expressed by pathogens have been found to signal 
through various TLRs, including LPS, lipoproteins, bacterial DNA and flagellin, though 
much of this work has been performed on transfected cell lines.
Human myeloid DCs have been shown to express mRNA for TLRs 1, 2, 3, 4, 5, 6, 8 
and 10, but not TLRs 7 or 9 (Kadowaki N. et al., 2001)(Visintin A. et al., 2001). Studies 
using transfected HeLa cells have shown that both TLR4 and TLR2 are important for 
the recognition and signalling of wild type N. meningitidis. However the LPS deficient 
IpxA- organism however was found to signal through TLR2 and not TLR4 (Ingalls R.R. 
et al., 2001)(Pridmore A.C. et al., 2001). These findings suggest that TLR2 and TLR4 
are both likely to be involved in DC recognition of N. meningitidis.
Due to the lack of antibodies for many of the TLR family members, much of the work 
analysing expression in primary cells has been by PCR or Northern blots to detect 
mRNA. Though mRNA levels can be a good indicator of protein, the correlation is not 
always clear. Factors such as mRNA stability and post translation modification may 
effect over all protein levels. Also detection of mRNA in cells does not give any clues 
as to the eventual location of the protein. The development of polyclonal antibodies 
specific for TLRs 1-4 by colleagues at GSK meant that expression of TLRs by DCs 
could be investigated at the protein level.
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There is a naturally occurring polymorphism in the human tlr4 gene, which is known to 
disrupt TLR4-mediated responses to E. coli LPS (Arbour N.C. et al., 2000). This 
polymorphism was used to further investigate the functional role of TLR4 signalling in 
response to N. meningitidis. The polymorphism consists of two point mutations in the 
Human TLR4 gene that co-segregate. The first is a substitution of A (adenine) to G 
(guanine) resulting in amino acid 299 changing from aspartic acid to glycine. The 
second is a cystine to thymine change, resulting in a change from threonine to 
isoleucine at amino acid 399. Both mutations are in the fourth exon of TLR4, which 
codes for part of the extra cellular domain. These polymorphisms were found to occur 
with an allelic frequency of 6.6% in the studied population (Arbour N.C. et al., 2000). 
Individuals with this phenotype had an impaired response to inhaled LPS. Moreover 
THP-1 cells transfected with mutated TLR4 Asp299Gly had impaired NFxB signalling, 
though the Thr399Ile had no effect (Arbour N.C. et al., 2000). Unlike the mouse TLR4 
mutation that is in the intracellular TIR domain, the human TLR4 polymorphisms occur 
in the extracellular region and their ability to disrupt TLR4 signalling is not yet 
understood.
This next chapter aims to investigate TLR expression on dendritic cells and the 
relevance for responding to N. meningitidis in individual with the TLR4 polymorphism 
Asp299Gly.
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6.2 Methods
6.2.1 Staining of blood leukocytes and dendritic cells with polyclonal antibodies 
against Toll-Like Receptors 1-4
There are few commercially available antibodies against the TLR family. Dr. Ginnette 
Squires and her team at GSK have produced and affinity purified rabbit polyclonal 
antibodies to human TLRs 1, 2, 3 and 4 raised against TLR peptides. The peptides used 
for immunisation mapped to the following sequences within the extra cellular domain of 
each TLR (table 6.1). The specificity of these antibodies has been proven by ELISA, 
fluorescent immunohistochemistry, Western blotting and specific blocking assays as 
reported (Fenhalls G. et al., 2002).
Position Amino acid Sequence Stock
TLR1 170-194 VLGET Y GEKEDPEGLQDFNTESLHI 50 pg/ml
TLR2 295-321 FRASDNDRVIDPGKVETLTIRRLHIPR 260 pg/ml
TLR3 145-169 KQKNLITLDLSHNGLSSTKLGTQVQ 45 pg/ml
TLR4 223-245 FKEIRLHKLTLRNNFD SLN VMKT 152 pg/ml
Table 6.1 Peptide sequence for human TLR antibody production
Peptide sequences used to produce antibodies against human TLR proteins by rabbit 
immunisation. Antibodies were affinity purified on peptide columns
Antibody for each of the TLRs or rabbit IgG was added at a final concentration of 
10 pg/ml to 200 pi of blood diluted 1:1 in RPMI 1640 or to day 6 monocyte derived 
DCs at 5x105 cells/ml and incubated on ice for 30 minutes. The cells were then washed
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with cold FACS wash and the second layer of FITC or PE conjugated F(ab’)2 goat anti 
rabbit IgG added at 5 pg/ml for 30 minutes on ice in the dark. The samples were washed 
once again with cold FACS wash. Erythrocytes in blood samples were lysed with 1 ml 
Lysing Solution for 1-2 minutes until the samples became translucent. The cells were 
washed again in cold FACS wash followed by fixation in CellFix solution. Fixed cells 
were analysed by flow cytometry on a FACScalibur using CellQuest software. For 
whole blood leukocytes, at least 3000 events were collected within the gate 
corresponding to the forward and side scatter characteristics of monocytes. For DCs at 
least 5000 events within the DC gate were collected.
6.2.2 Intracellular Dendritic Cell TLR staining
Day 6 DCs were fixed in 1 ml of 2% paraformaldehyde in PBS for 15 minutes and then 
permeabilised by washing twice in saponin wash solution (HBSS with 0.1% saponin, 
2mM Hepes buffer and 0.02% Sodium Azide). To block non specific binding DCs were 
incubated with 10% human serum in saponin wash for 15 minutes at room temperature, 
then washed once again in saponin wash and resuspended to 5 x 105 cells/ml and 
transferred in 200 pi aliquots to 5 ml Falcon tubes. TLR antibody or normal rabbit IgG 
was added to each of the tubes at a final concentration of 10 pg/ml and incubated for 
30 minutes at room temperature. DCs were washed twice in saponin wash and the 
second antibody layer of biotinilated F(ab’)2 goat anti-rabbit IgG was added at 5 pg/ml 
for 30 minutes, followed by two further washes with saponin wash. The final layer of 
streptavidin conjugated PE, FITC or cy5 was added for a further 30minutes in the dark 
at room temperature. The DCs were then washed twice in saponin wash, fixed with 
200 pi CellFix and analysed by flow cytometry. At least 5000 events within the DC gate 
were collected.
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Confocal microscopy was also used to analyse intracellular TLR staining. 
Approximately 10 pi (about 5000 DC) of cell suspension stained intracellularly with 
TLR antibodies were dropped on to polylysine coated microscope slides and left to air- 
dry overnight at room temperature in the dark. The cells were mounted with citifluor 
and sealed with a cover slip. Confocal images were obtained using a Leica SP2 
scanning microscope system fitted with appropriate filters sets. Between 10 and 20 
optical sections of approximately 0.5 pm spanning the entire DC were taken. Images 
were projected and superimposed with Leica confocal imaging software.
6.2.3 TLR polymorphisms
Two co-segregating missense mutations in the human TLR 4 gene have been described 
(Arbour N.C. et al., 2000). Of these polymorphisms, the Asp299Gly interrupted TLR4- 
mediated LPS signalling. A screen for this mutation was performed on blood samples 
from 50 healthy volunteers using a simple PCR (Polymerase Chain Reaction) based 
method and restriction enzyme digest. DNA was extracted using a QIAamp Blood mini 
kit from 200 pi samples of blood collected by venesection, according to the 
manufacturer’s instructions. Genomic DNA was amplified by PCR using 12.5 pi of 
aqueous DNA (approximately 10 ng/pl), 0.75 pi of each of the primers, 5 pi of dNTP 
mix (2 mM each of dATP, dCTP, dGTP, and dTTP) 5 pi of 10X PCR buffer, 3 pi of 
MgCL, 0.5 pi AmpliTaq Gold DNA polymerase, and sterile water to make the volume 
up to 50 pi. PCRs were carried out at 94 °C for 5 minutes, followed by 35 cycles of 
94 °C for 1 minute, 55 °C for 1 minute and 72 °C for 1 minute. These cycles were 
followed by a final extension step of 72 °C for 10 minutes. Primer pairs designed
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specifically to incorporate the 896-nucleotide substitution were ordered from Sigma- 
Genosys
Forward GAAATGAAGGAAACTTGGAAAAGTT
Reverse CATTTGTCAAACAATTAAATAAGTCAATAGTA
The presence of PCR product was confirmed by running 5 pi of product with 1 pi of 
loading dye on a 2% agarose gel containing 0.5 pg/ml ethidium bromide in IX TBE 
running buffer for 1 hour. The gel was visualised under UV light.
Enzyme digests were carried out in 20 pi reactions with 14.6 pi of amplified PCR 
product, 0.4 pi BSA, 1 pi of Rsa 1 enzyme and 4 pi of corresponding buffer. The 
reaction was incubated at 37 °C for 2 hours. Products were analysed by running 15 pi of 
enzyme product with 3 pi of loading dye along side 15 pi of un-cut PCR product on a 
2% agarose gel containing 0.5 pg/ml ethidium bromide in IX TBE running buffer for 
1 hour. The gel was visualised under UV light.
6.2.4 Monocyte TNFa and IL-6 production in response to LPS
The function of the TLR4 polymorphism was tested by monocyte responses to LPS 
using a whole blood assay (Uronen H. et al., 2000). One ml of blood was taken by 
venesection from TLR4 Asp299Gly and healthy human volunteers known not to have 
this polymorphism. The blood was transferred to a heparinized 15 ml sterile falcon tube 
(10 IU/ml sodium heparin) and diluted in an equal volume of RPMI-1640 medium. The
n
cells were stimulated with 10 organisms/ml of N. meningitidis wild type or IpxA-, or
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with 10 ng/ml purified meningococcal LPS in the presence of brefeldin A (10 pg/ml) 
for 4 hours at 37 °C. Intracellular TNFa and IL-6 was detected as in section 2.3.6.
6.3 Results
6.3.1 Expression of TLRs by blood leukocytes
Blood leukocytes were stained with polyclonal rabbit antibodies against human TLRs 1, 
2 and 4. Following lysis of erythrocytes, cells were analysed on the FACScalibur and 
the different populations gated on forward and right angle scatter (Fig 6.1).
In preliminary experiments gate R1 was shown to contain mainly CD14+ cells 
(monocytes), gate R2 to contain CD3+ and CD19+ cells (T and B lymphocytes) and gate 
R3 to contain CD66a+ cells (neutrophils). Monocytes and neutrophils (gates R1 and R3) 
expressed TLR1, TLR2 and TLR4. Whereas some lymphocytes (gate R2) expressed 
very low levels of TLR1 and TLR2, but all were negative for TLR4 (Fig 6.1).
6.3.2 Expression of TLRs on the surface of Dendritic Cells
Day 6 immature Dendritic cells were stained for expression of TLRs 1, 2, 3 and 4 using 
the rabbit polyclonal antibodies and a second layer of PE conjugated F(ab’)2 goat anti 
rabbit IgG. No surface expression of TLRs 1, 2, 3 or 4 could be detected on DCs (Fig 
6.2).
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Figure 6.1 Expression of TLR 1, 2 and 4 on cells in whole blood
W h ole  b lood  w a s stained w ith  polyclon a l antibodies to  T L R s w ith  a PE conjugated  
F (a b ’ )2  goat anti rabbit IgG  secon d  layer. Three d istinct ce ll popu lations w ere identified  
b y  their forward and right angle scatter. E xpression  o f  TL R  1, 2 and 4  are sh ow n  (filled  
histogram s) com pared to  norm al rabbit IgG  used  as a control (so lid  lines). D ata are a 
representative o f  3 independent experim ents.
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Figure 6.2 Surface staining for Toll Like Receptors on dendritic cells
D a y  6 im m ature D C s w ere stained w ith  p o lyc lon a l antibodies to T L R s 1, 2 , 3 and 4  
w ith  a PE conjugated secon d  layer. D C s w ere gated  according to s ize  and granularity. 
E xp ression  o f  T L R s 1, 2 , 3 and 4  are sh ow n  (filled  h istogram s) a lon g  w ith  norm al rabbit 
IgG  used  as a control (so lid  lines). D ata are a representative o f  6 independent 
experim ents.
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6.3.3 Surface expression of TLRs on dendritic cells following stimulation with N.
meningitidis
There have been some reports that DC TLR expression changes following stimulation 
(Visintin A. et al., 2001). To determine whether this could explain the absences of TLRs 
on immature DCs, DCs were stained for expression of TLR2 and TLR4 after activation. 
There was no surface expression of TLR2 or TLR4 following stimulation with N. 
meningitidis wild type, IpxA- or purified meningococcal LPS (Fig 6.3).
6.3.4 Intracellular TLR staining in dendritic cells
No significant TLR expression was detected on the surface of DCs, however mRNA 
analysis has shown that DCs do express RNA for TLRs 1-5 (Thoma-Uszynski S. et al.,
2000)(Visintin A. et al., 2001). Also there have been reports of intracellular TLR 
expression in epithelial cells and macrophages. This suggests that TLRs may be 
expressed internally by DCs. To see whether TLR expression could be detected 
intracellularly, immature monocyte derived DCs were fixed in 2% paraformaldehyde 
and permeabilised with saponin and stained with the rabbit polyclonal antibodies for 
TLRs 1-4.
DCs were found to express intra cellular TLRs 1, 2, 3 and 4 by flow cytometry (Fig 
6.4). Activation of DCs with N. meningitidis had no effect on the intracellular 
expression of TLRs 1, 2, 3 and 4 as measured by FACS (data not shown).
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T h e location  and distribution o f  the TLR s w ith in  D C s w a s investigated  b y  confocal 
m icroscop y . Strong intracellular stain ing o f  T L R s 1, 2 , 3 and 4  in D C s w as observed  by  
c o n fo ca l scanning m icroscop y. W ith all the T L R s the sta in ing appeared to be 
throughout the cytop lasm  w ith  areas o f  h igh  d en sity  found in the para-nuclear region, 
e sp e c ia lly  w ith  TLR  4  (F ig  6 .5).
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Figure 6.3 TLR expression in dendritic cells following stimulation with N.
meningitidis
D a y  6 im m ature D C s w ere cultured for 6 hours in the presence o f  m edium  alone,
10 n g/m l o f  purified m en in gococca l L PS, or 107 organ ism s/m l o f  w ild  type or IpxA- N. 
meningitidis. The ce lls  w ere then stained w ith  p o lyclon a l antibodies for T L R s 2 and 4  
w ith  a PE conjugated secon d  layer. E xpression  o f  T L R s fo llo w in g  stim ulation  (filled  
h istogram s) is  com pared to D C s cultured in m edium  alone (so lid  lines). D ata are 
representative o f  5 independent experim ents.
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Figure 6.4 Intracellular staining for Toll Like Receptors in DCs
D a y  s ix  im m ature D C s w ere fixed  in 2% paraform aldehyde, perm eabilised  w ith  saponin  
and stained w ith  p o lyc lon a l antibodies to  TLR s 1 , 2 , 3  and 4  fo llo w ed  b y  a secon d  layer  
o f  b iotin ilated  F (ab ’ )2  goat anti rabbit IgG and b y  streptavidin conjugated PE. D C s w ere  
gated  accord ing  to  s ize  and granularity. E xpression  o f  T L R s 1, 2 , 3 and 4  are show n  
(filled  h istogram s) a long w ith  norm al rabbit IgG  u sed  as a control (so lid  lines). D ata are 
a representative o f  6 independent experim ents.
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Figure 6.5 Intracellular dendritic cell expression of TLRs
Day 6 immature DCs were fixed in 2% paraformaldehyde, permeabilised with saponin 
and stained with polyclonal antibodies to TLRs 1, 2, 3 and 4 followed by a second layer 
of biotinilated F(ab’)2 goat anti rabbit IgG and then streptavidin conjugated FITC. 
Normal rabbit IgG was used as a control. Staining is throughout the cytoplasm for all 
TLRs, with areas of high density found in the para-nuclear region (white arrows). Data 
are a representative of at least 6 independent experiments.
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Figure 6.6 TLR expression in dendritic cells after phagocytosis of N  meningitidis 
Day 6 DCs were incubated with 108 organisms/ml of FITC labelled wild type N. 
meningitidis (green) for 2 hours. The DCs were fixed in 2% paraformaldehyde 
permeabilised with saponin and stained with polyclonal antibodies to TLRs 2 & 4 and 
then a second layer of biotinilated F(ab’)2 goat anti rabbit IgG followed by streptavidin 
conjugated cy5 (red).
17 A
Chapter 6 Dendritic Cell expression o f  Toll-Like Receptors (TLRs)
TLR 2
TLR 4
Chapter 6 Dendritic Cell Expression of Toll-Like Receptors (TLRs)
To investigate the intracellular TLR location and distribution in relation to
O
phagocytosed bacteria, DCs were stimulated with 10 organisms/ml of FITC labelled 
wild type N. meningitidis and TLR expression examined by confocal microscopy. As 
shown in Fig 6.6, there was wide a distribution of the FITC labelled bacteria and TLRs 
2 and 4 inside the DCs. However there was no evidence of co-localisation as would be 
indicted by yellow colour in merged images (Fig 6.6).
6.3.5 TLR 4 Polymorphism
In order to investigate the potential role of TLR4 in N. meningitidis recognition and 
signalling the functional human TLR4 polymorphism was investigated.
6.3.5.1 Detection of theTLR4 polymorphism by PCR and enzyme digestion
The Asp399Gly polymorphism in tlr4 was detected using simple PCR followed by 
restriction enzyme digestion. The PCR was designed so that the product would 
incorporate a restriction enzyme site for Rsa 1 only if the original DNA template 
contained the TLR4 polymorphism. Prior to digestion, the PCR product was 138 base 
pairs (bp). When the polymorphism was present, digestion with Rsal resulted in a 
product of 118 bp and a 20 bp fragment that was lost from the gel.
Individuals without the polymorphism were identified by the presence of a single band 
at 138 bp (lanes 1-5, 7-11 & 13 Fig 6.7). Heterozygous individuals had two bands seen 
at 138 bp and 118 bp (lanes 6, 12&14 Fig 6.7). Homozygous individuals would have 
one band at 118 bp assuming complete digestion but none were found in the population 
studied.
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Figure 6.7 Detection of the tlr4 polymorphism by restriction enzyme digestion
The reg ion  contain ing the T LR 4 polym orphism  w a s am plified  b y  PC R , fo llo w ed  b y  
restriction en zym e d igestion  b y  R s a l. The P C R  product w as 138 bp and the d igested  
product, w h en  the p olym orphism  w as present, w a s 118bp (w h ite  arrow s). The d igested  
fragm ent o f  20bp  w as n ot seen. O dd num bered lanes contain  PC R  product before  
d igestion , ev en  num bered lanes contain the en zy m e d igest product.
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Of the 50 healthy adult human volunteers analysed for this TLR4 polymorphism, 4 
heterozygous individuals for polymorphism Asp399Gly were identified. This 
corresponds to an allelic frequency of 4%, which compares with the allelic frequency of 
3.3-7.9% described in the literature (Arbour N.C. et al., 2000).
6.3.5.2 Effect of TLR4 polymorphism on monocyte responses to LPS and N.
meningitidis
The functionality of the TLR4 polymorphism was tested by monocyte cytokine 
production in response to LPS or N. meningitidis bacteria. Whole blood collected from 
Asp299Gly individuals and from healthy volunteers known not to have the 
polymorphism was cultured with 107 organisms/ml wild type or IpxA- N. meningitidis, 
or with 10 ng/ml purified meningococcal LPS for 4 hours. Intracellular TNFa and IL-6 
production was measured in CD14+ monocytes (Fig 6.8)
There was no detectable difference in cytokine production by monocytes from 
individuals with the TLR polymorphism compared to wild type controls in response to 
purified meningococcal LPS or the wild type N. meningitidis (fig 6.8). However the 
response to IpxA- was more varied between the controls, with 2 out of 3 individuals 
having a response lower than the polymorphic individuals (Fig 6.8).
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Figure 6.8 Effect of TLR4 Asp399Gly polymorphism on TNFa and IL-6 
production in monocytes
W h ole  b lood  from  individuals w ith  and w ith  out the T L R 4 polym orphism s w as cultured  
w ith  107 organ ism s/m l o f  w ild  type or IpxA- N. meningitidis, purified  m en in gococca l 
LPS (10  n g /m l) or in m edium  alone for 4  hours. F o llo w in g  erythrocyte ly s is , c e lls  w ere  
stained for intracellular T N F and IL -6 production. A t least 3 0 0 0  even ts w ere co llec ted  
in the C D 1 4 + gate. D ata are representative o f  3 ind iv idual experim ents.
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6.4 Discussion
The first part of this chapter describes TLR expression in DCs and other cells. 
Monocytes were found to express surface TLR1 TLR2 and TLR4, agreeing with other 
studies although expression can be highly variable between different donors, ranging 
from undetectable levels to a few thousand TLR4 molecules per cell (Visintin A. et al., 
2001). Neutrophils were found to express surface TLRs 1, 2 and 4, whilst lymphocytes 
expressed very low levels of these molecules. These findings are consistent with mRNA 
analysis of TLR expression which found PMNs and monocytes expressed TLRs 1, 2, 3,
4 & 5, and T cells, B cells and NK cells only expressed low levels of TLR1 mRNA 
(Muzio M. et al., 2000a)(Muzio M. et al., 2000b).
TLR expression has been studied during the differentiation of DCs from monocytes in 
culture with GMCSF and IL-4. During differentiation, mRNA levels for TLRs 1, 2, 4 &
5 decreased, whilst mRNA levels of TLR3 and MD-2 increased (Thoma-Uszynski S. et 
al., 2000)(Visintin A. et al., 2001). RNA levels of TLRs in immature DCs have been 
reported to increase transiently following activation in the first 3 hours after which 
mRNA levels decreased (Visintin A. et al., 2001). In the absence of appropriate 
antibodies, surface expression of DC TLRs has not been generally described. Using 
polyclonal TLR antibodies raised against peptides, no surface expression for any of the 
TLRs tested could be detected on DCs (Figs 6. and 6.). Furthermore no surface TLR2 or 
TLR4 expression was detected on DCs following stimulation with wild type or IpxA- N. 
meningitidis or purified meningococcal LPS.
The lack of detectable surface TLRs on immature and activated DCs described here 
together with the many reports of TLR mRNA expression in DCs as well as reports of
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intracellular TLR detection in other systems (Hornef M.W. et al., 2002) (Underhill D.M. 
et al., 1999) led to the investigation of intracellular TLRs in DCs. Intracellular TLR 1, 
2, 3 and 4 were all readily detected in DCs by FACS analysis. By comparison 
lymphocytes, which were also negative for surface TLRs, did not express any 
intracellular TLRs (data not shown). Confocal imaging revealed that TLR staining was 
present throughout the cytoplasm in a vesicular pattern. There were concentrated areas 
of staining in a para-nuclear location, particularly with TLR4. Intracellular TLR4 
concentrated around the Golgi has been detected in epithelial cells, monocytes and 
transfected Hek293 cells (Hornef M.W. et al., 2002)(Latz E. et al., 2002). TLR4 
complexed with MD-2 has also been observed to traffic from the Golgi to the plasma 
membrane (Latz E. et al., 2002)(Nagai Y. et al., 2002).
The intracellular localisation of TLR molecules may be fundamental in DC biology. 
DCs rapidly phagocytose and endocytose pathogens. Studies with latex beads have 
shown that phagocytosis is not dependent on a danger signal from the pathogen. 
Phagocytosis of bacteria has also proven to be fundamental in DC cytokine production, 
especially IL-12 (Uronen-Hanson et al 2003). It seems possible that DCs phagocytose 
potential pathogens and then sample the phagosome with TLRs. The DC can then 
mount the appropriate response to the phagocytosed pathogen. This hypothesis was 
tested by confocal imaging of internalised N. meningitidis and TLRs 2 & 4 in DCs. 
Internalised bacteria were found in close proximity to TLRs 2 & 4 but there was no 
evidence for colocalisation which would show up as yellow staining in the merged 
images. This apparent lack of co-localisation between TLRs and the phagocytosed 
bacteria may occur if the contact between TLRs and the bacteria is transient and not 
detectable after 2 hours. Alternatively only a few TLR molecules maybe needed to
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interact with the bacteria in order to signal appropriately. There is also the possibility 
that contact between TLRs and phagocytosed bacteria does not happen. The methods 
used here are not sensitive enough to detect interactions of individual TLRs. Further 
investigations and more sensitive time courses need to be undertaken on order to verify 
these speculations.
Both TLR2 and TLR4 have been shown to play a role in the detection and signalling of 
N. meningitidis (Ingalls R.R. et al., 2000) (Pridmore A.C. et al., 2001). Although TLR4 
signalling has been implicated in the response to N. meningitidis by TLR4 transfected 
cell lines, the role of TLR4 in monocyte or DC responses to N. meningitidis has not 
been investigated. This was approached here by examining responses of monocytes 
with a naturally occurring mutation that has been reported to decrease signalling to LPS. 
The allelic frequency of this polymorphism was found in this study to be 4%, which 
compares well with other studies where allelic frequency ranges between 3.3% and 
7.9% have been reported (Arbour N.C. et al., 2000)(Read R.C. et al., 2001). Of the 50 
healthy volunteers screened, 4 individuals were found to be heterozygous for the 
Asp299Gly substitution.
No difference in the monocyte response to N. meningitidis wild type and purified 
meningococcal LPS was found between those with the Asp299Gly substitution and wild 
type individuals. There are several possible explanations why this TLR4 polymorphism 
does not affect N. meningitidis signalling. The individuals identified with the 
Asp299Gly substitution were all heterozygotes, and may be one copy of the functional 
TLR4 gene is enough in heterozygotes. Though decreased responses to inhaled LPS 
have been observed in heterozygotes (Arbour N.C. et al., 2000). However the decreased
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responses reported were to E. coli LPS, whereas N. meningitidis LPS was used here. It 
is possible that the functional polymorphism affects the binding of E. coli LPS to TLR4 
but has no effect on the binding of LPS from N. meningitidis. The structure of the lipid 
A is thought to determine the interaction of LPS with TLR4, and the structure of N. 
meningitidis lipid A is different to that of E. coli Lipid A (Netea M.G. et al., 2002). A 
study of patients with meningococcal disease found no correlation with the Asp299Gly 
polymorphism and the likelihood or severity of N. meningitidis infections (Read R.C. et 
al., 2001). Extensive genetic studies however, have revealed that not one particular 
TLR4 mutation can be linked to susceptibility or severity of meningococcal disease, but 
collectively significantly more rare TLR4 coding variants were found in patients with 
meningococcal disease than a control population (Smirnova I. et al., 2003). 
Interestingly decreased responses to the LPS deficient IpxA- was seen in two out of 
three individuals without the Asp299Gly polymorphism. The IpxA- bacteria have been 
shown to signal through TLR2. The data here could be explained by other genetic 
differences between individuals, perhaps related to TLR2 or TLR2 adaptor molecules. 
Though genetic studies found no TLR2 variants were over represented in the 
meningococcal patients studied (Emonts M. et al., 2003) (Smirnova I. et al., 
2003).(Emonts M. et al., 2003)
A further explanation for why the TLR4 polymorphism does not affect responses to N. 
meningitidis is that TLR4 is not the major receptor for the detection and signalling to N. 
meningitidis. This explanation could also account for why there was no co-localisation 
observed between TLR4 and phagocytosed N. meningitidis and why the TLR4 
polymorphism has no effect on the outcome of meningococcal disease (Read R.C. et al.,
2001). The studies that have implicated TLR4 in the detection of N. meningitidis have
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been with transfected cell lines, which may not express the receptor, or receptors that 
signal for N. meningitidis. In this case, TLR-4 maybe a secondary receptor that is not 
required for N. meningitidis signalling in the presence of other receptors.
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7.1 Current vaccine strategies
Polysaccharide based conjugate vaccines have offer successful protection against 
group A and C N. meningitidis, the structural homology shared between the group B 
polysaccharide capsule and the glycopeptides of human NCAM have prevented this 
approach for group B organisms. Therefore current vaccine strategies are focussed 
on bacterial proteins rather than the polysaccharide capsule.
Considerable attention has been directed at outer membrane vesicle (OMV) based 
vaccines. OMVs are prepared easily by detergent extraction from meningococcal 
bacterial cells. They contain outer membrane proteins, mainly porins, and can be 
prepared with reduced levels of LPS. The high endotoxicity of LPS means that its 
presence is undesirable in a vaccine because of the potential host response. This 
OMV based approach has been largely unsuccessful as these vaccines only elicit 
strain specific protection and do not offer protection in infants (reviewed (Jodar L. et 
al., 2002)). Vaccine candidates based on conserved antigens are under investigation, 
including the transferrin protein B (TbpB) and the neisserial surface protein A 
(NspA) (Rokbi B. et al., 2000)(West D. et al., 2001).
Vaccine development is a lengthy and costly process. Components of the bacteria 
must be identified and purified before their ability to induce immunity is tested. Even 
if a potential vaccine is identified, its efficacy and safety must be thoroughly 
investigated before a clinical trial is considered. Testing the immunogenicity of 
potential vaccines for group B N. meningitidis is more complicated as it is a human 
specific pathogen with no suitable animal model for disease. Even when a vaccine 
shows potential immunogenicity in an animal model, does not necessarily translate to
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disease protection in humans. Transgenic mice expressing human CD46 have 
recently been described. N. meningitidis binds to human CD46 expressed on 
epithelial cells, leading to bacterial invasion. Thus these transgenic mice are 
susceptible to meningococcal disease and present a potentially useful model for 
investigating the protectiveness of vaccines against disease (Johansson L. et al., 
2003).
7.2 Dendritic cells as an in vitro model system highlights the 
importance of LPS
As an alternative model, activation of human monocyte derived DCs were used to 
investigate the immunogenicity of N. meningitidis and the importance of LPS. 
Although this approach has its limitations, DCs have an advantage in that they are 
involved in all stages of generating an immune response. All of these stages can be 
measured in vitro including inflammatory cytokine production, antigen uptake and 
processing, migration, T cell activation and subsequent B cell antibody production. 
This thesis examined these different stages of DC responses to N. meningitidis. There 
were two main objectives for this work. Firstly to examine aspects of basic DC 
biology, including the role of LPS in DC activation. Secondly to gather useful 
information on which properties of the bacteria might be important for a vaccine.
Monocytes can differentiate into DCs following transendothelial migration into the 
tissues and/or phagocytosis (Randolph G.J. et al., 1998)(Randolph G.J. et al., 1999). 
Following the initial recognition and uptake of bacteria DCs release pro- 
inflammatory cytokines, including IL-1, IL-6 and TNFa. DC activation is further
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enhanced by the local release of pro-inflammatory cytokines by tissues at the site of 
infection. LPS is thought to be the major component of Gram-negative bacteria in 
inducing this pro-inflammatory response. It was found here that wild type N. 
meningitidis induced IL -la, IL-6 and TNFa production in DCs. The LPS deficient 
IpxA- was found to induce some cytokine production, but to a lesser extent than the 
wild type. Thus demonstrating that LPS is important, but is not the only contributing 
factor in this response and other bacterial components are involved.
Following activation and maturation by a pathogen DCs must migrate from the 
peripheral tissues to the draining lymph nodes in order to present antigen to naive T 
cells. This migration is facilitated by changes in DC chemokine receptor expression. 
In vitro experiments here found that a change in chemokine receptor expression from 
CCR5 to CCR7 occurred following stimulation with wild type N. meningitidis, which 
was proven to be functional as these DCs responded to MIP3|3. Stimulation with the 
LPS deficient IpxA- only induced a decrease in CCR5 expression without an increase 
in CCR7 and there was no response to MIP3(3. This would imply that LPS expression 
is required for optimal migration of DCs from the peripheral tissues to the secondary 
lymphoid organs in vivo following N. meningitidis stimulation. The emigration of 
DCs from the tissues would involve their crossing of endothelial layers. This was 
modelled here by using an in vitro HUVEC based system. Optimal DC migration 
required activation of both DCs and endothelium, which is a likely situation during 
N. meningitidis infection.
Following migration to the T cell areas of the secondary lymphoid organs, DCs 
present antigen to T cells. The ability of DCs to activate T cells is fundamental in the
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initiation of an adaptive immune response. The T cell stimulatory capabilities of DCs 
activated by N. meningitidis were assessed here. DCs stimulated with either the wild 
type or IpxA- N. meningitidis both induced T cell proliferation. However differences 
were found in T cell polarisation. DCs stimulated with wild type N. meningitidis 
induced a strong Thl response, demonstrated by IFNy production but with very little 
IL-4. DCs stimulated with IpxA- induced neither a strong Thl response nor a strong 
Th2 response.
T helper cells control the antibody isotype switching in B cells by CD40 ligation and 
cytokine production. Protection against N. meningitidis is ultimately reliant on the 
induction of the correct antibody response. For group A and C organisms IgG2 
antibodies against capsular polysaccharides elicit protection, however IgGl and IgG3 
antibody sub types are protective against group B infections (Pollard A.J. et al., 
1999)(Vermont C.L. et al., 2002). How Th cells activated by DCs in this study will 
influence antibody isotype switching has not yet been addressed.
The requirement of LPS in the bacteria to activate DCs, induce CCR7 expression and 
migration, and to stimulate Th cell polarisation suggest that LPS maybe an important 
component in vaccines to generate effective immune responses against N. 
meningitidis. The findings of this study are consistent with a previous study which 
showed that IpxA- was a poor inducer of bactericidal antibodies compared to the wild 
type N. meningitidis in mice. Interestingly this study found that the response to outer 
membrane complexes (OMCs) derived from the IpxA- organism could be restored to 
wild type OMC responses with the addition of exogenous LPS (Steeghs L. et al., 
1999). However the addition of LPS with heat killed IpxA- whole organisms did not
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enhance the response. One suggested reason for this difference is that the negatively 
charged LPS molecules could associate with the available membrane complexes of 
the OMCs, but could not associate with the membranes of the heat killed 
encapsulated bacteria.
The use of an in vitro system as a model for an immune response to a pathogen does 
have limitations. For example the effects of other cells that are involved in the onset 
of meningococcal disease, including neutrophils, macrophages and endothelial cells, 
are not considered in this situation (Dixon G.L. et al., 1999) (Heyderman R.S. et al., 
1999). Also factors present in serum such as complement, immunoglobulin or 
cytokines are not taken into account (reviewed (Hackett S.J. et al., 2001))(Vogel U. 
et al., 1999). These additional aspects may affect DC interactions with N. 
meningitidis and should be considered in future studies.
7.3 The future for group B N. meningitidis vaccine design
The toxicity of LPS has meant that most vaccine strategies using OMVs or purified 
components of group B bacteria have avoided its inclusion. One approach to this 
problem is to engineer bacteria to express modified LPS that does not have the 
toxicity of wild type LPS. An isogenic mutant of N. meningitidis has been created 
which has the same adjuvant capabilities as the wild type organism but with reduced 
toxicity (van Der L.P. et al., 2001). This mutant IpxLl was created by the insertional 
inactivation of the IpxL gene, which interrupts lipid A acyloxyacylation resulting in 
LPS with a penta- instead of hexa- acylated lipid A. Experiments in mice have shown 
that IpxLl induced equivalent antibody titres to the wild type N. meningitidis but 
reduced TNFa production (van Der L.P. et al., 2001). This mutant should be
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examined in the DC assays described here, and if it activates DCs similarly to the 
wild type bacteria it could potentially be considered as a basis for a vaccine.
Further N. meningitidis LPS mutants have been created by replacing the IpxA gene 
with the equivalent gene from E. coli or P. aeruginosa. In both strains a 10-fold 
reduction in their ability to induce TNFa production was observed, but their adjuvant 
activity compared to the wild type was not affected (Steeghs L. et al., 2002). These 
findings enable the toxicity of LPS to be separated from its adjuvant capabilities. The 
interaction of these organisms with human DCs also needs to be investigated.
The work described here represents a good model for assessing immune function and 
potential vaccine design, although there are other aspects still to be addressed. Most 
notable is the resulting antibody response. DC and T cell interactions with B cells 
following N. meningitidis stimulation needs to be explored as B cell stimulation and 
antibody production represent a fundamental aspect in any long-term protective 
immune response, which is the ultimate goal for a successful vaccine. Interactions of 
the wild type N. meningitidis induced Thl cells and B cells could be assessed for 
antibody isotype switching. The Ig class and subclass of antibody produced by B 
cells following culture with DC activated T cells could be measured along with the 
bactericidal properties of the antibodies.
The H44/76 strain of N. meningitidis was used exclusively in the work presented 
here. This bacterium was isolated from a fatal case of septicaemia, and displays 
many characteristics of meningococci that have entered and survived in the blood 
stream. Including expression of a polysaccharide capsule and LPS with sialyated
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terminal sugars (de Vries F.P. et al., 1996), both of which aid survival in the blood 
stream by conferring resistance to complement and phagocytosis. It is likely, 
however, that newly invaded bacteria encountering DCs in the sub-epithelial stromal 
tissues will not express capsule but may express Opa and Opc, which are crucial in 
inducing bacterial invasion across the nasopharynx endothelium. Future studies using 
this system of assessing DC interactions with N. meningitidis should take into 
account this phase variable proteins and assess their relevance in DC activation.
A successful vaccine for group B meningococcal infections has still not been 
achieved. The recent publication of the complete genome for a group B organism has 
altered the approach to vaccine design (Tettelin H. et al., 2000). The use of PCR and 
cloning techniques allowed for the identification of 29 surface exposed proteins, 
against which antibodies were raised. By assessing these proteins in a variety of N. 
meningitidis strains, epitopes conserved across multiple strains were identified 
(reviewed Adu-Bobie 2003). This novel approach to identifying potential vaccine 
candidates offers promise in the continuing search for a group B vaccine, and the 
ability to assess these candidates promptly and easily in an in vitro DC system may 
well result in a successful vaccine in the near future.
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